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Helicobacter pylori is a major etiological agent of various gastroduodenal 
diseases. Of the known virulence factors of H. pylori, γ-glutamyl transpeptidase 
(GGT) is reported to induce apoptosis in host cells. However, its role in H. pylori 
pathogenesis is still not well characterized. 
H. pylori GGT is a heterodimer consisting of a large and small subunit. 
Cloning, expression and purification of recombinant full length GGT (rGGT), large 
subunit (rGGTL) and small subunit (rGGTS) were carried out. Monoclonal antibodies 
raised against rGGT inhibited the enzymatic activity of H. pylori GGT by up to 93%. 
The neutralizing epitope was identified as 428-GNPNLYG-434 and spans a Tyrosine-
433 containing loop previously reported to be important for catalysis.  
Purified native GGT (nGGT) was found to generate H2O2 through thiol-
dependent iron reduction as treatment with desferrioxamine (an Fe3+ chelator) 
significantly inhibited this effect. GGT was further found to activate NF-κB and 
induce interleukin-8 (IL-8) generation in various cell types including primary human 
gastric cells and macrophages, suggesting a pro-inflammatory effect.  
Intriguingly, GGT was discovered to localize in host cell nuclei as observed 
by transmission electron microscopy, confocal laser scanning microscopy and western 
blot analysis. The internalization of GGT by AGS cells was identified to occur via the 
clathrin-mediated endocytosis pathway. GGT was also demonstrated to co-
immunoprecipitate with importin β1, suggesting that nuclear import of GGT may be 
mediated by importin β1. Indeed, siRNA knockdown of importin β1 significantly 
inhibited the nuclear import of GGT, confirming our hypothesis. Interestingly, nuclear 
localization of GGT coincided with a decrease in the levels of glutathione in the 




H. pylori has been reported to cause cellular vacuolation in host cells, a 
phenomenon attributed to vacuolating cytotoxin and the presence of weak bases. In 
this study, the process of vacuolation was recorded over 24 hours using real-time 
microscopy and it was observed that Δggt induced less vacuolation in AGS cells as 
compared to the parental strain. Vacuolating ability of wild type was also significantly 
reduced in the absence of glutamine while exogenous ammonium chloride rescued the 
ability of Δggt to induce vacuolation as determined by neutral red assay. Hence, this 
indicates that ammonia generated by GGT through glutamine hydrolysis is an 
important contributory factor to vacuolation. 
rGGT was also shown to exhibit potential as a diagnostic marker for H. pylori 
infection as significantly higher anti-GGT antibody levels (P<0.01) were detected in 
H. pylori-positive subjects (n=58) compared to H. pylori-negative controls (n=65). 
This suggests that GGT is capable of provoking an immune response in the host. 
In conclusion, this study has demonstrated the capability of GGT in generating 
H2O2, activating NF-κB and upregulating IL-8 in host cells. Furthermore, GGT is 
endocytosed by gastric cells and subsequently transported into the cell nucleus where 
it depletes nuclear glutathione. In addition, GGT also strongly potentiates vacuolation 
by generating ammonia from glutamine hydrolysis. Taken together, GGT has been 
shown to be a potent virulence factor that ignites multiple pathways leading to host 
cell damage. 
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1.1 Association of Helicobacter pylori and gastroduodenal diseases 
 Helicobacter pylori was first isolated in 1983 from human gastric biopsy 
specimens of patients with active chronic gastritis (Warren and Marshall, 1983). This 
landmark discovery initiated a major revolution in the field of gastroenterology during 
a time when stomach ulcers and gastritis were thought to be caused by excessive acid 
production in the stomach due to stress or the intake of spicy food (Marshall and 
Warren, 1984). Also, it was believed that no bacterium could survive for long in the 
acidic environment of the stomach. Further research then found H. pylori infection to 
be strongly associated with the development of a range of gastroduodenal diseases 
such as peptic ulcer disease (Peterson, 1991), chronic gastritis (Cover and Blaser, 
1992a), mucosa-associated lymphoid tissue lymphomas (Parsonnet et al., 1994) and 
even gastric cancer (De Koster et al., 1994). In 1994, H. pylori was classified as a 
type I carcinogen for gastric cancer by the International Agency for Research on 
Cancer (IARC, 1994). This knowledge led to a major change in the clinical 
management of these diseases where antibiotics were subsequently added into the 
treatment regimen, along with histamine H2 receptor antagonists and proton pump 
inhibitors (Veldhuyzen van Zanten and Sherman, 1994). 
 
1.2 Virulence factors of H. pylori 
 Approximately half of the world’s population is reported to be infected with 
H. pylori (Covacci et al., 1999; Linz et al., 2007). Among these, approximately 10% 
develop peptic ulcer disease while 1-3% eventually develop gastric adenocarcinoma 
(Wroblewski et al., 2010).  
Disease progression largely depends on the virulence of the infecting H. pylori 
strain although host and environmental factors have also been reported to affect 
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clinical outcomes (Shanks and El-Omar, 2009). H. pylori is a highly heterogeneous 
bacterium (Linz et al., 2007; Moodley et al., 2009), having co-evolved with humans 
ever since they migrated out of Africa about 58000 years ago (Moodley and Linz, 
2009). As a result, the virulence of the pathogen has also diverged and bacterial 
virulence factors are likely to play a major role in determining the outcome of H. 
pylori infection. One of the more extensively studied pathogenic factors is cytotoxin-
associated gene A (CagA) where in western countries, individuals infected with cagA-
positive H. pylori strains have a higher risk of developing more severe gastroduodenal 
diseases compared to those infected with cagA-negative strains (Covacci et al., 1993; 
van Doorn et al., 1998). However, in East Asia, where majority of H. pylori strains 
are cagA-positive, the presence or absence of cagA cannot fully account for 
differences in clinical pathologies (Maeda et al., 1998; Zheng et al., 2000). 
The second most extensively studied virulence factor is vacuolating cytotoxin 
A (VacA). Differences in vacA gene structure can be found at the signal (s) region 
(namely s1 and s2), the middle (m) region (m1 and m2) (Atherton et al., 1995) and 
the more recently identified intermediate (i) region which is located between the s and 
m regions (Rhead et al., 2007). Similar to cagA, vacA s1/m1 alleles have been 
strongly associated with peptic ulcer disease and gastric cancer in western populations 
(Atherton et al., 1997; Miehlke et al., 2000) but in East Asia, where strains are mostly 
vacA s1/m1, such correlations were not observed (Yamaoka et al., 1999).  
From these studies, it can be inferred that CagA and VacA are probably not 
the only factors contributing to H. pylori pathogenesis. To date, many other virulent 
determinants have also been identified. Some examples include urease which helps 
neutralize the acidic environment of the stomach (Eaton et al., 1991), flagella which 
confers motility to the organism (Ottemann and Lowenthal, 2002), and various 
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adhesins such as blood group antigen binding adhesin (BabA) (Ilver et al., 1998), 
outer inflammatory protein A (OipA) (Yamaoka et al., 2000) and sialic acid binding 
adhesin (SabA) (Yamaoka, 2008). This study focuses on another important virulence 
factor of H. pylori known as γ-glutamyl transpeptidase (GGT) [EC. E.3.2.2] 
(McGovern et al., 2001). 
  
1.3 γ-glutamyl transpeptidase (GGT) 
 GGT is fairly ubiquitous and can be found across several kingdoms such as 
bacteria (Xu and Strauch, 1996; Wada et al., 2008), plants (Martin and Slovin, 2000; 
Martin et al., 2007) and animals (Chikhi et al., 1999). In mammalian tissues, GGT is 
embedded in the plasma membrane and plays an important role in glutathione (GSH, 
L-γ-glutamyl-L-cysteinylglycine) metabolism (Tate and Meister, 1981). It catalyzes 
reactions in which a γ-glutamyl moiety is transferred from γ-glutamyl compounds, 
such as GSH, to amino acids (transpeptidation) or water (hydrolysis) (Keillor et al., 
2005).  
 
1.3.1 H. pylori GGT 
GGT in H. pylori is synthesized as a 60 kDa pro-enzyme and is subsequently 
autoprocessed into a heterodimer comprising a large and small subunit with masses of 
about 40 and 20 kDa respectively. It is a secreted protein (Bumann et al., 2002) that is 
highly conserved within the H. pylori species and has been reported to be expressed in 






1.3.2 GGT and H. pylori pathogenesis 
 H. pylori GGT was found to confer a colonizing advantage to the bacteria in 
both mice and gnotobiotic piglet animal models (Chevalier et al., 1999; McGovern et 
al., 2001). In addition, H. pylori GGT has been reported to induce apoptosis in gastric 
epithelial cells (Shibayama et al., 2003) via the mitochondrial pathway (Kim et al., 
2007). It has also been shown to upregulate cyclooxygenase-2 and epidermal growth 
factor-related peptide expression (Busiello et al., 2004), inhibit T-cell proliferation 
(Schmees et al., 2007), induce cell cycle arrest (Kim et al., 2010) as well as 
upregulate microRNA-155 (miR-155) expression in T cells (Fassi Fehri et al., 2010). 
In addition, it was earlier found in our laboratory by Dr. Gong M. (2006) that purified 
H. pylori native GGT (nGGT) induces production of hydrogen peroxide (H2O2) 
leading to nuclear factor kappa B (NF-κB) activation and interleukin-8 (IL-8) 
generation in gastric cancer cells. Furthermore, in the same study, H. pylori GGT was 














1.4 Objectives of the study 
 Despite many studies describing the effects of H. pylori GGT on the host, the 
underlying mechanisms are relatively unknown. Hence, this work aims to further 
characterize H. pylori GGT and its pathogenic effects, as well as to determine the 
mechanism(s) behind its actions. To address this, the study will focus on the 
following objectives: 
 Cloning of ggt gene (full length and individual large and small subunits) from 
H. pylori and expressing the recombinant proteins in E. coli 
 Raising and characterizing specific polyclonal and monoclonal antibodies 
against GGT 
 Determining the subcellular localization of GGT in H. pylori 
 Investigating the mechanism by which GGT produces reactive oxygen species 
(ROS)  
 Assessing the ability of GGT in inducing IL-8 generation in various cell types 
 Analyzing GGT entry into host cells and its probable downstream effects  
 Examining the role of GGT in vacuolation induction 


















2.1 Helicobacter pylori – the organism 
2.1.1 History 
 Gastric spiral microorganisms were first described in the 19th century by 
Giulio Bizzozero who observed them in the stomach of dogs (Bizzozero, 1893). Soon 
after, similar spiral bacteria were also seen in the human stomach (Doenges, 1938; 
Freedberg and Baron, 1940). However, the microbes did not gain much attention until 
the 1970s when spirals were observed, using transmission electron microscopy 
(TEM), on the surface of epithelial cells in gastric biopsies from gastric ulcer patients 
(Steer, 1975). Eight years later, Warren and Marshall successfully isolated a spiral 
Campylobacter-like organism from human gastric biopsy specimens (Warren and 
Marshall, 1983). Self-ingestion of a pure culture of H. pylori by Marshall and Morris 
on separate occasions later demonstrated that these bacteria were capable of 
colonizing the human stomach and inducing inflammation of the gastric mucosa 
(Marshall et al., 1985; Morris and Nicholson, 1987), thus fulfilling Koch’s postulates. 
 When first isolated, the organism was described as Campylobacter-like 
(Warren and Marshall, 1983). A year later, it was subsequently renamed formally as 
Campylobacter pyloridis (Marshall et al., 1984) and changed again to Campylobacter 
pylori in 1987 (Marshall and Goodwin, 1987). However, due to taxonomic differences 
such as in ultrastructure features (Goodwin et al., 1985) and ribonucleic sequences 
(Romaniuk et al., 1987) from the Campylobacter genus, coupled with its helical 
morphology, the genus Helicobacter was created and the organism was then renamed 
as Helicobacter pylori (Goodwin et al., 1989). The discovery of H. pylori fuelled 
further research over the next 30 years and it is now considered the most common 
etiologic agent of various gastroduodenal diseases including chronic gastritis, peptic 
ulcer disease, gastric lymphoma and gastric adenocarcinoma (Ernst and Gold, 2000; 
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Atherton, 2006). For their groundbreaking work on the discovery of H. pylori and its 
role in peptic ulcer disease, Warren and Marshall were subsequently awarded the 
Nobel Prize in Physiology or Medicine in 2005. 
 
2.1.2 Characteristics of H. pylori 
 H. pylori is a Gram-negative bacterium that selectively colonizes the human 
gastric mucosa. The spiral-shaped microorganism measures 2-4 μm in length and 
approximately 0.5 μm in width. On culture plates, H. pylori forms small translucent 
colonies of about 0.5-2 mm in diameter after 2 to 3 days. 
 
2.1.2.1 Morphological forms 
 H. pylori exists in two morphological forms, namely spiral and coccoid. The 
spiral form is considered to be the active form where the organism is viable, 
culturable, virulent and able to colonize experimental animals (Eaton et al., 1995; 
Cole et al., 1997). Conversion from the actively dividing spiral form to the non-
culturable coccoid form can occur after prolonged in vitro culture (Hua and Ho, 1996) 
or under unfavourable conditions such as antibiotic treatment (Berry et al., 1995; 
Kusters et al., 1997) or increased oxygen tension (Catrenich and Makin, 1991). The 
role of the coccoid form in H. pylori pathogenesis has been controversial. It has been 
suggested that the coccoid form of H. pylori is a degenerate nonviable phase which is 
non-virulent (Eaton et al., 1995; Kusters et al., 1997) while others have presented 
evidence that the coccoid form is metabolically active, hence likely to be viable 
although non-culturable (Zheng et al., 1999; Willen et al., 2000) and may be involved 




2.1.2.2 Growth requirements 
 H. pylori is a microaerophile, requiring between 2-5% O2 levels and 5-10% 
CO2 for optimal growth. The organism is able to grow at temperatures between 33-
40°C, with 37°C being the most ideal (Owen, 1995). Although H. pylori will survive 
brief exposures to pH < 4.0, growth occurs only between pH 5.5-8.5 with good 
growth between pH 6.9 and 8.0, hence classifying it as a neutralophile (Owen, 1995; 
Scott et al., 2002). 
 Being a fastidious microorganism, H. pylori requires complex media which 
are often supplemented with blood or serum. Commonly used solid media include 
Columbia or Brucella agar supplemented with 7-10% lysed horse or sheep blood 
(Andersen and Wadström, 2001). Chocolate blood agar (containing 5% lysed horse 
blood) has also been frequently used (Xia et al., 1996; Hua et al., 2000). High 
humidity and moist plates are important for its growth (Marshall and Warren, 1984). 
Liquid media can also be used to culture H. pylori and these include Mueller-Hinton 
broth, Columbia broth, brucella broth or brain heart infusion broth supplemented with 
10% horse serum (Shahamat et al., 1991; Ho and Vijayakumari, 1993).  
  
2.2 Epidemiology of H. pylori infections 
2.2.1 Prevalence of H. pylori 
 H. pylori has been reported to chronically infect at least half of the world’s 
population (Covacci et al., 1999; Linz et al., 2007). The prevalence of H. pylori 
infection, however, exhibits large geographical variations. In various developing 
countries, infection rates are high such that more than 80% of the population are 
positive for H. pylori. In contrast, the rate of infection in developed countries 
generally remains under 40% (Perez-Perez et al., 2004). Within geographical areas, 
Literature Survey 
9 
socioeconomic status (defined by occupation, family income level and living 
conditions) has been shown to be inversely related to H. pylori prevalence (Graham et 
al., 1991; Dattoli et al., 2010; Bauer et al., 2011). Other factors which have also been 
statistically associated with H. pylori prevalence include ethnicity (Graham et al., 
1991; Zaterka et al., 2007) and increasing age (Dube et al., 2009; Jackson et al., 
2009). 
 In Singapore, prevalence of H. pylori has been found to increase with age, 
from 3% of children below the age of five to 71% of adults above 65 years 
(Epidemiological News Bulletin, 1996). Interestingly, distinct racial patterns have 
also been observed where H. pylori seroprevalence was found to be consistently 
higher in Indians and Chinese compared to Malays who displayed unusually low 
prevalence (Epidemiological News Bulletin, 1996; Kang et al., 1997; Goh and 
Parasakthi, 2001), suggesting that environmental factors (e.g. diet, culture, etc) and 
genetic predisposition may play a role in H. pylori infection.  
 
2.2.2 Routes of transmission  
 The route of transmission for H. pylori is still not completely understood. H. 
pylori has a narrow host range where it has been found almost exclusively in humans 
(Megraud and Broutet, 2000) and in some cases, non-human primates (Dubois et al., 
1995; Solnick et al., 2003) and domestic cats (Handt et al., 1994). New infections, 
including vertical transmission (Ng et al., 2001), however, are thought to occur via 
direct human-to-human transmission by gastro-oral, oral-oral and fecal-oral routes. H. 
pylori has been successfully isolated from fecal samples (Thomas et al., 1992), saliva 
(Ferguson et al., 1993) and vomitus (Leung et al., 1999) but none of these have been 
conclusively proven to be the predominant vehicle of transmission. There is also 
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evidence that transmission of H. pylori may be waterborne and this could be 
particularly important in areas with poor sanitation (Klein et al., 1991; Mazari-Hiriart 
et al., 2001). However, most of these studies have only detected the presence of H. 
pylori DNA in water sources by molecular techniques and not by direct culture with 
the exception of a few reports (Lu et al., 2002; Al-Sulami et al., 2010). Water as a 
route of transmission would also require H. pylori to remain viable in the extragastric 
environment and this has faced much controversy given the fastidious nature of the 
organism in terms of oxygen sensitivity, nutrient availability and temperature range. 
Hence, the transmission of H. pylori is still a largely inconclusive area of study. 
  
2.3 H. pylori-associated diseases 
Gastric colonization with H. pylori causes chronic gastric inflammation in 
virtually all infected individuals although majority remain asymptomatic (Peek and 
Blaser, 2002). However, long-term carriage of the pathogen significantly increases the 
risk of various gastroduodenal diseases. For instance, the lifetime risk of developing 
peptic ulcer disease (including gastric and duodenal ulcers) in H. pylori-positive 
subjects is estimated to be 10-20% (Kuipers et al., 1995) which is 3-4 fold higher than 
in non-infected individuals (Nomura et al., 1994). It has not been clearly established 
as to how H. pylori causes peptic ulcers but there is evidence indicating that H. pylori 
infection elevates gastrin levels which plays an important role in the regulation of 
gastric acid secretion (Calam et al., 1997). Elevated gastric acid secretion predisposes 
patients to duodenal ulcers while low acid secretion has been associated with gastric 
ulcers (Kuipers et al., 1995). 
Apart from peptic ulcer development, H. pylori infection has also been 
strongly associated with an increased risk of developing gastric adenocarcinoma – the 
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second highest cause of cancer deaths worldwide (Uemura et al., 2001; Atherton, 
2006). Approximately 1-3% of infected individuals eventually develop gastric cancer 
and less than 0.1% develop mucosa-associated lymphoid tissue lymphoma 
(Wroblewski et al., 2010). It is believed that H. pylori causes gastric cancer both 
directly (through induction of protein modulation and gene mutation) as well as 
indirectly (through induction of chronic inflammation) (Chiba et al., 2008). The 
progression of gastric carcinogenesis has been well described by the Correa pathway 
(Correa, 1988). However, the exact mechanism involved is still not completely 
understood. 
Non-ulcer dyspepsia has also been linked to H. pylori infection although the 
relationship remains controversial (Armstrong, 1996). Non-ulcer dyspepsia is defined 
as persistent or recurrent pain or discomfort centred in the upper abdomen without 
any definite structural explanation for the symptoms (Talley and Xia, 1998). 
Prevalence of H. pylori in non-ulcer dyspepsia patients have been found to be as high 
as 50% but a causal relationship remains to be established (Talley and Quan, 2002). 
Symptom improvement after eradication of H. pylori in non-ulcer dyspepsia patients 
has also yielded conflicting results where some groups have reported a small but 
significant improvement (Moayyedi et al., 2006) while others did not find any 
significant difference (Laine et al., 2001).  
 
2.4 Virulent determinants of H. pylori pathogenesis 
2.4.1 Cell surface factors  
2.4.1.1 Flagella 
In addition to its spiral shape, H. pylori possesses 2-6 unipolar sheathed 
flagella, about 3-5 μm in length. Often, a club-shaped terminal structure or bulb is 
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seen at the end of the filament (Geis et al., 1989). The flagella give the organism 
strong motility for burrowing into the viscous stomach mucus to reach the gastric 
epithelium (Hazell et al., 1986). It also enables it to overcome peristaltic flushing 
(Dubois, 1995) and has been reported to be important for colonization of the gastric 
mucosa in the gnotobiotic piglet model (Eaton et al., 1992). 
 
2.4.1.2 Adhesins and outer membrane proteins 
 Adherence of H. pylori to the gastric epithelium is important for initial 
colonization and persistence as it protects the organism from clearance mechanisms 
such as peristaltic movements and liquid flow. H. pylori possesses several adhesins to 
aid in its adhesion to host cell receptors where approximately 4% of its genome 
encodes for outer membrane proteins (Yamaoka, 2010). The role of three such 
proteins will be described here and they include BabA, SabA and OipA (Magalhaes 
and Reis, 2010). 
 BabA is a 78 kDa protein encoded by the babA gene and mediates binding to 
fucosylated Lewis b (Leb) blood group antigens on human host cells (Ilver et al., 
1998). There are two distinct babA alleles, namely babA1 and babA2, but only babA2 
encodes active BabA. Strains possessing the babA2 gene have been found to be 
strongly associated with increased epithelial proliferation and inflammation as well as 
an increased risk for peptic ulcer and gastric adenocarcinoma (Gerhard et al., 1999; 
Yu et al., 2002). 
 SabA has been found to mediate binding to sialyl-Lewis x/a antigens (sLex and 
sLea) (Mahdavi et al., 2002). This is important as H. pylori-induced gastric 
inflammation and gastric carcinoma have been reported to be associated with the 
replacement of non-sialylated Lewis antigens by sLex and sLea (Sakamoto et al., 
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1989; Ota et al., 1998). Clinically, SabA has also been associated with severe 
intestinal metaplasia, gastric atrophy and the development of gastric cancer (Yamaoka 
et al., 2006). As such it has been proposed that H. pylori adherence during chronic 
infection may occur via two separate receptor-ligand interactions, one of which occurs 
by Leb-mediated adherence through BabA and the other through the weaker 
sLex/sLea-mediated adherence by SabA (Mahdavi et al., 2002). 
 OipA is a 34 kDa phase-variable outer membrane protein of H. pylori which 
was originally identified as a proinflammatory response-inducing protein (Yamaoka 
et al., 2000). The oipA gene is present in all strains but expression of the protein is 
regulated by a variable number of CT dinucleotide repeats in the 5’ region of the 
gene, leading to either an “on” or “off” status (Yamaoka et al., 2000). In vitro, OipA 
has been shown to facilitate attachment of H. pylori to gastric epithelial cells 
(Dossumbekova et al., 2006). It has also been reported to play a role in H. pylori 
colonization of the gastric mucosa in both the mice and Mongolian gerbil animal 
models (Akanuma et al., 2002; Yamaoka et al., 2002b). Clinically, an oipA-positive 
status has been significantly associated with duodenal ulcers and gastric cancer 
(Yamaoka et al., 2006). However, as the oipA “on” status is closely linked to other 
virulence factors such as functional vacA, babA and cagA (Dossumbekova et al., 
2006), oipA may be linked to gastroduodenal diseases because of this association.  
 
2.4.1.3 Lipopolysaccharides (LPS) 
 Similar to other Gram-negative bacteria, the cell envelope of H. pylori consists 
of an inner membrane, periplasm with peptidoglycan and an outer membrane. The 
outer membrane is made up of phospholipids and LPS. The latter comprises the core 
oligosaccharide, an O antigen side chain and lipid A. Unlike the lipid A moiety of 
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other Gram-negative bacteria, the LPS of H. pylori has low endotoxic activity 
(Muotiala et al., 1992). In addition, the O antigen side chain of H. pylori can be post-
translationally fucosylated to generate Le antigens which are also found on human 
blood erythrocytes and epithelial cells (Nilsson et al., 2006), including those found in 
the gastric mucosa (Appelmelk et al., 1996). This molecular mimicry is thought to 
help the pathogen evade the host immune system and allow persistance of infection 
(Vandenbroucke-Grauls and Appelmelk, 1998). 
 
2.4.2 Cytotoxin-associated gene pathogenicity island (cagPAI) 
 The cagPAI is a genomic region of about 40 kb that contains between 27 to 31 
genes (Censini et al., 1996; Akopyants et al., 1998). A subset of these genes have 
been found to encode for multiple structural components of a bacterial type IV 
secretion system (T4SS) which forms a syringe-like structure responsible for the 
translocation of various effector molecules from the bacteria into host gastric 
epithelial cells (Busler et al., 2006). To date, two bacterial molecules have been 
shown to be selectively translocated into host cells via the T4SS, namely CagA 
(Backert et al., 2000) and peptidoglycan (Viala et al., 2004). The latter, upon 
translocation, is recognized by a cytosolic pathogen recognition molecule known as 
nucleotide-binding oligomerization domain protein (Nod1), leading to a cascade 
effect resulting in NF-κB activation and induction of IL-8 secretion by epithelial cells 
(Viala et al., 2004). Importantly, infection with cagPAI-positive H. pylori strains has 
been shown to be associated with more severe disease outcome compared to cagPAI-
negative strains in humans (Nilsson et al., 2003). A long-term infection study (2-64 
weeks) has also been conducted in Mongolian gerbils (Wiedemann et al., 2009). In 
their study, it was found that the T4SS is essential for inducing severe corpus 
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inflammation, increase in proinflammatory cytokines as well as mucous gland 
metaplasia in the first 4-8 weeks of infection. Similarly, at later time points, only 
those animals infected with wild type H. pylori possessing T4SS developed 
hypochlorhydria and hypergastrinemia in parallel to gastric ulcers and focal dysplesia. 
These results strongly suggest the important role of cagPAI in triggering the events 
leading to gastric carcinogenesis which is also a multistep process in humans. 
 
2.4.3 Cytotoxin-associated gene A (CagA) 
 CagA, a 120-140 kDa immunodominant protein, is arguably the most 
extensively studied virulence factor of H. pylori. In the West, numerous reports have 
found that H. pylori strains harbouring CagA are more commonly associated with 
peptic ulceration and gastric adenocarcinoma as compared to strains which lack the 
oncoprotein, suggesting its clinical importance in H. pylori infections (Blaser et al., 
1995; Nomura et al., 2002). However this may only be true for the Western 
population as studies conducted in the East - where almost all strains are CagA-
positive - have not observed such correlations between cagA status and clinical 
outcome (Maeda et al., 1998; Zheng et al., 2000). 
CagA is encoded by the cagA gene which is found within the cagPAI and is 
the only known protein to date that is translocated into host epithelial cells by the 
T4SS of H. pylori (Odenbreit et al., 2000). Upon translocation into host cells, CagA is 
phosphorylated by host cell Src and Abl family kinases on tyrosine residues within 
conserved Glu-Pro-Ile-Tyr-Ala (EPIYA) sequence motifs which are found at the C-
terminus of the protein (Selbach et al., 2002; Tammer et al., 2007). Phosphorylated 
CagA then interacts with the Src homology 2 domains of several eukaryotic signalling 
proteins including SHP-2, a host cytoplasmic tyrosine phosphatase (Higashi et al., 
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2002). Subsequent conformational change in SHP-2 leads to inhibition of its 
phosphatase activity which in turn induces gastric cells cultured in vitro to elongate 
and develop long processes termed the hummingbird phenotype (Segal et al., 1999). 
Another major effect of phosphorylated CagA is the stimulation of transcription 
factors such as c-Fos and c-Jun (through increased Erk MAP kinase activation) which 
in turn leads to a deregulation of epithelial cell proliferation (Meyer-ter-Vehn et al., 
2000). 
 Effects of CagA independent of its phosphorylation status have also been 
reported. These include disruption of cell-cell junctions, loss of cell polarity and 
induction of proinflammatory and mitogenic responses (Backert and Selbach, 2008). 
Such diverse effects are due to the interaction of unphosphorylated CagA with various 
host proteins. For example, CagA binds to the adaptor protein Grb2 which can then 
lead to a cascade of signalling events resulting in the stimulation of the Raf/Mek/Erk 
pathway and subsequent cell scattering (Mimuro et al., 2002). Unphosphorylated 
CagA can also bind to Par1b (a central regulator of cell polarity) and inhibit its kinase 
activity, resulting in the eventual loss of cell polarity (Hatakeyama, 2008). Injected 
CagA also complexes with various tight junction proteins such as zona occludens-1 
and junctional adhesion molecule which can result in an ectopic assembly of tight-
junction components, leading to loss of function of both tight and adherens junctions 
(Amieva et al., 2003).  
   
2.4.4 Vacuolating cytotoxin A (VacA) 
 Another extensively studied virulence factor of H. pylori is VacA, a secreted 
cytoxin that induces cytotoxic vacuolation in cells (Leunk et al., 1988). Unlike the 
cagPAI, the vacA gene is present in virtually all strains of H. pylori (Atherton et al., 
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1995). The gene codes for a 140 kDa protoxin which subsequently undergoes 
proteolytic cleavage during secretion to produce a 90 kDa toxin (Papini et al., 2001). 
Secreted VacA is then further processed into an N-terminal fragment of 33 kDa (p33) 
and a C-terminal fragment of 55 kDa (p55) which remain covalently attached (Telford 
et al., 1994). The p55 domain is responsible for host cell binding (Reyrat et al., 1999) 
while the p33 domain exhibits pore-forming activity required for the formation of 
vacuoles in cells (McClain et al., 2003). Several cell receptors for VacA have been 
identified and these include receptor protein tyrosine phosphatases α and β (RPTPα 
and β) (Yahiro et al., 1999 and 2003), epidermal growth factor receptor (EGFR) (Seto 
et al., 1998) as well as sphingomyelin (Gupta et al., 2008). Upon binding to a specific 
receptor, oligomerization of monomeric VacA occurs and VacA is subsequently 
endocytosed into the cells via a clathrin-independent pathway. 
 After internalization, VacA can induce several multiple cellular activities 
including disruption of endosomal and lysosomal functions (Montecucco and de 
Bernard, 2003), induction of apoptosis via a mitochondria-dependent pathway 
(Yamasaki et al., 2006) as well as immunomodulation by inhibiting T and B cell 
proliferation (Torres et al., 2007). The best studied and most prominent feature of 
VacA, however, is its ability to induce massive vacuolation in cells, a phenomenon 
observed both in vitro (Cover and Blaser, 1992b) and in vivo (Tricottet et al., 1986; 
Telford et al., 1994). Vacuolating activity, however, varies between different H. 
pylori strains (Cover and Blaser, 1992b). This is primarily due to polymorphism in the 
vacA gene at the signal (s) and middle (m) regions (Atherton et al., 1995). Signal 
region types include s1 and s2 while mid-region types include m1 and m2. In vitro 
experiments have shown that s1/m1 strains are more cytotoxic than s1/m2 strains 
while s2/m2 strains are non-toxic and s2/m1 strains are rarely found (Atherton et al., 
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1995; Letley et al., 1999). Clinically, strains with s1/m1 genotype are also typically 
associated with more severe gastroduodenal diseases (Sugimoto et al., 2009; 




 H. pylori produces abundant urease, an enzyme which hydrolyzes urea to 
generate ammonia and carbon dioxide (Mobley, 2001). The ammonia produced forms 
a protective microenvironment around the organism and protects it from the acidity of 
the stomach (Mobley, 1996). Urease is a cytoplasmic enzyme but has also been found 
on the outside surface of the bacteria due to lysis of a subset of the cell population 
(Marcus and Scott, 2001). It is a nickel-containing enzyme that consists of UreA and 
UreB subunits which are encoded in an operon containing the ureA and ureB genes 
(Dunn et al., 1990). The effective urease activity is dependent on the availability of 
urea, its substrate, whose transport into the bacterium is controlled by the proton-
gated urea channel UreI (Weeks et al., 2000). Although urease is not essential for in 
vitro viability, it has been reported to be an essential colonization factor in the 
gnotobiotic piglet model (Eaton et al., 1991). In addition, urease has also been 
implicated in the dysregulation of tight junctions in gastric epithelial cells through 
myosin regulatory light chain phosphorylation and occludin internalization 
(Wroblewski et al., 2009).    
 
2.4.5.2 Catalase 
Similar to catalase of other organisms, H. pylori catalase catalyzes the 
decomposition of H2O2 into water and oxygen to protect itself against oxygen-
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dependent killing mechanisms (Hazell et al., 1991). Although catalase is not required 
for in vitro viability of H. pylori (Odenbreit et al., 1996), it is important for survival 
against the presence of extracellular ROS produced by professional phagocytes 
(Ramarao et al., 2000) and within the phagosomes of macrophages upon phagocytosis 
(Basu et al., 2004). Using the H. pylori SS1 mouse model, it was also shown that H. 
pylori mutants deficient in catalase had a reduced ability to maintain long-term 
colonization in the gastric mucosa of the mice compared to the wild type strain, 
indicating the importance of catalase in the chronic persistence of H. pylori (Harris et 
al., 2003). 
 
2.4.5.3 Phospholipase A 
 H. pylori produces phospholipase A, an enzyme that targets the phospholipidic 
components of the gastric mucosa and is thus believed to damage the protective 
gastric mucosal barrier (Figura, 1997). Phospholipase A has also been shown to 
hydrolyze phospholipids to generate lysolecithin and fatty acids which are cytotoxic 
and may act as precursors to ulcerogenic components (Langton and Cesareo, 1992). 
Additionally, the role of phospholipase A in colonization of the gastric mucosa has 
been studied where it was found that H. pylori isogenic mutants lacking 
phospholipase A were unable to colonize mice (Dorrell et al., 1999). 
 
2.5 Effects of H. pylori infection on host 
 H. pylori has been strongly associated with the development of several 
gastroduodenal diseases and has also been linked to gastric cancer progression (Ernst 
and Gold, 2000). Thus, understanding the mechanisms underlying H. pylori 
pathogenesis has been a major research target. Several possible mechanisms 
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describing how H. pylori could induce epithelial damage have been proposed and 
some of these are discussed below. 
 
2.5.1 Oxidative stress 
The term oxidative stress refers to the state of a cell that is characterized by 
the presence of excessively high levels of ROS and/or the lack of antioxidant defences 
(Franco et al., 2008).  
 
2.5.1.1 H. pylori and reactive oxygen species (ROS) generation 
ROS are chemically reactive molecules that include hypochlorite ions (ClO-), 
hydroxyl radicals (·OH), superoxide anions (O2-) and H2O2. Excessive generation of 
ROS could potentially damage various host cellular components such as proteins, 
lipids and nucleic acids (Valko et al., 2007). It has been widely established that 
oxidative stress can increase DNA mutation rates which could lead to permanent 
modification of genetic material and initiate tumour development (Franco et al., 2008; 
Kryston et al., 2011). Apart from inducing DNA damage, ROS has also been reported 
to activate NF-κB (Schreck et al., 1991; Takada et al., 2003), a transcription factor 
that controls the expression of various pro-inflammatory genes. Some of these include 
cytokines such as IL-6 (Zhang et al., 2001) and IL-8 (Roebuck, 1999a), both of which 
have also been implicated in gastric carcinogenesis (Crabtree and Lindley, 1994; Kai 
et al., 2005). Additionally, ROS has also been documented to induce gastric mucosa 
injury which could potentially predispose host tissue to ulcer formation (Davies et al., 
1992). 
Interestingly, high levels of ROS production have been reported in H. pylori-
infected gastric mucosa (Davies et al., 1994; Suzuki et al., 1996). Possible sources of 
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ROS may derive from infiltrating neutrophils, vascular endothelial cells, gastric 
mucosa and epithelial cells and the bacterium itself (Handa et al., 2010). Although 
neutrophils are believed to be the main contributor to ROS (Naito and Yoshikawa, 
2002), it has been reported that H. pylori itself can produce ROS (Nagata et al., 1998). 
Moreover, reduced intracellular GSH levels and DNA damage have also been 
reported in H. pylori-infected gastric cell lines (Beil et al., 2000; Obst et al., 2000), 
further supporting the ability of the bacterium in directly synthesizing ROS. Despite 
this, the exact mechanism and the possible bacterial factors which contribute to ROS 
generation have not been clearly established.   
 
2.5.1.2 H. pylori decreases antioxidant levels 
 Antioxidants scavenge ROS and hence protect cells against the damaging 
effects of free radicals. Several cellular antioxidant defences exist to prevent the 
accumulation of ROS and they may be either enzymatic or non-enzymatic in nature. 
Superoxide disumutase, glutathione peroxidase and catalase are the three major 
classes of enzymatic antioxidants (Mates et al., 1999) while non-enzymatic 
antioxidants include Vitamin C, Vitamin E, carotenoids and thiol antioxidants such as 
GSH (Valko et al., 2006). 
 The GSH antioxidant system is one of the major protective mechanisms of the 
cell (Bounous and Molson, 2003). GSH (L-γ-glutamyl-L-cysteinylglycine) is highly 
abundant in the cytosol, nuclei and mitochondria, and it quenches ROS by donating 
the hydrogen atom required for their reduction (Valko et al., 2006). A deficiency in 
GSH puts the cell at risk for oxidative damage as GSH has been shown to be involved 
in the repair of oxidative DNA lesions (Lenton et al., 1999), supporting its role in 
protecting against mutagenesis and transformation. Apart from neutralizing ROS, 
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GSH is also a co-factor of many cellular enzymes (Townsend et al., 2003) and helps 
regulate the activity of redox-sensitive enzymes such as protein-tyrosine kinases and 
phosphatases by maintaining their active sites in a reduced state (Staal et al., 1994).  
 It has been reported in several studies that gastric mucosa harbouring H. pylori 
have significantly decreased levels of GSH as compared to H. pylori-negative mucosa 
(Beil et al., 2000; Jung et al., 2001; Shirin et al., 2001), suggesting a possible role of 
H. pylori in the depletion of this important antioxidant. In addition, it has also been 
shown that H. pylori directly metabolizes extracellular GSH as a source of glutamate 
for its own amino acid metabolism (Shibayama et al., 2007). Thus the observed 
decrease of GSH is probably not merely due to an increase in ROS levels but a more 
direct effect of the bacterium. Taken together, a decrease in GSH level, along with an 
increase in ROS generation as discussed in section 2.5.1.1 would lead to a redox 
imbalance in cells and may explain the onset of carcinogenesis in H. pylori infections. 
 
2.5.2 H. pylori and inflammation 
 All H. pylori-infected subjects develop an inflammatory and immune response 
towards the pathogen. However, this response is ineffective in clearing the bacteria 
and results in chronic gastric inflammation which may eventually lead to pathogenesis 
(Robinson et al., 2007). H. pylori produces several virulence factors which have been 
associated with inflammation. Some of these include the cagPAI (Wiedemann et al., 
2009), OipA (Yamaoka et al., 2002a) and the induced by contact with epithelium 
antigen (IceA) (Peek et al., 1998). iceA exists as two mutually exclusive genotypes, 
iceA1 or iceA2, and it is iceA1 which has been associated with gastric inflammation 
(Nishiya et al., 2000; Sheu et al., 2002). 
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Apart from causing direct cell damage through bacterial factors, H. pylori may 
also indirectly induce mucosal damage as a consequence of the persistent 
inflammatory response. Histologically, chronic H. pylori infection is characterized by 
infiltration of the mucosa by polymorphonuclear and mononuclear leukocytes, as well 
as neutrophils which are important components of the inflammatory response 
(Dundon et al., 2002).  
 
2.5.2.1 Interleukin-8 (IL-8) generation 
Numerous proinflammatory cytokines including IL-1β, IL-6, IL-8 and tumour 
necrosis factor alpha (TNF-α) have been reported to be upregulated in the gastric 
mucosa during H. pylori infection (Crabtree et al., 1991 and 1994; Noach et al., 
1994a). Of these, special interest has been focused on the chemokine IL-8 which is a 
potent neutrophil recruitment factor thought to play a pivotal role in the 
immunopathogenesis of H. pylori infection (Yamaoka et al., 1996).  
A major source of IL-8 in the gastric mucosa is the epithelium (O'Hara et al., 
2006) and whole genome profiling of H. pylori-infected gastric epithelial cells has 
revealed IL-8 to be the most significantly upregulated gene (Eftang et al., 2012). 
Indeed, numerous studies have shown that in vitro co-culture of H. pylori with gastric 
epithelial cells stimulates significant IL-8 secretion (Crabtree et al., 1995a; Sharma et 
al., 1995). In vivo, gastric mucosal IL-8 levels have also been found to correlate 
strongly with histological severity of H. pylori-induced gastritis (Ando et al., 1996) 
and gastric ulcers (Shimizu et al., 2000). Several virulence factors of H. pylori have 
been reported to induce IL-8 production including OipA (Yamaoka et al., 2002a), 
urease (Beswick et al., 2006) and CagA (Kim et al., 2006).  
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Expression of IL-8 is regulated primarily at the transcriptional level (Roebuck, 
1999b). In gastric epithelial cells, several transcription factors have been found to be 
involved in H. pylori-induced IL-8 promoter activation, including NF-κB (Keates et 
al., 1997) and to a lesser extent, activator protein-1 (Chu et al., 2003). NF-κB is an 
inducible transcription factor sequestered in the cytoplasm by association with 
proteins of the inhibitor of NF-κB (IκB) family (Jacobs and Harrison, 1998). In 
unstimulated cells, IκB proteins bind to and mask the nuclear localization signals 
(NLS) of NF-κB, preventing the latter from entering into the nucleus (Beg et al., 
1992). On exposure to external stimuli such as ROS (Schreck et al., 1992) or TNF-α 
(Fitzgerald et al., 2007), IκB is phosphorylated by IκB kinase which targets it for 
proteosome degradation, hence liberating NF-κB to migrate into the nucleus to 
regulate gene expression (Mercurio et al., 1997). Various studies have shown that H. 
pylori infection activates NF-κB in gastric epithelial cells both in vitro and in vivo 
(Keates et al., 1997; Ferrero et al., 2008), possibly through an upstream mitogen-
activated protein kinase pathway (Seo et al., 2004). In addition, it has also been 
reported that H. pylori can induce Toll-like receptor (TLR) and Nod-like receptor 
(NLR) activation in host cells (Smith et al., 2003; Viala et al., 2004), leading to the 
expression of several pro-inflammatory genes including IL-8 (Torok et al., 2005). 
  
2.5.3 Cellular vacuolation 
 Intracellular vacuolation has been observed by ultrastructural microscopy in 
the gastric epithelial cells of patients infected with H. pylori (Chen et al., 1986; 
Fiocca et al., 1989). In vitro, broth culture supernatants of H. pylori have also been 
reported to induce vacuolation in primary human gastric epithelial cells (Smoot et al., 
1996), indicating that H. pylori induces a cytopathic effect on the host. Cellular 
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vacuolation has been attributed to a cytotoxin secreted by H. pylori known as VacA 
(Cover and Blaser, 1992b). 
 
2.5.3.1 Role of VacA in vacuolation 
 The unique function of VacA in inducing cellular vacuolation has been widely 
reported and studied (Leunk et al., 1988; Papini et al., 1994). VacA is able to induce 
vacuolation in several cell types although cell line sensitivity may differ (de Bernard 
et al., 1998). The membranes of VacA-induced vacuoles contain both late endosomal 
and lysosomal markers, in particular Rab7, lysosomal-associated membrane protein 1 
and lysosomal glycoprotein 110 (Papini et al., 1994; Molinari et al., 1997), indicating 
that VacA may disrupt normal membrane trafficking at the late endosomal stage 
(Montecucco and de Bernard, 2003). Vacuolation not only depends on VacA, but also 
requires the presence of permeant weak bases, such as ammonia, in the extracellular 
medium (Cover et al., 1992). In addition, several enzymes required for vacuole 
formation have been identified and these include vacuolar-type ATPase (V-ATPase) 
(Cover et al., 1993), and the small GTPases Rab7 (Papini et al., 1997) and Rac1 
(Hotchin et al., 2000).  
 A current model outlining the mechanism by which VacA induces vacuolation 
is illustrated in Figure 1. In this model, it is proposed that after binding to receptors on 
the cell surface, VacA is internalized and forms anion-selective channels in the 
membranes of late endosomes and lysosomes (Cover and Blanke, 2005). These VacA 
channels conduct anions (e.g. chloride) into the endosomal compartment which in 
turn stimulates V-ATPase activity. To compensate for the increase in anion 
concentration, V-ATPase activity increases and an influx of protons occurs which 
then reduces the intralumenal pH. Membrane permeant weak bases such as ammonia 
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then diffuse into the acidified endosome, become protonated and are trapped in these 
compartments. Subsequently, osmotic swelling of these endosomes results in the 












Figure 1. Schematic illustration of a model depicting how VacA induces cellular 
vacuolation. 
 
2.5.3.2 Role of urease and ammonia in vacuolation 
 Based on the model as described above, it is apparent that the presence of 
weak bases (e.g. ammonia) in the extracellular medium is necessary for vacuolation to 
occur (Cover et al., 1992). Previous studies have attributed the source of ammonia 
required for vacuolation to come from the hydrolysis of urea by urease as it was 
observed that ammonia generated from urease greatly potentiated VacA-induced 
vacuolation (Cover et al., 1991). However, it was also reported in the same study that 
in the absence of urea, supernatant from a urease deficient mutant induced 
vacuolation to a similar extent as compared to the wild type strain. In addition, 
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acetohydroxamic acid (a urease inhibitor) failed to inhibit vacuolation induction by H. 
pylori supernatants. These observations indicate that urease is probably not the only 
factor contributing to ammonia required for VacA-induced vacuolation.  
 
2.6 GGT 
2.6.1 Human GGT 
2.6.1.1 Properties and catalytic action 
Human GGT, a member of the N-terminal nucleophile hydrolase family, is 
first synthesized as an inactive 569-amino acid single propeptide which undergoes 
post-translational autocleavage to produce the mature heterodimeric enzyme 
consisting of a large and small subunit (West et al., 2011). The large subunit consists 
of an aminoterminal sequence which is intracellular, a single transmembrane domain, 
as well as an extracellular component that binds the small subunit (Whitfield, 2001). 
The active site of the enzyme faces the external side of the plasma membrane and is 
found in the small subunit (Taniguchi and Ikeda, 1998). Human GGT is also heavily 
N-glycosylated and this has been found to be important for the proper folding and 
autocatalytic cleavage of the proenzyme (West et al., 2011). 
GGT catalyzes the cleavage of the γ-glutamyl amide bond found in γ-glutamyl 
compounds (e.g. GSH) where the γ-glutamyl moiety is transferred to an acceptor 
either through a transpeptidation or hydrolysis reaction (Lieberman et al., 1995). A 
general formula illustrating the catalytic action of GGT is shown below (Hanigan, 
1998) where R represents any chemical group and the acceptor can be amino acids, 










The first step is the cleavage of the γ-glutamyl bond of the substrate and the formation 
of a transient enzyme-glutamyl substrate complex (Wickham et al., 2011). The γ-
glutamyl group then forms a transient acyl bond with the enzyme while the remainder 
of the substrate is released (Tate and Meister, 1974). In the transpeptidation reaction, 
the γ-glutamyl moiety is transferred to the amine of an acceptor (e.g. an amino acid or 
dipeptide) to form new γ-glutamyl compounds (Thompson and Meister, 1976). In the 
hydrolysis reaction - the predominant reaction catalyzed by GGT in vivo (Wickham et 
al., 2011) - water hydrolyzes the acyl bond between the substrate and the nucleophilic 
residue, leading to the release of glutamate and the free enzyme (Keillor et al., 2005). 
Physiologically, the most abundant substrates of GGT are GSH and GSH-conjugated 
compounds (Hanigan, 1998) although a wide variety of γ-glutamyl compounds can 
also be used as substrates (Magnan et al., 1982).   
 The catalytic activity of GGT can be effectively inhibited by L-serine in the 
presence of borate buffer (Tate and Meister, 1978). This occurs because L-serine 
binds to the γ-glutamyl binding site of the enzyme by interacting with the α-carboxyl 
and α-amino binding groups in a competitive manner (Thompson and Meister, 1977). 
Binding is further enhanced by complex formation between the serine hydroxyl 
group, borate and a hydroxyl group at the active center of GGT which is thought to 




reaction, thus making the serine-borate complex (SBC) an inhibitory transition-state 
analog (Tate and Meister, 1978).  
Apart from SBC, other inhibitors of GGT that have been used include 6-diazo-
5-oxo-L-norleucine (DON) (Tate and Meister, 1981) and acivicin (Meister and 
Anderson, 1983). Both DON and acivicin are potent non-reversible inhibitors that 
bind covalently to the small subunit of GGT (Tate and Meister, 1977; Smith et al., 
1995). However, although extremely effective in inhibiting GGT, DON and acivicin 
are also glutamine antagonists that inhibit many glutamine-dependent 
amidotransferases involved in purine biosynthesis, rendering them cytotoxic to cells 
(Lyons et al., 1990). Furthermore, acivicin has also been demonstrated to induce 
apoptosis independently of GGT activity in the V79 cell line (Aberkane et al., 2001). 
 
2.6.1.2 Physiological function 
The physiological role of GGT relating to GSH has been studied extensively. 
As exported GSH cannot be reabsorbed by cells in the tripeptide form, GGT initiates 
the cleavage of extracellular GSH to release the γ-glutamyl group from 
cysteinylglycine. The latter is then hydrolyzed into cysteine and glycine by 
dipeptidases present on the cell surface (McIntyre and Curthoys, 1982). The 
constituent amino acids of GSH (i.e. glutamate, cysteine and glycine) can then be 
readily absorbed and used for resynthesis of GSH intracellularly (Hanigan and 
Ricketts, 1993). This cyclic process is known as the γ-glutamyl cycle and is illustrated 
in Figure 2. As GGT is the only enzyme known to cleave intact GSH, it thus plays a 





Figure 2. The γ-glutamyl cycle. 
 
2.6.1.3 Cellular expression  
 GGT is most prominently expressed on luminal surfaces of cells that align 
ducts and glands throughout the body (West et al., 2011) and the highest 
concentration can be found on the luminal surface of renal proximal tubules in the 
kidney (Hanigan, 1998). Additionally, the presence of GGT has also been observed 
on hepatic bile canaliculi, pancreatic acini, intestinal crypts, salivary gland ducts and 
testicular tubules among many others (Hanigan and Frierson, 1996). It is believed that 
GGT functions to retain the constitutive amino acids of GSH (especially cysteine) in 































2.6.2 H. pylori GGT 
2.6.2.1 Properties of GGT 
 H. pylori GGT is a highly conserved 60 kDa polypeptide encoded by a single 
gene (HP1118) that is located far from both the vacA gene and the cagPAI 
(Shibayama et al., 2003). The ggt gene of 1704 bp codes for a protein consisting of 
567 amino acids and is translated in a single-chain precursor form which is inactive 
(Boanca et al., 2006). Following secretion into the periplasmic space, the pre-
proenzyme is first cleaved of its N-terminal signal peptide at the site between alanine 
26 and alanine 27 (Chevalier et al., 1999). Subsequently, intramolecular autocatalytic 
cleavage of the proenzyme then occurs (between asparagine 379 and threonine 380), 
resulting in a fully active heterodimer comprising a 40 kDa and 20 kDa subunit which 
remain non-covalently associated (Shibayama et al., 2003). The new N-terminal 
residue (threonine 380) has been demonstrated to serve as a catalytic nucleophile in 
both the autoprocessing and enzymatic reactions (Boanca et al., 2007).  
 
2.6.2.2 Comparison between H. pylori GGT and human GGT  
H. pylori GGT shares 22% amino acid sequence similarity with human GGT, 
suggesting a certain degree of conservation in their overall structure and function 
(Boanca et al., 2007). Indeed, H. pylori GGT is also capable of metabolizing γ-
glutamyl substrates such as GSH and glutamine in the extracellular medium 
(Shibayama et al., 2007). However, several differences do exist. For example, human 
GGT is membrane-bound and heavily N-glycosylated while H. pylori GGT is a 
soluble protein and is not glycosylated (Boanca et al., 2006). In addition, H. pylori ggt 
gene also lacks the GY residues at the C-terminal end which are present on 
mammalian homologues, including human ggt (Chevalier et al., 1999). The 
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significance of this difference, however, is still unclear. Catalytic differences have 
also been observed between H. pylori GGT and human GGT. For instance, human 
GGT is >100 fold more effective than H. pylori GGT in catalyzing the 
transpeptidation reaction (Boanca et al., 2006), suggesting considerable structural 
differences in their catalytic sites. Hydrolysis rates, on the other hand, are comparable 
between the two (Boanca et al., 2007). 
 
2.6.2.3 Physiological role of GGT in H. pylori 
GGT is highly conserved, constitutively expressed and common in all H. 
pylori strains (Chevalier et al., 1999), suggesting its importance in the physiology of 
the bacterium. As reported by Shibayama et al. (2007), one of the main physiological 
functions of H. pylori GGT is to enable the bacterium to utilize extracellular GSH and 
glutamine as a source of glutamate for its own metabolism. This is because H. pylori 
is unable to take up GSH or glutamine directly, thus GGT functions to hydrolyze 
these substrates extracellularly to glutamate which is then transported into the 
bacterium in a Na+-dependent manner. In the same study, it was further demonstrated 
that the transported glutamate was subsequently incorporated into the tricarboxylic 
acid cycle and also used as a substrate for glutamine synthesis in the cytosol of H. 
pylori. Hence, GGT has been shown to be an important metabolic enzyme of H. 
pylori.  
 
2.6.2.4 Effects of H. pylori GGT on the host  
 H. pylori GGT was first described as an essential colonization factor in a study 
done on Swiss specific pathogen-free mice (Chevalier et al., 1999). However, a later 
study using two different animal models (C57/BL/6 mice and gnotobiotic piglets) 
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demonstrated that GGT was not essential for colonization but did contribute to the 
virulence of the pathogen (McGovern et al., 2001). Subsequently, GGT was found to 
induce apoptosis in gastric epithelial cells (Shibayama et al., 2003) via the 
mitochondria-mediated pathway (Kim et al., 2007). In addition, GGT also induces 
cell cycle arrest at the G1-S phase transition (Kim et al., 2010). On the other hand, it 
was also demonstrated that GGT upregulates cyclooxygenase-2 and epidermal growth 
factor-related peptides in gastric epithelial cells which are events that inhibit apoptosis 
(Busiello et al., 2004). Interestingly, it has been postulated that the ability of H. pylori 
to both stimulate and inhibit apoptosis may increase the risk of gastric carcinogenesis 
as mutations of apoptosis-regulating genes may occur more frequently (Peek and 
Blaser, 2002). Hence, it has been speculated that GGT may play an important role in 
promoting H. pylori-mediated gastric adenocarcinoma (Shibayama et al., 2003).  
 Apart from gastric epithelial cells, H. pylori GGT has also been found to affect 
cells of the immune system, in particular T cells (Schmees et al., 2007). In their study, 
it was demonstrated that GGT inhibited the proliferation of human T lymphocytes by 
inducing G1 arrest through an apoptosis-independent mechanism. The authors hence 
suggested a contributory role of GGT in immune evasion by H. pylori through the 
inhibition of immune effector cells. Recently, it has also been reported that GGT is an 
inducer of miR-155 expression in human lymphocytes (Fassi Fehri et al., 2010). 
Interestingly, miR-155 is one of the key regulators of the immune system and 
overexpression of miR-155 has been linked to carcinogenesis (Tili et al., 2011). 
 As described in the previous section 2.6.2.3, one of the physiological roles of 
GGT is to utilize extracellular GSH and glutamine as a source of glutamate for the 
bacterium. However, the depletion of these important nutrients inevitably also 
damages the host in several ways. Firstly, excessive hydrolysis of GSH (an important 
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antioxidant) may impair the redox balance in the host and secondly, compensatory 
GSH synthesis by the host incurs excessive energy consumption on the cell and may 
subsequently affect its viability (Shibayama et al., 2007). Taken together, it is evident 
that GGT is a formidable virulence factor of H. pylori whose actions cannot be 
underestimated. 
 
2.7 Host internalization of H. pylori proteins  
 Several virulence factors of H. pylori have been reported to be internalized by 
host cells. One of the best studied is that of the oncogenic CagA, which is delivered 
from the bacterium into the host via the T4SS where it then hijacks the host cell 
signalling system (Odenbreit et al., 2000). In addition, peptidoglycan is another 
polymer that has been described to be transported through the T4SS into the host 
(Viala et al., 2004). Apart from CagA and peptidoglycan, however, there have been 
no other reports to date describing other effectors which are translocated through the 
T4SS (Fischer, 2011).  
Other H. pylori factors that have been reported to be taken up by host cells 
include VacA (Gauthier et al., 2005) and TNF-α inducing protein (Tipα) (Watanabe et 
al., 2010). These proteins are not mediated through the H. pylori T4SS but rather are 
secreted by the bacterium and subsequently taken up by the host cell via various 
pathways of endocytosis. Internalized VacA induces several cellular effects 
(previously discussed in section 2.4.4) including vacuolation induction (Isomoto et 
al., 2010). Interestingly, Tipα has been found to subsequently localize to host cell 
nuclei where it is postulated to regulate the expression of genes such as TNF-α, 
resulting in tumour development (Suganuma et al., 2006). Another route which H. 
pylori utilizes to deliver proteins into host cells is through the shedding of outer 
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membrane vesicles (OMVs) which have been shown to be subsequently taken up by 
gastric epithelial cells (Parker et al., 2010). Importantly, these vesicles contain a range 
of virulence-associated factors including CagA, VacA and GGT (Olofsson et al., 
2010). Given that most H. pylori do not adhere directly to the gastric epithelium 
during an infection (Hessey et al., 1990), it is believed that internalization of some of 
its secreted virulence factors plays an important role in its pathogenesis. 
 
2.7.1 Endocytosis pathways 
The plasma membrane of a cell is a dynamic and complex structure which 
serves to physically segregate intracellular contents from the extracellular 
environment. Passage of molecules into and out of the cell is tightly regulated and 
only some small molecules (e.g. CO2, O2, water, etc) are able to diffuse freely across 
the membrane. Macromolecules, on the other hand, cannot traverse the membrane on 
their own and must be brought into the cell via membrane-bound vesicles that are 
pinched off from the plasma membrane, a process known as endocytosis (Conner and 
Schmid, 2003). Endocytosis occurs by multiple mechanisms and these can be 
classified into two main categories, namely phagocytosis (uptake of large particles) 
and pinocytosis (uptake of fluid and solutes) (Soldati and Schliwa, 2006). These 




















 Phagocytosis is generally restricted to specialized mammalian cells such as 
macrophages, monocytes and neutrophils (Conner and Schmid, 2003) and is a major 
mechanism used by the immune system to remove pathogens (Stuart and Ezekowitz, 
2008). The process involves the cell-surface recognition of specific particles (e.g. 
bacteria, apoptotic cells, etc), their engulfment through a cup-shaped membrane 
distortion encircling the object and the subsequent formation of internalized 
phagosomes (Kumari et al., 2010). Once formed, phagosomes undergo maturation to 
become acidic and hydrolytic, ultimately resulting in the degradation of the cargo 




 Macropinocytosis is the bulk engulfment of extracellular fluid that mediates 
the non-selective uptake of solute macromolecules (Swanson and Watts, 1995). It 
involves actin-mediated plasma membrane ruffling where a subset of the lamellipodia 
formed fold back onto themselves, fuse at the base of the membrane and trap solutes 
in macropinosomes (Lim and Gleeson, 2011). Macropinosomes are heterogeneous in 
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size and can range from 0.2 μm to 10 μm in diameter (Swanson, 2008). The process is 
constitutively activated in immune cells such as dendritic cells and macrophages 
(Norbury et al., 1997; Krysko et al., 2006) while in other cells types (e.g. epithelial 
cells), macropinocytosis can be activated by growth factor stimulation (Haigler et al., 
1979). 
 
2.7.1.2.2 Clathrin-dependent endocytosis 
Clathrin-mediated endocytosis occurs constitutively in all mammalian cells 
(Conner and Schmid, 2003) and is the best understood among all the known pinocytic 
pathways. It typically involves the concentration of receptor-ligand complexes into 
clathrin-coated pits on the plasma membrane that invaginate and pinch off to form 
endocytic vesicles, thus bringing cargo molecules into the cell (Kumari et al., 2010).  
The large GTPase dynamin is responsible for scission of the clathrin-coated vesicle 
from the plasma membrane (van der Bliek et al., 1993). Unlike the sizes of 
phagosomes and macropinosomes, clathrin-coated vesicles are only ~100 nm in 
diameter (Traub, 2011).  Some examples of pathogens that enter into the cell via 
clathrin-mediated endocytosis include Ebola virus (Bhattacharyya et al., 2010) and 
severe acute respiratory syndrome coronavirus (Inoue et al., 2007). 
 
2.7.1.2.3 Caveolin-mediated endocytosis 
Caveolin-mediated endocytosis, on the other hand, is less well-characterized. 
It generally involves formation of flask-shaped invaginations (termed caveolae) at the 
cell surface lined by caveolin which are integral membrane proteins that bind to 
membrane cholesterol (Kumari et al., 2010). Formation of caveolae is dependent on 
cholesterol and loss of membrane cholesterol results in their disassembly (Hailstones 
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et al., 1998). Binding of specific cargoes to receptors within the caveolae then 
stimulates the endocytosis of these caveolae into the cell. Similar to clathrin-mediated 
endocytosis, severing of caveolin-coated vesicles is also dependent on dynamin 
(Henley et al., 1998). Caveolae can be found in various cell types but are most 
abundantly expressed on endothelial cells, smooth-muscle cells, fibroblasts and 
adipocytes (Parton et al., 1994). Examples of cargoes endocytosed by this pathway 
include Simian virus 40 (Norkin et al., 2002) and cholera toxin (Parton et al., 1994).  
 
2.7.1.2.4 Clathrin- and caveolin-independent endocytosis 
 The mechanisms underlying clathrin and caveolin-independent endocytosis 
remain poorly understood. These pathways involve the internalization of non-coated 
vesicles which may or may not be dependent on fission by dynamin. In addition, in 
the case of endocytosis of glycosylphosphatidylinositol-anchored proteins (GPI-APs), 
they are delivered to the early endosome via intermediate structures known as 
clathrin- and dynamin-independent carriers (CLICs) and GPI-AP enriched early 
endosomal compartments (GEECs) (Sabharanjak et al., 2002). Other cargoes known 
to be endocytosed in a clathrin and cavelin-independent manner include IL-2 receptor 
(Lamaze et al., 2001) and human papillomavirus type 16 (Spoden et al., 2008). 
 
2.7.2 Mechanisms of nuclear import  
2.7.2.1 Classical pathway 
Nuclear import is tightly regulated and is an energy-requiring process (Kohler 
et al., 1999). Proteins targeted for the nucleus have to be ferried through the nuclear 
pore complex (NPC) by transport carriers called importins although small molecules 
(< ~20 kDa) may passively diffuse through the pore (Chook and Blobel, 2001). The 
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primary determinant of nuclear localization is the nuclear targeting signal and the best 
characterized nuclear import signal to date is the classical NLS. Classical NLSs are 
highly basic consensus sequences that are usually rich in lysines and can either be 
monopartite (consisting of a single cluster of 5-7 amino acids) or bipartite (having two 
clusters of basic amino acids separated by a linker of 10-12 amino acids) (Kosugi et 
al., 2009). Transport substrates are recognized through their classical NLSs by 
importin α which serves as an adaptor protein by binding both NLS-containing 
cargoes and importin β1 to form a trimeric protein complex (Lange et al., 2007). This 
complex then docks on the NPC via importin β1 and is subsequently imported into the 
nucleus through the NPC. Once inside the nucleus, the complex is dissociated by Ran 
GTP and importins α and β are recycled back into the cytoplasm. This pathway is 











Figure 4. The classical nuclear import cycle. 
2.7.2.2 Alternative pathways 
Apart from the classical nuclear import pathway, alternative pathways have 
also been described. For instance, several proteins are imported through direct 
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interactions with importin β1without the need for the adaptor importin α (Takizawa et 
al., 1999; Forwood et al., 2001). The NLSs recognized directly by importin β1, 
however, are less well-defined. They are generally longer than classical NLSs and are 
rich in arginine (Palmeri and Malim, 1999) although non-arginine rich NLSs have 
also been identified (Lam et al., 2001). Interestingly, direct importin β-cargo transport 
was found to be faster and more efficient than that mediated by the importin α-
importin β complex although the latter pathway may exist to control nuclear import 
rates (Riddick and Macara, 2007).  
Importin β2 is another relatively well-described nuclear import carrier that 
binds directly to cargoes and transports them across the NPC. Unlike the well-defined 
classical NLSs, the NLSs that importin β2 recognize are diverse in sequence and 
structure. However, although they do not have a consensus sequence, they do have 
some common characteristics such as being structurally disordered, having an overall 
basic character and possessing a set of weakly conserved sequence motifs (Lee et al., 
2006). Accordingly, these atypical NLSs have been categorized in a new class termed 
as PY-NLS.  
Apart from importins β1 and β2, several other importins have also been 
described to import cargoes into the human nucleus (Mosammaparast and Pemberton, 
2004). However, few cargoes have been identified. This is because most of their 
import signals have not been determined. Furthermore, many nuclear proteins do not 
have a recognizable NLS and several also contain import signals that do not resemble 
previously described NLSs (Christophe et al., 2000), thus making nuclear localization 
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3.1 H. pylori strains used in the study 
 
H. pylori strain 88-3887 (kindly provided by Prof. Berg D.E., Washington 
University School Medicine, St Louis, USA) was the predominant strain used in this 
study. This strain is a pig-passaged motile variant of 26695 with an ability to colonize 
mice (Hoffman et al., 2003). Different isogenic H. pylori mutants (Δggt, ΔvacA, 
ΔvacA/ggt, ΔcagA, ΔcagA/ggt, ΔureAB, ΔureAB/ggt and ΔcagPAI) were constructed 
from the wild type strain 88-3887 and used in the study. In addition, three other 
standard H. pylori strains: 26695, SS1 and NCTC11637 were also utilized. A total of 
seven clinical strains isolated from biopsies obtained from the gastric antrum within 2 
cm of the pylorus (Lui et al., 2003) in patients who underwent upper gastrointestinal 
endoscopy at the National University Hospital in Singapore were also used in this 
study. Informed consent was obtained from all patients for gastroscopy and biopsies. 
 
3.1.1 Growth conditions 
All standard and clinical H. pylori strains were cultured on non-selective 
chocolate blood agar (CBA) plates containing Blood Agar base No. 2 (Oxoid) and 
supplemented with 5% lysed horse blood (Quad Five) (Appendix 1). Isogenic mutants 
were cultured on selective CBA plates supplemented with kanamycin (20 μg/ml) or 
chloramphenicol (15 μg/ml) (Appendix 2) according to the respective antibiotic 
resistance cassette inserted (Table 1). All cultures were incubated at 37°C in an 
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Table 1. Antibiotic resistance of constructed H. pylori mutants. 
 
H. pylori mutant Antibiotic resistance 
Δggt kanamycin 
ΔvacA chloramphenicol 
ΔvacA/ggt chloramphenicol and kanamycin 
ΔcagA chloramphenicol 
ΔcagA/ggt chloramphenicol and kanamycin 
ΔureAB chloramphenicol 





3.1.2 Maintenance of H. pylori cultures 
Confluent growth of H. pylori cultures were harvested from 2 CBA plates 
using sterile cotton swabs (Copan). The bacteria were then resuspended in a cryotube 
(Nunc) containing 1 ml of brain heart infusion (BHI) broth (Oxoid) supplemented 
with 10% horse serum and 20% glycerol (Appendix 3). The cultures were stored at -
80°C until use. 
 
3.2 Genotyping of H. pylori virulence genes 
3.2.1 Genomic DNA extraction 
 Bacterial cells from CBA plates were harvested and transferred to microfuge 
tubes containing 1.5 ml Tris-EDTA (TE) buffer (Appendix 4). The bacterial 
suspension was centrifuged at 8000 × g for 5 minutes at room temperature and the 
pellet washed once with TE buffer. Thereafter, chromosomal DNA was extracted by 
silica-membrane-based nucleic acid purification using the QIAamp DNA Mini Kit 
(Qiagen) according to the manufacturer’s protocol. The amount of extracted DNA 
was measured spectrophotometrically at wavelength 260 nm using NanoDropTM 1000 
Spectrophotometer (Thermo Scientific). 
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3.2.2 Polymerase Chain Reaction (PCR) 
PCR was carried out to determine the presence of various virulence genes, 
namely cagA, vacA, iceA1, iceA2 and babA2, in the chromosomal DNA of H. pylori 
strain 88-3887. The PCR reaction was carried out in an amplification thermal cycler 
(Bio-Rad) according to the method as described by Zheng et al. (2000). To amplify 
cagA, vacA, iceA1 and iceA2, a 50 µl reaction mixture consisting of 50 ng genomic 
DNA, 1 × incubation buffer, 50 pmol primers (forward and reverse) (Table 2), 1 unit 
of Taq DNA polymerase (DynaZyme), 200 µM each of dNTPs (dATP, dGTP, dTTP 
and dCTP) and sterile distilled water (Appendix 5) was used. For the amplification of 
babA2, a 50 µl reaction mixture consisting of 40 ng genomic DNA, 1 × incubation 
buffer, 10 pmol primers (forward and reverse) (Table 2), 1 unit of Taq DNA 
polymerase (DynaZyme), 200 µM each of dNTPs (dATP, dGTP, dTTP and dCTP) 
and sterile distilled water was prepared. 
 The amplification reaction included an initial denaturation at 94°C for 5 
minutes, annealing at 50°C for 1 minute and elongation at 72°C for 1 minute. This 
was followed by 39 cycles of denaturation at 94°C for 1 minute, annealing at 50°C for 
1 minute and elongation at 72°C for 1 minute. In the final cycle, the reaction 
comprised denaturation at 94°C for 1 minute, annealing at 50°C for 1 minute and 
elongation at 72°C for 5 minutes. At the end of the PCR process, the reaction 
temperature was brought down to and held at 4°C. The PCR products were stored at -
20°C until use. For babA2, all amplification steps were similar except that annealing 
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Table 2. Primers used to amplify various virulence genes of H. pylori. 
 
Primer 







cagAR TTGTTGCCGCTTTGCTCTC 50 400 
vacAF GCTTCTCTTACCACCAATGC 
vacAR TGTCAGGGTTGTTCACCATG 50 1160 
iceA1F GTGTTTTTAACCAAAGTATC 
iceA1R CTATAGCCAGTCTCTTTGCA 50 246 
iceA2F GTTGGGTATATCACAATTTAT 
iceA2R TTGCCCTATTTTCTAGAGGT 50 229/334 
babA2F AATCCAAAAAGGAGAAAAAGTATGAAA
babA2R TGTTAGTGATTTCGGTGTAGGACA 52 831 
F: Forward primer; R: Reverse primer; Ta : annealing temperature. 
 
3.2.3 Agarose gel electrophoresis 
An aliquot of 10 µl of PCR product was mixed with 2 μl of 6 × loading buffer 
(Appendix 6) and electrophoresed in a 1% horizontal agarose (Seakem) gel containing 
ethidium bromide (Appendix 7) for 1-2 hours at 80 V in 1 × Tris acetate EDTA 
(TAE) buffer (Appendix 8). Molecular weight markers (100 bp ladder) (Fermentas) 
were also included in the run to enable easy identification of the band sizes of the 
PCR products. At the end of each electrophoresis gel run, the ethidium bromide-
stained gel was photographed with filtered ultraviolet illumination under the 
Electrophoresis Documentation and Analysis System 290 (Kodak).  
 
3.3 Bradford protein assay 
Bradford protein assay was used to determine the amount of protein in 
samples. The protocol was carried out according to the manufacturer’s instructions 
(Bio-Rad). A standard curve was constructed using different known concentrations 
(0.2 – 1 mg/ml) of bovine serum albumin (BSA; Merck). Determination of protein 
content in samples was carried out by adding 1 µl of each sample in 0.1 ml dye 
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reaction solution. The dye reaction solution was earlier prepared by mixing 1 part of 
concentrated Bio-Rad dye solution with 4 parts of deionized water and filtered 
through Whatman filter paper. The mixture was vortexed and incubated at room 
temperature for 15 minutes. The optical density (OD) was measured at 595 nm in a 
microplate reader (Bio-Rad). The protein concentration of samples was calculated 
based on the standard curve.  
 
3.4 Sodium dodecyl sulphate – polyacrylamide gel electrophoresis (SDS-PAGE)  
3.4.1 Preparation of SDS-polyacrylamide gel 
Vertical minislab gels (1 mm) comprising 12% resolving gel and 4% stacking 
gel (Appendix 9) were cast using the Mini-protean II system (Bio-Rad). The two-gel 
system (stacking and resolving gel) significantly enhances the sharpness of the bands 
within the gel.  
 
3.4.2 Sample preparation and electrophoretic gel run 
 Protein samples (10 μl) were mixed with 3 μl of 5 × SDS loading buffer 
(Appendix 10) and boiled for 5 minutes before being loaded into the wells of the gel 
slab placed in a mini-PROTEAN 3 vertical electrophoresis system (Bio-Rad). 
Electrophoresis was performed in running buffer (Appendix 11) at 0.03A/gel at room 
temperature with Power Pac 250 (Bio-Rad) until the dye front reached the bottom of 
the gel. Prestained Protein Ladder (Bio-Rad) was used as the molecular marker. 
 
3.4.3 Gel staining and visualization of protein bands 
 Gels were stained with Coomassie blue solution R-250 (Appendix 12) with 
gentle shaking for 30 minutes. Following which, the gels were destained with 
destaining solution (Appendix 13) until the background became clear.  
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3.5 Cloning and expression of recombinant full length GGT (rGGT), large 
subunit (rGGTL) and small subunit of GGT (rGGTS)  
3.5.1 Construction of pRSET-ggt, pRSET-ggtl and pRSET-ggts 
3.5.1.1 Cloning strategy 
pRSET-A expression vector (Invitrogen) was used for the cloning of full 
length ggt excluding the signal peptide (ggt; 79th-1704th bp), the ggt gene fragment 
encoding the large (ggtl: 79th-1137th) and small subunit of GGT (ggts; 1138th-1704th 
bp). Inserts ggt (red), ggtl (green) and ggts (blue) were ligated separately into the 





















Figure 5. Schematic construction of pRSET-ggt, pRSET-ggtl and pRSET-ggts 
recombinant expression vector. (A) Diagrammatical representation of H. pylori full 
length ggt gene (1704 bp). (B) Physical map of pRSET-ggt (red), pRSET-ggtl (green) 
and pRSET-ggts (blue) recombinant expression vectors. (C) Multiple cloning site of 
pRSET-A vector.  
pRSET-ggts (3447 bp) 
PstI 
6 × His tag  89 bp 
HindIII 
1626 / 1059 / 567 bp 
ATG 
12 bp 
pRSET-ggt (4506 bp) 
pRSET-ggtl (3939 bp)
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3.5.1.2 PCR amplification of ggt, ggtl and ggts 
H. pylori strain 88-3887 genomic DNA was used as the template. Primers 
were designed according to the genomic sequence of H. pylori strain 26695 (Tomb et 
al., 1997). Primer sequences are illustrated in Table 3. PstI and HindIII restriction 
sites (underlined) were introduced in the 5’ and 3’ ends respectively for insertion into 
the expression vector downstream of Histidine-tag. The PCR amplification condition 
was set as 30 cycles of denaturation at 94°C for 1 minute, annealing at 50°C for 45 
seconds and elongation at 72°C for 2 minutes. The PCR cycles were carried out in an 
amplification thermal cycler (Bio-Rad) and the amplified gene products were purified 
using QIAquick PCR Purification Kit (Qiagen) according to the manufacturer’s 
protocol. 
 
Table 3. Sequences of primers used to amplify ggt, ggtl and ggts. 
 
Target Primer Primer sequence (5’ → 3’) Length (bp) 
ggtF GCCGCTGCAGCGCGAGTTACCCCCCCATTAAA ggt ggtR GCCGAAGCTTTTAAAATTCTTTCCTTGGATCCGTT 1626 
ggtlF GCCGCTGCAGCGCGAGTTACCCCCCCATTAAA ggtl ggtlR GCCGAAGCTTATTGCTCCCCTCATGCAACTG 1059 
ggtsF GCCGCTGCAGCACCACGCATTATTCTGTAGCGGAC ggts ggtR GCCGAAGCTTTTAAAATTCTTTCCTTGGATCCGTT 567 
PstI (CTACAG) and HindIII (AAGCTT) restriction sites are underlined. 
 
3.5.1.3 Restriction enzyme digestion 
Restriction enzyme digestion of the plasmid vector pRSET-A and the 
respective PCR products (from section 3.5.1.2) was carried out using PstI and HindIII 
(Promega) simultaneously at 37°C for 4 hours. Buffers compatible to both enzymes 
were used for this double digest. Respective restriction enzymes were used to digest 
0.5 to 1.0 µg of DNA sample. After digestion, restriction enzymes were heat-
inactivated at 65°C for 20 minutes. 
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3.5.1.4 Extraction and purification of insert and plasmid vector 
The products from the restriction enzyme reactions were analyzed by agarose 
gel electrophoresis as described in section 3.2.3. The desired DNA bands were 
excised from the agarose gel with a clean surgical blade. QIAquick Gel Extraction Kit 
(Qiagen) was used to purify the excised bands as recommended by the manufacturer. 
Purified DNA samples were stored at -20°C until use.  
 
3.5.1.5 Ligation of insert into expression vector pRSET-A 
The amount of DNA from the purified digested inserts and pRSET-A was 
measured spectrophotometrically as described in section 3.2.1. The molar ratio of 
insert DNA to vector DNA used was 3:1. Ligation reaction (10 μl) containing ligase 
buffer, insert DNA, plasmid vector and T4 DNA ligase (Promega) was carried out at 
4°C overnight. 
 
3.5.2 Transformation of Escherichia coli 
3.5.2.1 E. coli strains 
E. coli Top10 was used as a host for cloning and maintenance of plasmids as it 
gives high transformation efficiency and good plasmid yield. E. coli BL21 (DE3) 
pLysS (Novagen) was used as an expression host because it contains a chromosomal 
copy of the gene for T7 polymerase which facilitates the production of recombinant 
protein upon induction with isopropyl-β-D-thiogalactopyranoside (IPTG). 
E. coli Top10 and BL21 (DE3) pLysS were grown in Luria-Bertani (LB) broth 
(Appendix 14) or on LB agar plates (Appendix 15) at 37°C. Plasmid-transformed E. 
coli was grown at 37°C on LB agar plates supplemented with 50 µg/ml ampicillin 
(Appendix 16). 
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3.5.2.2 Preparation of competent E. coli 
Competent cells were prepared as previously described (Sambrook et al., 
1989). Briefly, a single bacterial colony of E. coli was inoculated into 5 ml LB broth 
and incubated overnight at 37°C on a shaker incubator (Certomat) at 200 rpm. From 
the overnight bacterial culture, 1 ml was transferred into 100 ml LB broth and 
incubated at 37°C on a shaker incubator at 200 rpm for 2-4 hours. The growth of the 
bacteria was monitored periodically by measuring at OD600 using a spectrophotometer 
(Beckman Coulter) . The cells were harvested when OD600 reached approximately 0.3. 
Thereafter, 30 ml of bacterial culture was transferred into a sterile 50 ml centrifuge 
tube (Falcon) and cooled on ice for 10 minutes before centrifuging at 6000 × g for 5 
minutes at 4°C to obtain a cell pellet. The supernatant was discarded and the tube was 
inverted to drain off excess liquid. The cell pellet was resuspended in 15 ml of ice-
cold 0.1 M CaCl2 (Appendix 17) and placed on ice for 30 minutes. The CaCl2-treated 
cells were centrifuged at 6000 × g for 5 minutes at 4°C. The supernatant was 
discarded and the tube was inverted to remove excess fluid. The cell pellet was then 
resuspended in 2 ml ice-cold 0.1 M CaCl2 containing 20% glycerol. Aliquots of 200 
µl were stored in microfuge tubes at -80°C until use. 
 
3.5.2.3 Transformation and selection of positive clones 
The ligated products (from section 3.5.1.5) were added into 200 µl of thawed 
E. coli Top10 competent cells and gently mixed by tapping. The suspension was 
incubated on ice for 30 minutes and then heat-shocked at 42°C in a water bath for 90 
seconds without shaking. The suspension was quickly transferred on ice for 2 
minutes. An aliquot of 800 µl of LB broth was then added into the DNA-cell 
suspension and incubated at 37°C for 1.5 hours with gentle shaking at 90 rpm. From 
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the suspension, 200 µl was spread onto LB agar plates containing 50 µg/ml 
ampicillin, IPTG and 5-bromo-4-chloro-indolyl-β-D-galactopyranoside (X-Gal) 
(Appendix 18) and incubated overnight at 37°C for a maximum of 20 hours. Blue-
white selection was used to screen for E. coli transformed with plasmid vector and 
insert.  
 
3.5.3 Purification and identification of recombinant plasmid 
A single white colony of E. coli grown on LB agar plate (supplemented with 
ampicillin, IPTG and X-Gal) was inoculated into 5 ml LB broth containing 50 µg/ml 
ampicillin and incubated overnight at 37°C on a shaker incubator at 200 rpm. Plasmid 
DNA was extracted using MiniPrep Kit (Qiagen) according to the manufacturer’s 
instructions.  
Extracted plasmids were digested with PstI and HindIII to screen for positive 
pRSET-ggt, pRSET-ggtl and pRSET-ggts clones as described in section 3.5.1.3. PCR 
was also carried out using the primers as recorded in Table 3 to screen for the 
presence of the respective gene fragments in the extracted plasmids. 
 
3.5.3.1 DNA sequencing 
 DNA sequencing was performed using the ABIPRISM BigDyeTM Terminator 
sequencing kit (Applied Biosystems). A total of 4 primers, T7 and T7R (specific to 
sequence on the pRSET-A vector upstream and downstream of the multiple cloning 
site respectively), F2 and F3 (specific to regions on ggt gene) were used (Table 4). 
The sequencing reaction included 25 cycles of 96°C for 10 seconds, 50°C for 5 
seconds and 60°C for 4 minutes. After the reaction was completed, ethanol 
precipitation was used to remove excess terminators and primers. Precipitated 
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products were sequenced using ABI 100 model 377 DNA sequencer (Applied 
Biosystems).  
 
Table 4. Primers for DNA sequencing of ggt, ggtl and ggts gene inserts cloned 
into pRSET-A vector. 
 
Primer name Sequence (5’ → 3’) Position on ggt gene 
T7 TAATACGACTCACTATAGGG - 
T7R TATGCTAGTTATTGCTCAG - 
F2 GCGATTTCACAAAGACAAGC  511-531  
F3 ATGGGGCAGTTGCATGAG  1111-1129  
  
 
3.5.4 Expression of rGGT, rGGTL and rGGTS 
3.5.4.1 Induction of target proteins 
The recombinant proteins (rGGT, rGGTL or rGGTS) were induced as 
recommended by the manufacturer (Invitrogen). The constructed recombinant 
expression vector pRSET-ggt, pRSET-ggtl or pRSET-ggts was transformed into E. 
coli expression strain BL21 (DE3) pLysS by the method described in section 3.5.2.3. 
To optimize the conditions for induction, a single colony of transformed E. coli BL21 
(DE3) pLysS was picked and inoculated into 5 ml of LB medium supplemented with 
50 µg/ml ampicillin. The culture was shaken overnight vigorously in a 37°C shaking 
incubator at 200 rpm. An aliquot of 100 µl of overnight culture was inoculated into 5 
ml LB medium supplemented with 50 µg/ml ampicillin and the cultures were shaken 
vigourously at 200 rpm at 37°C until an OD600 of 0.5 was reached. Cultures were then 
supplemented with IPTG (ranging from 0.2 mM to 0.8 mM final concentration) and 
shaking was continued. Induced cells were collected after 3 hours of incubation. 
Uninduced cells served as the negative control. After centrifugation at 6000 × g for 5 
minutes, cell pellets were thoroughly resuspended in 50 µl of SDS loading buffer and 
subjected to SDS-PAGE analysis as described in section 3.4. The large scale 
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expression of rGGT, rGGTL and rGGTS was subsequently carried out in 100 ml LB 
medium according to the respective optimized conditions for induction. 
 
3.5.4.2 Localization of target proteins 
Induction of respective E. coli clones in 5 ml LB medium was carried out 
under the optimized conditions (rGGT: 0.4 mM IPTG; rGGTL: 0.2 mM IPTG; 
rGGTS: 0.2 mM IPTG) as described in section 3.5.4.1. Cells were then centrifuged at 
6000 × g for 10 minutes at 4°C. The supernatant was collected and the pellet was 
resuspended in 0.5 ml of phosphate-buffered saline (PBS) (Appendix 19).  This cell 
suspension was sonicated on ice at 10 MHz for 10 seconds with 10 seconds rest for 20 
cycles using a Soniprep 150 sonicator (Sanyo). The whole cell lysate was then 
centrifuged at 8000 × g for 10 minutes at 4°C. The supernatant and pellet obtained 
served as the soluble and insoluble fraction respectively. The pellet was resuspended 
in SDS loading buffer and all fractions were subjected to SDS-PAGE as described in 
section 3.4.  
 
3.5.5 Purification of rGGT, rGGTL and rGGTS 
3.5.5.1 Preparation of cell extracts 
 Induction of respective E. coli clones in 100 ml LB medium was carried out. 
Cells were harvested at 6000 × g at 4°C for 5 minutes, resuspended in binding buffer 
(Appendix 20A) and sonicated on ice 20 times for 10 seconds at 10 MHz amplitude 
with 10 seconds rest using a Soniprep 150 sonicator (Sanyo). The whole cell lysate 
was then centrifuged at 8000 × g for 10 minutes at 4°C to separate the soluble and 
insoluble fractions. As rGGT was found to be substantially present in both the soluble 
and insoluble fractions, the soluble fraction was used in the downstream purification 
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process as insolubility generally indicates misfolding of the protein (Fahnert et al., 
2004). The solution was filtered through a 0.45 µm syringe filter (Millipore) before 
purification. On the other hand, rGGTL and rGGTS were exclusively found in the 
insoluble fraction. Hence, purification of rGGTL and rGGTS was carried out under 
denaturing conditions. After centrifugation of the whole cell lysate, the pellet was 
resuspended in binding buffer containing 6 M urea for 2 hours at 4°C with gentle 
shaking to completely dissolve the protein. The remaining insoluble content was 
removed by centrifugation at 6000 × g for 10 minutes while the supernatant was 
filtered through a 0.45 µm syringe filter (Millipore).  
 
3.5.5.2 His-Tag affinity chromatography 
Purification of rGGT was carried out using affinity chromatography through a 
nickel chelating column (GE Healthcare) according to the manufacturer’s instructions. 
The column was first washed with distilled water and subsequently charged with 1 × 
charge buffer (Appendix 20B). The column was then equilibrated with 1 × binding 
buffer (Appendix 20A). Following which, the sample (from section 3.5.5.1) was 
loaded onto the column and washed with 1 × binding buffer to remove unbound 
proteins. The column was then washed again with 6 volumes of 1 × wash buffer 
(Appendix 20C). The target protein was eluted with an ascending gradient of 
imidazole ranging from 0.1 – 1 M using 6 column volumes of 1 × elute buffer 
(Appendix 20D). After elution, the column was stripped with 1 × strip buffer 
(Appendix 20E). All fractions collected throughout the purification procedures were 
subjected to SDS-PAGE as described in section 3.4 and protein concentration was 
measured by Bradford protein assay (as described in section 3.3). Purification of 
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rGGTL and rGGTS was subjected to the same procedures except that binding, wash 
and elute buffers loaded onto the column contained 6 M urea. 
 
3.5.5.3 Dialysis of purified recombinant proteins 
The eluted rGGT protein was dialyzed against three changes of PBS at 4°C for 
10-12 hours each. For rGGTL and rGGTS, the proteins were first diluted to a 
concentration of 50 µg/ml. Following which, step-wise dialysis against three changes 
of PBS buffer containing decreasing concentrations of urea (4 M – 0 M) was carried 
out at 4°C for 10-12 hours each. Concentration of the recombinant proteins was 
carried out using PEG 35000 (Merck). 
 
3.5.5.4 Mass spectrometry 
Purified recombinant proteins were subjected to SDS-PAGE and the 
coomassie blue-stained protein bands of interest were individually excised. In-gel 
trypsin digestion was then carried out according to the method as described by 
Shevchenko et al. (1996). All reagents used were of high performance liquid 
chromatography (HPLC) grade. The target protein bands were excised from the gel 
with a clean blade and grinded into small pieces in a microcentrifuge tube. The gel 
pieces were immersed in 100 μl of 100 mM ammonium bicarbonate/50% (v/v) 
acetonitrile (Merck), vortexed and left to stand for 5 minutes at room temperature. 
The solution was removed and the step was repeated 2-3 times until the gel washings 
came out colourless. The white and opaque gel pieces were then treated with 50 μl 
acetonitrile for 5 minutes. After removal of the acetonitrile, the gel pieces were dried 
in a vacuum centrifuge (Thermo Electron Corporation). 
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Reduction of the protein sample was carried out by adding a fresh solution of 
10 mM dithiothreitol (DTT) in 100 mM ammonium bicarbonate with a volume 
enough to cover the gel fully. The sample was incubated at 57°C for 60 minutes. 
Afterwhich, the excess DTT was aspirated and the protein samples were alkylated 
with 55 mM iodoacetamide solution in 100 mM ammonium bicarbonate. The reaction 
was carried out in the dark and left at room temperature for 60 minutes. After 
alkylation, the gel pieces were washed thrice with 100 µl of 100 mM ammonium 
bicarbonate solution and dehydrated twice with 100 µl acetonitrile. Washing and 
dehydration steps were repeated twice before drying to completion with a vacuum 
centrifuge. 
The dried gel pieces were incubated with 12.5 ng/μl modified sequencing 
grade trypsin (Promega) in 50 mM ammonium bicarbonate (15-30 μl, depending on 
the size of the gel pieces) for 30 minutes at 4°C. Excess trypsin solution was then 
removed and 15 μl of 50 mM ammonium bicarbonate solution was added. The 
digestion was continued overnight at 37°C, afterwhich the digested gel pieces were 
centrifuged at 6000 × g for 10 minutes and the supernatant transferred to a fresh 
microcentrifuge tube. The gel pieces were then further treated with 20 mM 
ammonium bicarbonate and the supernatant was again saved after centrifugation. 
Finally, the gel pieces were treated with 5% formic acid in 50% aqueous acetonitrile 
(10-25 µl) for 5-10 minutes at room temperature before centrifugation. All three 
supernatants containing the digested peptides were pooled and dried in a vacuum 
centrifuge to completion. The peptides were subsequently purified and concentrated 
using Zip Tip C18 (Millipore) before being sent for identification by mass 
spectrometry. Peptide mass fingerprints and sequence were obtained using a matrix-
assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometer 
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(Micromass Q-Tof Tandem Mass Spectrometer; Applied Biosystems). Mass 
spectrometry was performed at the Protein and Proteomics Centre, National 
University of Singapore and the data was analyzed using NCBI database search 
(www.matrixscience.com) to determine the identity of the proteins. 
 
3.5.5.5 GGT activity assay 
GGT activity was assayed according to the method described by Gong and Ho 
(2004). γ-glutamyl-ρ-nitroanilide (Sigma-Aldrich) was used as a donor substrate and 
glycyl-glycine (Sigma-Aldrich) was used as the glutamate acceptor for the 
transpeptidation reaction. Briefly, purified rGGT was incubated at 37°C for 30 
minutes in 1 ml of 100 mM Tris-HCl (pH 8.0) in the presence of 1 mM γ-glutamyl-ρ-
nitroanilide and 20 mM glycyl-glycine (Appendix 21). The production of free ρ-
nitroanilide released in the incubation medium was determined by spectrophotometry 
at 405 nm. One unit of GGT activity was defined as the quantity of enzyme that 
releases 1 μmol ρ-nitroaniline per minute per mg of protein at 37°C. Bovine GGT 
(Sigma-Aldrich) served as control. 
 
3.6 Raising antibody against rGGTS and rGGT 
3.6.1 Raising polyclonal antibody in rabbits using rGGTS 
 Polyclonal antibodies were generated against rGGTS as the small subunit of 
GGT is more conserved than the large subunit (Chevalier et al., 1999). These 
antibodies were later used to detect for the presence of GGT in gastric epithelial cells 
by western blot analysis. 
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3.6.1.1 Immunization procedure 
 Antibody against rGGTS was raised in rabbits according to the method as 
described (Coligan and Current Protocols Online., 1992) with slight modifications. 
The study was approved by the Institutional Animal Care and Use Committee, 
National University of Singapore. After refolding, the mixture of purified rGGTS 
(150 μg) and Complete Freund’s adjuvant (Sigma-Aldrich) was injected into a New 
Zealand white rabbit (~1.2 kg) subcutaneously at 7-8 different spots. Two boosters 
(consisting of 150 μg rGGTS and Incomplete Freund’s adjuvant) were given on days 
28 and 42 after the first immunization respectively. Blood (~15 ml) was drawn from 
the rabbit’s ear before each booster and subsequently on days 56, 71 and 85 after the 
first immunization. The rabbit was sacrificed after the final bleed on day 85. Serum 
was separated from whole blood by centrifugation at 1500 × g for 10 minutes. 
 
3.6.1.2 Enzyme-linked immunosorbent assay (ELISA) 
Antibody production profile was determined by indirect ELISA method as 
previously described (Delves, 1995). In brief, H. pylori wild type or Δggt were first 
lysed in lysis buffer (Appendix 22). The total cell lysate was then diluted in carbonate 
coating buffer (Appendix 23) to a concentration of 100 ng/ml. An aliquot of 100 μl of 
the diluted antigen was coated onto each well of a microtitre plate (Nunc) and 
incubated overnight at 4°C. The coated plate was washed 3 times with 0.05% PBS-
Tween buffer (PBS-T; Appendix 24) and blocked with 2% BSA-PBS (w/v) at room 
temperature for 2 hours. Aliquots of 100 μl of rabbit sera diluted in 2% BSA-PBS 
(1:400) were then added in triplicates and incubated at room temperature for 2 hours. 
The plates were then washed thrice with 0.05% PBS-T before 100 μl of horseradish-
peroxidase-conjugated goat anti-rabbit secondary antibody (1:2000) 
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(DakoCytomation) was added to each well and incubated for another 2 hours at room 
temperature. The plate was then washed thrice with 0.05% PBS-T. Substrate solution 
consisting of tetramethylbenzidine (TMB) and H2O2 (BD Pharmingen) was added to 
each well (100 μl/well) and incubated in the dark for 30 minutes. The reaction was 
stopped using 2N H2SO4 (50 μl/well). Absorbance was read at OD450 with 
substraction of background OD570 using a microplate reader (Bio-Rad). 
 
3.6.1.3 Purification of anti-rGGTS antibody 
 Protein A sepharose CL-4B (Amersham Biosciences) affinity column was 
used to purify IgG from antiserum (Coligan and Current Protocols Online., 1992) 
according to the manufacturer’s protocol. The serum was diluted with 4 volumes of 
50 mM Tris-Cl buffer (pH 7.0) and loaded into the equilibrated column. The specific 
IgG was eluted with 0.1 M glycine-Cl buffer (pH 3.0) and neutralized with 1 M Tris-
Cl (pH 9.0; 50-100 μl/ml fraction) immediately after elution. All buffers used were 
kept on ice during the purification process. The purified IgG was analyzed by SDS-
PAGE (as described in section 3.4) and protein concentration was measured by 
Bradford protein assay (as described in section 3.3). The purified IgG was stored at -
80°C until use. 
 
3.6.1.4 Characterization of antibody by western blot analysis 
Purified IgG was characterized on its binding specificity using Western blot 
analysis. H. pylori wild type and Δggt whole cell lysates (10 μg) were run on SDS-
PAGE (as described in section 3.4) and transferred onto a polyvinylidene fluoride 
(PVDF) membrane (ImmobilionP, Millipore) by semi-dry blotting using Trans-Blot® 
SD Semi-Dry Transfer Cell (Bio-Rad) for 1 hour at 150 mA (Appendix 25). The non-
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specific binding sites of the membrane were blocked overnight with 2% BSA-PBS 
with slight rotation at 4°C. The membrane was then incubated with the purified IgG 
against rGGTS in 2% BSA-PBS (1:4000 dilution) for 2 hours at 4°C on a belly dancer 
(Stovall Life Sciences, Inc). Following which, the membrane was washed with 0.1% 
PBS-T five times for 5 minutes each and incubated with horseradish-peroxidase-
conjugated goat anti-mouse secondary antibody (1:2000 dilution; DakoCytomation) 
for 2 hours at room temperature with slight agitation. The membrane was washed 
again in 0.1% PBS-T for five times. Signals were detected using enhanced 
chemiluminescence detection kit (Pierce) according to the manufacturer’s protocol. 
 
3.6.2 Raising monoclonal antibody (MAb) in mice using rGGT 
3.6.2.1 Immunization, fusion and ascites production 
MAb production was done in collaboration with Dr. Hwang Le-Ann 
(Monoclonal Antibody Unit, Institute of Molecular & Cell Biology, Singapore). 
Briefly, five BALB/c female mice, aged 8 weeks old were immunized with 100 μg of 
purified rGGT emulsified in Complete Freund's Adjuvant (Sigma-Aldrich) by 
intraperitoneal injection. Booster injections were administered 4 times in the same 
manner using Incomplete Freund's Adjuvant (Sigma-Aldrich) at 3-week intervals. 
Prior to hybridoma fusion, GGT-specific antibodies in the serum of immunized mice 
were tested by ELISA and Western blot assays as described in sections 3.6.1.2 and 
3.6.1.4 respectively. The mouse with the highest antibody titre was selected for a final 
boost of 100 μg of purified rGGT intravenously 2 days before the fusion.  Hybridoma 
cells were generated by fusing immune spleen cells with mouse SP2-0/Ag14 
myeloma cells following the manufacturer’s instructions of the ClonaCell®-HY 
hybridoma kit (StemCell technologies).  MAb in supernatants of hybridoma cultures 
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were screened with an ELISA test using purified rGGT as antigen. Positive 
hybridoma clones were subcloned twice by limiting dilution.  Ascitic fluid was 
obtained by introducing 1 x 105 hybridoma cells via intraperitoneal inoculation into 
BALB/c mice pre-primed with Incomplete Freund's Adjuvant. All procedures on the 
use of laboratory animals were done in accordance with the regulations and guidelines 
of the National Advisory Committee for Laboratory Animal Research, Singapore. 
 
3.6.2.2 Characterization of MAbs from different clones 
All anti-GGT MAbs were purified from ascitic fluid using Protein G 
sepharose columns and stored at -20°C.  The isotype of each MAb was determined 
using the IsoStrip Mouse Monoclonal Antibody Isotyping Kit (Roche). Specificity of 
MAb to H. pylori GGT was determined by western blot analysis as described in 
section 3.6.1.4. 
 
3.6.2.3 Epitope mapping strategy 
A library of 267 peptides, consisting of 15 amino acids overlapping by 12 (3-
offset) corresponding to the sequence of GGT, was commercially synthesized 
(PepSetsTM; Chiron Mimotopes). The biotinylated peptides were resuspended at a 
concentration of 5 mg/ml in 40% acetonitrile and stored in aliquots at −20°C. The 
peptides were diluted with 0.1% PBS-T before use. 
Indirect ELISA was performed as follows: 96-well flat-bottom plates (Nunc) 
were coated with 100 μl streptavidin (Sigma-Aldrich) at a concentration of 5 μg/ml 
and left to evaporate to dryness overnight at 37°C. Wells were blocked with 2% BSA-
PBS-T for 1 hour at room temperature and coated with 100 μl of peptides (2.5 μg/ml) 
for another 1 hour. Respective MAbs (1:1000 dilution) were used as primary antibody 
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and goat anti-mouse IgG conjugated with horseradish peroxidase (1:2000 dilution, 
DakoCytomation) was used as secondary antibody. The substrate used was TMB (BD 
PharMingen) as described in section 3.6.1.2. Absorbance was determined at a 
wavelength of 450 nm with subtraction of absorbance at 570 nm in a microplate 
reader (Bio-Rad). Overlapping regions on positive adjacent peptides were used to map 
the minimum epitope sequence specific to each MAb. 
 
3.7 Neutralization of GGT activity using MAbs 
A total of 5 × 106 H. pylori were pre-incubated with various amounts (0.25-30 
μg) of different MAbs for 1 hour at 37°C in a 96-well microtitre plate. Mouse IgG1, 
IgG2a and IgG2b isotype controls were used in parallel at the same concentrations. 
Quantitative detection of GGT activity was then carried out as previously described in 
section 3.5.5.5. Percentage inhibition of GGT activity was calculated as follows:  
 
GGT activity without MAb – GGT activity with MAb % inhibition = GGT activity without MAb × 100% 
 
Where indicated, ability of MAbs to neutralize bovine GGT (1 mU; Sigma-Aldrich) 
was also tested in the same manner. 
 
3.8 Purification of native GGT (nGGT) from H. pylori 
3.8.1 Culture of H. pylori 
H. pylori 88-3887 was used as the source for purification of nGGT. The 3-day 
old bacteria cultures grown on 30 CBA plates were harvested, washed twice with 20 
ml of PBS and resuspended in a final volume of 10 ml of PBS. Bacterial cells were 
disrupted by sonication (30 seconds × 10 with 30 seconds rest at each interval) and 
the cellular debris along with unbroken cells was removed by centrifugation at 8000 × 
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g for 15 minutes at 4°C. The supernatant was centrifuged at 20,000 × g for 90 minutes 
at 4°C and the clear supernatant was collected, membrane filtered (0.2 µm, Sartorius) 
and used for nGGT purification. 
 
3.8.2 Preparation of immunoaffinity resin 
 Purified MAb 1G1 (5 mg) was diluted in coupling buffer (Appendix 26A) at 5 
mg/ml and immobilized on 2 ml of CNBr-activated Sepharose 4B (Amersham 
Biosciences) overnight at 4°C with gentle rotation. Excess ligand was washed away 
with at least 5 medium volumes of coupling buffer. Remaining active groups were 
blocked with 0.1 M Tris-HCl buffer (pH 8.0) (Appendix 26B) for 2 hours and the 
resin was packed into a column according to the manufacturer’s instructions. 
 
3.8.3 Immunoaffinity chromatography 
 The sample obtained as described in section 3.8.1 was loaded in the CNBr-
activated Sepharose 4B column pre-equilibrated with PBS buffer. After 5 column 
volumes wash with PBS, bound nGGT was eluted with elution buffer (Appendix 26C) 
Fractions with GGT activity (measured using GGT activity assay as described in 
section 3.5.5.5) were neutralized by dropwise addition of neutralization buffer (50-
100 μl/ml fraction) (Appendix 26D) and stored at -20°C until use. The purified nGGT 
was analyzed by SDS-PAGE (as described in section 3.4) and the protein 
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3.9 Immunogold-labeling transmission electron microscopy (TEM) 
3.9.1 Preparation of cells and ultrathin sectioning 
Post-embedding immunogold-labeling TEM was performed as previously 
described (Kaur et al., 2002) with slight modifications. H. pylori strain 88-3887 was 
harvested from a 3-day old plate culture and washed with PBS. It was then fixed in 
PBS containing 4% paraformaldehyde, 0.2% glutaraldehyde and 2% sucrose for 5 
hours at 4°C. The fixed cells were washed in 2% sucrose-PBS thrice for 5 minutes 
each and resuspended in 2% sucrose-PBS overnight at 4°C. The next day, the cells 
were washed twice with water for 10 minutes and subsequently dehydrated in an 
ascending graded series of ethanol (ranging from 25% ethanol to absolute) at room 
temperature. Infiltration using LR white resin (Ted Pella) was carried out over 2 days. 
On the first day, the sample was passed through 4 changes of LR white (1 part 
ethanol: 1 part LR white for 30 minutes, 3 parts ethanol: 7 parts LR white for 30 
minutes, 1 change of pure LR white for 30 minutes, followed by another change of 
pure LR white overnight). On the second day, the sample was infiltrated with 4 
changes of pure LR white for 30 minutes each. After the fourth change, the sample 
was embedded in a gelatin capsule. Briefly, 1 mm of block sample was placed in the 
gelatin capsule and LR white was filled to the brim. The capsule was then incubated 
at 50°C for a minimum of 48 hours until polymerization of LR white had occurred. 
Ultrathin sections (70-100 nm) of the sample were cut using an ultramicrotome 
(Ultracut E, Leica) and subjected to immunogold-labeling on a nickel grid. 
 
3.9.2 Localization of GGT in H. pylori 
 The ultrathin sections were washed twice with PBS for 5 minutes each and 
neutralized with 3 changes of 0.05 M glycine-PBS for 5 minutes each. Following 
Materials and Methods 
65 
which, the sections were blocked with 5% BSA-PBS for 1 hour to reduce non-specific 
binding. The sections were then washed with 0.1% BSA-PBS and then incubated with 
MAb 1G1 (1:50 dilution) raised against rGGT (as described in section 3.6.2.1) for 2 
hours at room temperature. This was followed by incubation with anti-mouse 
antibody conjugated with 10 nm gold (1:30 dilution, Ted Pella) as the secondary 
antibody for an additional 2 hours at room temperature. After washing, sections were 
then fixed with 2% glutaraldehyde-PBS for 5 minutes. Thereafter, the sections were 
stained with 1% osmium tetroxide, 8% uranyl acetate, followed by lead citrate for 5 
minutes each before viewing under JEOL JEM-1010 transmission electron 
microscope. Pre-immune serum served as negative control.  
 
3.10 Construction of deletion mutants in H. pylori by a PCR-based approach 
3.10.1 Design of gene-targeting constructs 
The H. pylori deletion mutants (Δggt, ΔvacA, ΔvacA/ggt, ΔcagA, ΔcagA/ggt, 
ΔureAB and ΔureAB/ggt) were constructed using a modified 3-step PCR approach as 
described  by Tan and Berg (2004). Genomic DNA of H. pylori strain 88-3887 was 
extracted as described in section 3.2.1 and used as the template for PCR amplification. 
The ggt gene was replaced by a kanamycin resistance cassette while the cagA, vacA 
and ureAB genes were replaced by a chloramphenicol resistance cassette. Primers 
(Table 5) were designed according to the known H. pylori 26695 DNA sequence 
(Tomb et al., 1997) for the amplification of two flanking DNA sequences of the gene 
of interest. Using the construction of Δggt as an example (Figure 6), the 5’ flanking 
DNA fragment of 557 bp was amplified using primers ggt1 and ggt2. This fragment 
included part of HP1119 and a 3’ overhang complementary to the kanamycin 
resistance cassette. The 3’ flanking fragment was 522 bp and included part of HP1117 
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and a 5’ overhang complementary to the kanamycin resistance cassette. The 3’ 
flanking fragment was amplified using primers ggt3 and ggt4. Another two primers, 
kanF and kanR, were designed to amplify the kanamycin resistance cassette from 
plasmid pILL600 (kindly provided by Dr. Labigne A., Pasteur Institute, Paris, 
France). PCR amplification conditions were set as 30 cycles of denaturation at 94°C 
for 1 minute, annealing at 55°C for 45 seconds and elongation at 72°C for 2 minutes. 
The three PCR reactions were carried out separately in an amplification thermal 
cycler (Bio-Rad) and the PCR amplified gene products were purified using a gel 
extraction kit (Qiagen) as described in section 3.5.1.4. 
A second round of PCR amplification was carried out to ligate the three DNA 
fragments. The three separate DNA fragments were used as templates (50 ng of each) 
and ligation was carried out in one PCR mixture. Primers ggt1 and ggt4 were used 
and PCR conditions were set as 30 cycles of denaturation at 94°C for 1 minute, 
annealing at 55°C for 45 seconds and elongation at 72°C for 3 minutes. Vent 
polymerase (New England Biolabs) was used to amplify the 2442 bp fragment. The 
PCR amplified DNA fragment was purified using a gel extraction kit (Qiagen) as 
described in section 3.5.1.4. The other isogenic mutants (ΔvacA, ΔvacA/ggt, ΔcagA, 
ΔcagA/ggt, ΔureAB and ΔureAB/ggt) were constructed using a similar approach. 
ΔcagPAI was constructed by transforming plasmid pJP46 (kindly provided by Prof. 
Haas R., Ludwig-Maximilians-University Munich, Germany) (Odenbreit et al., 2001) 
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Table 5. Primers used for the construction of isogenic mutants. 
 
Deletion 
mutant Primer Primer sequence (5’ → 3’) Reference 
 camF TTATCAGTGCGACAAACTGGG  
 camR GATATAGATTGAAAAGTGGAT  
 kanF GATAAACCCAGCGAACCAT  
 kanR GGTACTAAAACAATTCATCCAGTA  







ggt4 CCACGGCTTTCTTTTCATCTTTA  







cagA4 ATTAAGAACGCGATTGATTTGC  

















Overlaps between primers ggt2 and kanF, primers ggt3 and kanR are shown in red. Overlaps 
between primers cagA2 and camF, primers cagA3 and camR, primers vacA2 and camF, 
primers vacA3 and camR, primers ure2 and camF, primers ure3 and camR are shown in blue. 
(F: Forward primer; R: Reverse primer; kan: kanamycin; cam: chloramphenicol). 
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Figure 6. Diagrammatical representation of gene-targeting construct. (A) 
Location of ggt gene in genome of H. pylori 26695. (B) Design of 3 sets of primers 
based on the known sequences. (C) Final construct of 2442 bp used to transform H. 
pylori.  
 
3.10.2 Transformation of H. pylori with gene-targeting DNA constructs 
Half a plate of a 3-day-old culture of H. pylori 88-3887 cells with confluent 
growth was transferred onto a fresh CBA plate and incubated at 37°C in a CO2 
incubator with 5% CO2 for 4 hours. Following which, approximately 300 ng of 
targeting DNA fragment was overlayed onto the surface of the bacterial culture on the 
CBA plate. After incubation at 37°C with 5% CO2 for 48 hours, the lawn of bacterial 
cells was transferred onto 2 fresh CBA plates containing 20 µg/ml kanamycin (for 
Δggt and ΔcagPAI) or 15 µg/ml chloramphenicol (for ΔcagA, ΔvacA and ΔureAB) 
using an inoculation loop and the plates were further incubated at 37°C with 5% CO2 
for 3-4 days. The colonies that grew on the selective CBA plates were selected and 
sub-cultured for three rounds to purify the deletion mutants. Subsequently, the 
isolated cultures were maintained on selective CBA plates supplemented with the 
respective antibiotics. The purified deletion mutants were also preserved in BHI broth 
medium supplemented with 10% horse serum, kanamycin (20 µg/ml) or 
chloramphenicol (15 µg/ml), 20% glycerol and stored at -80°C. 
HP 1119 HP 1117 
ggt1 ggt2 ggt3 ggt4 
kanamycinR cassette 
kanF kanR
5’ flanking fragment 
(538 bp) 
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3.10.3 Identification of isogenic H. pylori mutant of interest 
PCR amplification was used to identify the different H. pylori mutants using 
various primers. Due to homologous recombination of the antibiotic resistance gene in 
place of the gene of interest, the wild type and deletion mutant would give PCR 
products of different sizes as illustrated in Table 6. Confirmation of the cagPAI 
deletion in H. pylori 88-3887 was carried out by checking the presence of the cagPAI 
empty site.  
In addition, GGT assay was used to analyze GGT activity in Δggt as described 
in section 3.5.5.5. Urease assay was used to analyze urease activity in ΔureAB. In 
brief, equal volumes (0.5 ml/0.5 ml) of bacterial culture and urease reagent (pH 6.8) 
(Appendix 27) were mixed in a microfuge tube. A positive test for urease is indicated 
by a colour change of the reagent from orange to magenta within minutes. 
 
Table 6. Primers used to check for positive isogenic mutants. 
 
PCR product size Deleted gene(s) Primers (5’→3’) Wild type Isogenic mutant 
ggt ggt1 and ggt4 (Table 5) 2869 bp 2442 bp 
cagA cagA1 and cagA4 (Table 5) 4730 bp 1799 bp 
vacA vacA1 and vacA4 (Table 5) 5006 bp 1778 bp 
ureAB ure1 and ure4 (Table 5) 3619 bp 2010 bp 
cagPAI 
Luni1: ACA TTT TGG CTA 
AAT AAA CGC TG 
 
R5280: GGT TGC ACG 









3.11 Cell culture 
3.11.1 AGS gastric cancer epithelial cells 
 Human gastric adenocarcinoma cell line AGS (CRL-1739; American Type 
Culture Collection, Manassas, VA) was cultured in F-12K nutrient mixture, Kaighn’s 
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modification (Sigma-Aldrich) supplemented with 10% fetal calf serum (Gibco) 
(Appendix 28). The culture flasks were incubated at 37°C in a CO2 water-jacketed 
incubator (Forma Scientific) with 95% humidity and 5% CO2. 
  
3.11.2 HeLa cervical cancer cells 
 Human cervical adenocarcinoma cell line HeLa (CCL-2; American Type 
Culture Collection, Manassas, VA) was cultured in Roswell Park Memorial Institute 
(RPMI)-1640 medium (Sigma-Aldrich) supplemented with 10% fetal calf serum 
(Gibco) and 2 mM L-glutamine (Appendix 29). Cells were incubated at 37°C under 
5% CO2 in a CO2 water-jacketed incubator. 
 
3.11.3 Primary human gastric cells 
Human gastric biopsies were kindly provided by A/Prof. Yeoh K.G. (National 
University of Singapore). Primary gastric epithelial cells were isolated from these 
gastric biopsies and cultured according to the method described by Smoot et al. 
(2000).  
 
3.11.3.1 Tissue collection 
Gastric biopsies were obtained from patients undergoing upper endoscopy at 
National University Hospital. Informed consent was obtained from all patients for 
gastroscopy and biopsies. All biopsies were obtained from the antrum of the stomach 
and were taken from areas of grossly normal gastric mucosa. The specimens were 
collected in Leibowitz’s L-15 medium (Gibco) containing 1% penicillin/streptomycin 
(Gibco) (Appendix 30A) for transport to the research laboratory. 
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3.11.3.2 Coating of culture dishes 
 Type 1 rat tail collagen (Gibco) and fibronectin (Gibco) were diluted into 
Ham’s F-12 medium at a concentration of 0.05% and 0.01% respectively (Appendix 
30B) and culture dishes were incubated for 1-2 hours at 37°C before gastric cells were 
plated.  
 
3.11.3.3 Isolation and culture of gastric cells 
  The biopsies were placed into a 100 mm culture dish containing 5 ml of 
collagenase/dispase solution (Appendix 30C). They were then minced with a sterile 
scalpel into pieces approximately 1 mm in size. The minced tissue in 
collagenase/dispase solution was transferred into a sterile bottle (with addition of 20 
ml of collagenase/dispase solution) and incubated at 37°C for 1 hour. The bottle was 
gently shaken every 15 minutes. Afterwhich, the tissue was pelleted by centrifugation 
at 250 × g for 5 minutes at 4 °C. The collagenase/dispase was discarded and the tissue 
was washed once in 10 ml of PBS and pelleted again by centrifugation. Finally, the 
cell pellet was resuspended in Ham’s F-12 cell culture medium supplemented with 
10% fetal calf serum, 1% pencillin/streptomycin, 0.2% fungizone (Appendix 30D) 
and placed into a coated 12-well tissue culture plate (from section 3.11.3.2). 
Approximately 2-3 biopsies were placed into each well. The following day, the cell 
culture was rinsed twice with PBS containing 1% pencillin/streptomycin and 0.2% 
fungizone to remove non-adherent cells before the addition of fresh Ham’s F-12 cell 
culture medium (supplemented with 1% pencillin/streptomycin and 0.2% fungizone). 
The medium was changed every 3–4 days thereafter. Prior to infection with H. pylori, 
the culture medium containing antibiotics was removed and cells were rinsed thrice 
with Ham’s F-12 cell culture medium without antibiotics. 
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3.11.4 Primary human macrophages 
 Primary human macrophages were kindly provided by A/Prof. Lu J.H. 
(National University of Singapore) and cultured according to the method previously 
described (Cao et al., 2005). Monocytes were isolated from healthy adult blood 
donors (National University Hospital Blood Donation Centre, Singapore). In brief, 
peripheral blood mononuclear cells were isolated from the buffy coats using Ficoll-
Paque Plus (Amersham Biosciences). After washing, the cells were allowed to adhere 
to tissue culture plates for 2 hours at 37°C. Non-adherent cells were removed by 
washing, and the adherent monocytes were harvested. The isolated monocytes were 
cultured at 1 × 106/ml in complete RPMI medium (Appendix 29). Macrophages were 
cultured from isolated monocytes in the presence of macrophage colony-stimulating 
factor (20 ng/ml) for 6 days. 
 
3.12 Host-pathogen interaction study 
3.12.1 Enumeration of cells 
AGS cells were first washed twice with 10 ml of PBS to remove dead floating 
cells before the addition of 2 ml of 1% trypsin-EDTA. The cells were then incubated 
at 37ºC in a CO2 water-jacketed incubator (Forma Scientific) for 10 minutes to ensure 
that all the cells had been detached from the flask surface. Cells were then enumerated 
using a cell counting chamber (Weber Scientific International Ltd) viewed under the 
inverted microscope (Olympus CKX41) at 400× magnification.  
 
3.12.2 Enumeration of bacteria 
            Two CBA plates containing confluent growth of 3-day old H. pylori were 
harvested using sterile cotton swabs (Copan) into 10 ml of sterile PBS. The 
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suspension was centrifuged at 6000 × g for 5 minutes at 4°C. The bacterial cell pellet 
was washed thrice with sterile PBS as above. The pellet obtained was then 
resuspended in 2 ml of sterile PBS. The bacterial suspension was then used for 
enumeration by spread plate method and spectrophotometric reading at OD600.  
             Serial 10-fold dilutions were made from 1 ml of the bacterial suspension 
obtained. Aliquots of 100 µl of the respective dilutions were spread evenly onto CBA 
plates using a sterile glass spreader. Each dilution was carried out in duplicates. The 
plates were incubated at 37ºC in a humidified incubator with 5% CO2 for 3 days. 
Following which, the number of colonies (within the range of 30-300 colonies) 
formed on the CBA plate were counted.  
             Concurrently, serial 2-fold dilutions up to 1:64 were made from 1 ml of the 
bacterial suspension obtained. The turbidity of the suspension was measured at an 
absorbance of 600 nm using a spectrophotometer (Beckman Coulter). The viable 
bacterial cell count (CFU/ml) was plotted against the OD600 reading to obtain a 
standard curve. This curve was subsequently used as a guide for estimation of H. 
pylori population based on OD600 of the bacterial cultures in subsequent experiments. 
 
3.12.3 Infection study 
The bacterial cultures were harvested using sterile cotton swabs (Copan) and 
washed thrice in sterile PBS. The bacteria were then centrifuged at 6000 × g for 10 
minutes at 4°C. After washing, the bacterial cell pellet was resuspended in the 
appropriate volume of PBS and used for infecting the cell lines at a multiplicity of 
infection (MOI) of 100:1 (Li et al., 2009) for all experiments. Where indicated, cell 
lines were treated with nGGT or rGGT at an approximately equivalent amount to that 
produced by the viable bacteria. 
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3.13 Role of GGT in ROS generation 
3.13.1 Hydrogen peroxide (H2O2) assay 
H2O2 production from AGS cells or primary human gastric cells was measured 
as previously described (Mohanty et al., 1997) using the Amplex red hydrogen 
peroxide/peroxidase assay kit (Molecular Probes, USA) according to the 
manufacturer’s instructions. Briefly, cells were seeded in 96-well plates and allowed 
to adhere for 24 hours prior to the experiments. After treating with H. pylori or 
purified nGGT protein (1.5 mU), the cells (1.8 × 104 cells/well) were washed 3 times 
with PBS. The cell medium was then replaced by Krebs-Ringer phosphate buffer, pH 
7.4, containing 145 mM NaCl, 5.7 mM sodium phosphate, 4.9 mM KCl, 0.5 mM 
CaCl2, 1.2 mM MgSO4 and 1 g/L glucose. Cells incubated in the absence of H. pylori 
or GGT served as control. Stimulation of GGT activity was performed by adding the 
acceptor dipeptide glycyl-glycine (1 mM) and the substrate GSH (0.1 mM). To inhibit 
the GGT activity, the competitive GGT inhibitor SBC (10 mM) was added to cell 
samples just prior to the assay for H2O2 release. Where indicated, Fe3+ (20 μM) or iron 
chelator desferrioxamine (DFO; 50 μM) was added to stimulate and inhibit thiol-
dependent iron reduction, respectively (Stark et al., 1993). A combination of one or 
more of the compounds was also added to observe the effects on H2O2 generation. The 
fluorescence generated in each sample was measured in triplicates in a Tecan 
InfiniteTM M200 Spectrometer (excitation/emission wavelengths: 530/590 nm).  
 
3.13.2 NF-κB activation 
3.13.2.1 Extraction of cytosolic and nuclear fractions 
AGS cells were grown to confluency in 75 cm2 tissue culture flasks before the 
addition of H. pylori 88-3887 (wild type) or various isogenic mutants at an MOI of 
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100:1. Uninfected cells served as control. After 4 hours post-infection, the cells were 
harvested with a cell scraper, washed thrice with PBS and then pelleted by 
centrifugation at 250 × g for 5 minutes. Following which, cells were lysed in 2 pellet 
volumes of hypotonic buffer A (Appendix 31A) and incubated on ice for 10 - 15 
minutes with occasional tapping. After centrifugation at 500 × g for 5 minutes, the 
supernatant (cytosolic fraction) was collected and stored. The nuclear pellet was 
washed twice with buffer A before 100 μl of nuclear extraction buffer C (Appendix 
31B) was added to the pellet and incubated on ice for 45 minutes with periodic 
tapping. The sample was then centrifuged at 20,000 × g and the supernatant (nuclear 
extract) was collected. Cytosolic and nuclear protein concentrations were determined 
by Bradford protein assay (as described in section 3.3) before the proteins were 
quickly frozen at -20oC until use.  
 
3.13.2.2 Western blot analysis 
Cytosolic and nuclear protein fractions were subjected to SDS-PAGE (20 
μg/lane) and transferred onto PVDF membranes by electroblotting. Membranes were 
blocked with 5% skim milk overnight at 4°C. NF-κB subunit p65 and IκB were 
detected with respective MAbs at 1:1000 dilution for 2 hours at room temperature 
using anti-NF-κB subunit p65 (BD Biosciences) and anti-IκB (IMGENEX), 
respectively. Blots were then incubated with goat anti-mouse antibody conjugated 
with horseradish peroxidase (1:2000 dilution, DakoCytomation) for 1 hour at room 
temperature. Signals were detected using enhanced chemiluminescence detection kit 
(Pierce) according to the manufacturer’s protocol. Purity of the different cell fractions 
was tested using antibody against nuclear lamin A/C (1:1000 dilution; Cell 
Signalling) and cytosolic β-tubulin (1:1000 dilution; Cell Signalling). Densitometric 
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quantification of western blot bands was performed using ImageJ version 1.44i 
analysis software. 
 
3.13.3 Determination of IL-8 production 
AGS cells, primary gastric cells or macrophages were seeded in 12-well plates 
for 24 hours. The culture medium was replaced by fresh medium prior to the 
experiments. Cells incubated in the absence of H. pylori or nGGT were used as 
control. The supernatant of the cells (3 × 105 cells/well) incubated with H. pylori wild 
type (MOI 100:1) or the various deletion mutants or 25 mU purified H. pylori nGGT 
protein was collected after 4 or 24 hours. The aliquot supernatant was stored at -20oC 
until use. 
The concentration of IL-8 in cell culture supernatants was determined by 
commercially available ELISA kit (BD OptEIATM; BD Biosciences) according to the 
manufacturer’s instructions. Briefly, 96-well plates (Nunc) were coated overnight at 
4°C with 100 μl per well of capture antibody diluted in coating buffer (Appendix 23). 
Thereafter, the wells were washed thrice with 0.05% PBS-T and blocked with PBS 
containing 10% fetal calf serum for 1 hour at room temperature. Cytokine standards 
and supernatant samples after various treatments were added to the wells and any IL-8 
present will bind to the immobilized antibody. The wells were washed with 0.05% 
PBS-T and avidin-horseradish peroxidase conjugate mixed with biotinylated anti-
human IL-8 specific antibody was then added. The wells were again washed with 
0.05% PBS-T and TMB substrate solution (100 μl) was added for 30 minutes. A blue 
colour was generated in direct proportion to the amount of specific cytokine present in 
the initial sample. The reaction was stopped with 2N H2SO4 solution (0.05 ml) and the 
Materials and Methods 
77 
colour changed from blue to yellow. The OD was measured within 30 minutes using a 
microplate reader (Bio-Rad) at 450 nm with subtraction of absorbance at 570 nm. 
 
3.14 Role of intracellular GGT in AGS cells 
3.14.1 Presence of H. pylori GGT in host cells 
3.14.1.1 TEM 
 AGS cells were grown in 75 cm2 flasks to 80% confluency and incubated with 
H. pylori wild type or Δggt. After 24 hours, cells were harvested and processed for 
immunogold-labeling TEM as previously described in section 3.9.  
 
3.14.1.2 Confocal laser scanning microscopy (CLSM) analysis 
AGS cells were seeded on sterile coverslips placed in 6-well plates. After 24 
hours, the cells (3 × 105 cells/well) were treated with H. pylori wild type or Δggt at 
MOI 100:1 or rGGT (25 mU). After 24 hours, the culture medium was decanted and 
the AGS monolayer was washed with pre-chilled PBS. The cells were then fixed in 
3.7% formaldehyde (Merck) in PBS for 20 minutes at room temperature before being 
permeabilized with 0.2% PBS-Triton-X for 10 minutes at room temperature. The cells 
were washed thrice for 5 minutes each with PBS and blocked with 2% BSA-PBS 
overnight at 4°C. The monolayer was then incubated with MAb 1G1 against the small 
subunit of GGT (1:200 dilution in 2% BSA-PBS) for 90 minutes at 4°C. After 
washing with PBS thrice for 5 minutes each, the monolayer was incubated with Cy3-
labeled goat anti-mouse IgG (Invitrogen) at 1:300 dilution in 2% BSA-PBS for 90 
minutes at 4°C in the dark. The cells were then washed thrice for 5 minutes each with 
PBS. Cell nuclei were stained with Hoechst 33342 (2 μg/ml; Molecular Probes) for 10 
minutes. Coverslips were then mounted onto microscope slides, sealed with 
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FluorSaveTM Reagent (Calbiochem) and viewed using a confocal laser microscope 
(Olympus Fluoview 1000).  
 
3.14.1.3 Western blot analysis 
 AGS cells were grown in 75 cm2 flasks to 80% confluency and incubated with 
H. pylori wild type, Δggt or rGGT (500 mU). At the respective time-points (0h, 0.5h, 
1h, 2h, 4h and 24h), cells were harvested and the nuclear and cytosolic fractions were 
extracted as described in section 3.13.2.1. Cell fractions were then analyzed by 
western blot analysis for the presence of H. pylori GGT using polyclonal antibody 
raised against rGGTS (1:4000 dilution). β-tubulin and lamin A/C were used as 
loading controls for cytosolic and nuclear fractions respectively. 
 
3.14.2 Endocytosis of GGT 
3.14.2.1 Specificity of uptake 
 AGS cells were grown to confluency in a 6-well tissue culture plate. Cells 
were then co-incubated with either purified rGGT, heat-denatured rGGT (after boiling 
for 10 minutes), rGGTL or rGGTS for 4 hours. The cells were then lysed with lysis 
buffer (Appendix 32) and the whole cell lysates were probed for the presence of 
rGGT, rGGTL or rGGTS by western blot analysis. Antibodies used were MAb 2B5 
(1:3000) and MAb 1G1 (1:4000) to detect for the large and small subunits of GGT 
respectively. 
 
3.14.2.2 Inhibitor study 
The effects of two pharmacological agents: chlorpromazine (CPZ; Sigma-
Aldrich) and nystatin (NYS; Sigma-Aldrich) on rGGT uptake by AGS cells were 
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examined. The optimum concentration used for each drug was determined by 
incubating AGS cells with various concentrations of each drug (CPZ, 5-30 μg/ml; 
NYS, 5-50 μg/ml) for 5 hours and measuring the cell viability by 3-(4, 5- 
dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay. Briefly, the 
medium was changed and 0.5 ml of diluted MTT solution [100 µl MTT stock solution 
(Appendix 33A) per 1 ml medium] was added to each well. Following 2 hour 
incubation, the culture medium supernatant was removed from the wells without 
disrupting the formazan crystal precipitate. The crystals were then dissolved in 0.5 ml 
lysis solution (Appendix 33B) per well. Absorbance was measured at 570 nm using a 
microplate reader (Bio-Rad). Cell viability is expressed as a fraction of control cells 
absorbance (taken as 1).  
  After determining the optimal concentration for each drug, AGS cells were 
first pre-incubated with CPZ (15 μg/ml, 30 minutes) or NYS (25 μg/ml, 60 minutes) 
before the addition of rGGT to the cells. After 4 hours, uptake of rGGT by AGS cells 
was then analyzed by western blot analysis (as described in section 3.14.1.3) and 
CLSM (as described in section 3.14.1.2). Control cells were incubated without rGGT 
nor inhibitors while uninhibited cells were incubated with rGGT but without 
inhibitors for the same period of time. β-tubulin and hepatocyte growth factor receptor 
(c-Met; Santa Cruz) were used as loading controls for cytosolic and membrane 
fractions, respectively. Densitometric quantification of western blot bands was 
performed using ImageJ version 1.44i analysis software. 
 
3.14.3 Co-immunoprecipitation (Co-IP) 
 Co-IP analysis was carried out according to the protocol as described with 
slight modifications (Yahiro et al., 2003). In brief, 3-day-old H. pylori 88-3887 was 
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harvested and washed thrice with PBS. The bacterial cell pellet was suspended in lysis 
buffer (Appendix 32) and incubated on a rotary shaker in a slow head-to-tail motion at 
4°C for 2 hours. Separately, AGS cells were cultured to confluency (as described in 
section 3.11.1). Harvested AGS cells were then subjected to the same procedures. 
Following which, H. pylori and AGS cells lysates were centrifuged at 10,000 × g and 
the resultant protein supernatants were mixed and pre-cleared with Protein A/G 
sepharose (50 μl slurry) without antibody for another 2 hours at 4°C on a rotary 
shaker. Cleared lysates were then incubated with either MAb 1G1 against rGGT (1 
μg) or various anti-importin antibodies (1 μg; Santa Cruz) and the antibody complex 
was pulled down by Protein A/G sepharose (50 μl slurry) for 2 hours at 4°C on a 
rotary shaker. Protein A/G sepharose beads with antibody complex were centrifuged 
briefly and washed five times with lysis buffer to remove unbound proteins. 
Thereafter, the beads were re-suspended in 50 μl of 5 × SDS sample buffer (Appendix 
10) and subjected to SDS-PAGE analysis as described in section 3.4. Western blot 
was employed to detect for the presence of either GGT or specific importins (β1, β2 
and β3; Santa Cruz) in the pulled-down complexes. 
 
3.14.4 Small interfering RNA (siRNA) knockdown of importin β1 
 siRNA transfection was employed to down-regulate the expression level of 
human importin β1. Karyopherin β1 siRNA (h) which consists of a pool of 3 target-
specific 19-25 nucleotide siRNAs (sc-35736, Santa Cruz) was used according to the 
manufacturer’s protocol. The lyophilized siRNA was re-suspended in RNase-free 
water before use. In brief, AGS cells were first seeded in a 6-well tissue culture plate. 
After 24 hours, cells (50-60% confluency) were transfected with siRNA (20-80 
pmols) using siRNA transfection reagent (Santa Cruz) and further incubated for 6 
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hours, after which the transfection mixture was replaced with normal cell culture 
medium for another 24 hours. After 48 hours, cells were lysed to check for optimal 
siRNA concentration required to knockdown importin β1 expression using western 
blot analysis. Untreated cells were used as internal control and these cells were 
incubated with transfection reagent only without siRNA. In a separate experiment, 
AGS cells were transfected with the optimum amount of siRNA and subsequently 
treated with rGGT for 4 hours. Amount of rGGT in the cytosolic and nuclear fractions 
of the cells was determined by western blot analysis as previously described (section 
3.14.1.3). Densitometric quantification of western blot bands was performed using 
ImageJ version 1.44i analysis software. 
 
3.14.5 Intracellular glutathione (GSH) analysis 
 AGS cells were plated in 0.9 cm2 Lab-Tek chambered cover glass (Nunc) 24 
hours prior to infection with H. pylori or treatment with rGGT (0.5-10 mU). Triple 
staining was performed using 2 μg/ml propidium iodide (PI) (BD Biosciences) to 
identify dead cells, 2 μg/ml Hoechst 33342 (Molecular Probes) to localize nuclei and 
5 μM CellTracker green 5-chloromethylfluorescein diacetate (CMFDA; Molecular 
Probes) which detects GSH with a specificity of 95% (Markovic et al., 2007). After 
24 hours of treatment, AGS cells were first stained with 5 μM CMFDA in serum-free 
F-12K medium for 30 minutes at 37°C and 5% CO2. Following washing with pre-
warmed F12-K medium, the cells were left to rest for another 30 minutes at 37°C and 
5% CO2 in fresh F-12K medium containing 10% fetal calf serum. In the last 5 minutes 
of incubation, 2 μg/ml PI and 2 μg/ml Hoechst 33342 were added to the medium. 
Thereafter, the cells were washed with PBS and fixed with 3.7% formaldehyde in 
PBS for 15 minutes at room temperature. After fixing, cells were washed thrice with 
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PBS, mounted with a cover slip and sealed with FluorSaveTM Reagent (Calbiochem). 
The stained cells were then viewed under CLSM as described in section 3.14.1.2. 
Mean fluorescence intensity of CMFDA in 100 cell nuclei (as defined by Hoechst 
33342 staining) from at least 5 different fields was analyzed by ImageJ software 
version 1.44i.  
 
3.15 Assessment of role of GGT in vacuolation 
AGS cells, HeLa cells or primary human gastric cells were seeded in 12-well 
culture plates at a density of 1.5 × 104 cells per cm2 (Papini et al., 1994). After 24 
hours, the cells were treated with H. pylori wild type or the various deletion mutants 
for an additional 24 hours. Where indicated, rGGT (10 mU), ammonium chloride (3 
mM) or glutamine (2 mM) was co-incubated with the cells.  
 
3.15.1 Cell morphology 
AGS cells were seeded in a 35 mm plastic bottom dish (Nunc) at a density of 
1.5 × 104 cells per cm2. After 24 hours, cells were infected with H. pylori wild type or 
Δggt as described in section 3.12.3. Infected cells were then placed into the Biostation 
IMQ microscope chamber (Nikon) for real-time observation under phase-contrast 
microscopy. Uninfected AGS cells served as control. The water and chamber 
temperature were stabilized at 37°C to prevent focus drift during recording. Time-
lapse images were taken for a total period of 24 hours with 5 minutes interval between 
each image acquisition. Images were viewed using ImageJ software version 1.44i. 
Where indicated, cells were also inspected for vacuolation using a phase contrast 
microscope (Olympus CKX41). 
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3.15.2 Neutral red dye uptake assay 
Extent of vacuolation was quantified using neutral red uptake assay as 
previously described with slight modifications (Cover et al., 1991). Neutral red is a 
membrane permeable basic dye that accumulates in acidic vacuoles and provides a 
quantitative estimation of the total volume taken up by vacuolar compartments 
(Papini et al., 1993a). Briefly, the media overlaying the cells was removed and 
replaced with 0.2 ml of freshly prepared 0.05% neutral red in PBS containing 0.3% 
BSA for 5 minutes (Appendix 34A-B). Cells were then washed three times with 0.5 
ml of the same buffer. The neutral red dye taken up by the vacuoles was then 
extracted from the cells by the addition of 0.2 ml of 70% ethanol in water containing 
0.37% HCl (Appendix 34C). The OD was measured using a microplate reader (Bio-
Rad) at 534 nm with subtraction of absorbance at 405 nm. Neutral red dye uptake is 
expressed as absorbance per 105 cells. All experiments were done in triplicates. 
 
3.15.3 Inhibitor studies 
3.15.3.1 Serine-borate complex (SBC) 
 AGS cells were incubated for 24 hours at 37°C with H. pylori (as described in 
section 3.12.3) in the presence of SBC (10 mM; Sigma-Aldrich), a competitive 
inhibitor of GGT. Cytoplasmic vacuolation of AGS cells was quantitated using 
neutral red dye uptake assay as described in section 3.15.2. 
 
3.15.3.2 MAbs against GGT 
AGS cells were pre-incubated with MAbs (10 μg) for 24 hours at 37°C prior 
to incubation with H. pylori. Mouse IgG2a and IgG2b isotype controls were used in 
parallel at the same concentration. Cytoplasmic vacuolation of AGS cells was 
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quantitated using neutral red dye uptake assay as described in section 3.15.2. Results 
are expressed as a percentage of the maximal value of neutral red dye uptake as 
induced by wild type H. pylori in the absence of MAbs. 
 
3.16 Detection of serum antibody against rGGT in H. pylori-infected patients 
 rGGT (0.1 μg) was used as antigen to detect the presence of antibody against 
GGT in sera obtained from H. pylori-positive patients by ELISA (as described in 
section 3.6.1.2). A total of 58 and 65 sera samples (1:100 dilution) from patients with 
and without H. pylori infection respectively were tested. Horseradish-peroxidase-
conjugated rabbit anti-human IgG (1:2000) (DakoCytomation) was used as secondary 
antibody. Sera were collected with patients’ consent. Status of H. pylori infection was 
confirmed earlier by culture, histological examinations, rapid urease test and/or 
presence of serum antibodies to H. pylori acid glycine extract antigens by ELISA. All 
samples were randomly selected.  
 
3.17 Statistical analysis 
Data was analyzed with the SPSS statistical software package (version 10.0; 
SPSS Inc., Chicago, IL, USA). Values are expressed as mean ± standard deviation 
(SD). Statistical difference between two defined groups was determined with the 
unpaired two-tailed Student’s t test or Mann-Whitney U test. Values of P<0.05 were 
















4.1 Genotyping of H. pylori 
Chromosomal DNA extracted from H. pylori strain 88-3887 amplified by PCR 
and analyzed by agarose gel electrophoresis shows that H. pylori strain 88-3887 
harbours vacA, cagA and iceA1 genes but lacks iceA2 and babA2 genes (Figure 7). 
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Figure 7. Genotyping of virulence genes in H. pylori strain 88-3887. M, 100 bp 
DNA ladder marker; PCR products showing: Lane 1, 1160 bp vacA; Lane 2, 400 bp 
cagA; Lane 3, 246 bp iceA1; Lane 4, iceA2 (negative); Lane 5, babA2 (negative). 
Lanes 7-11 are the positive controls for cagA, vacA, iceA1, iceA2 and babA2 
respectively. Lane 6 is an empty lane. 
 
4.2 Cloning and expression of rGGT, rGGTL and rGGTS 
4.2.1 Construction of pRSET-ggt, pRSET-ggtl and pRSET-ggts 
 Genomic DNA of H. pylori strain 88-3887 was extracted and used as a 
template for PCR amplification of various constructs. Various inserts ggt (1626 bp), 
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Figure 8. DNA gel electrophoresis of gene fragments encoding ggt, ggtl and ggts. 
(A) M, 1 kb DNA ladder marker; Lane 1, ggt gene fragment (1626 bp). (B) M, 100 bp 
DNA ladder marker; Lane 1, ggtl gene fragment (1059 bp). (C) M, 100 bp DNA 
ladder marker; Lane 1, ggts gene fragment (567 bp). 
 
Restriction enzyme digest of expression vector pRSET-A with PstI and 
HindIII yielded a linearized fragment of 2.9 kb (Figure 9). The restriction digest 
yielded cohesive ends that were compatible with those of ggt, ggtl and ggts gene 
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Figure 9. Restriction enzyme digest of expression vector pRSET-A. M, 1 kb DNA 
ladder marker; Lane 1, uncut plasmid pRSET-A; Lane 2, linearized vector after 
digestion with PstI and HindIII (2.9 kb).  
 
 
4.2.2 Identification of positive clones after transformation 
After transformation into E. coli Top10 cells, the extracted recombinant 
plasmid from positive clones was digested with either PstI or HindIII alone. Digestion 
of pRSET-ggt gave a single band of size 4506 bp (Figure 10A, lanes 2 and 3), 
pRSET-ggtl gave a single band of size 3939 bp (Figure 10B, lanes 2 and 3) and 
pRSET-ggts gave a single band of size 3447 bp (Figure 10C, lanes 2 and 3). 
Simultaneous digestion with PstI and HindIII gave two DNA fragments 
corresponding to pRSET-A (~2.9 kb) and the inserts ggt (1626 bp; Figure 10A, lane 
4), ggtl (1059 bp; Figure 10B, lane 4) or ggts (567 bp; Figure 10C, lane 4). 



















Figure 10. Screening of positive clones by restriction enzyme digest. (A) M, 1 kb 
DNA ladder marker; Lane 1, uncut recombinant pRSET-ggt plasmid; Lane 2, pRSET-
ggt digested with PstI; Lane 3, pRSET-ggt digested with HindIII; Lane 4, pRSET-ggt 
digested with PstI and HindIII. (B) M, 1 kb DNA ladder marker; Lane 1, uncut 
recombinant pRSET-ggtl plasmid; Lane 2, pRSET-ggtl digested with PstI; Lane 3, 
pRSET-ggtl digested with HindIII; Lane 4, pRSET-ggtl digested with PstI and 
HindIII. (C) M, 1 kb DNA ladder marker; Lane 1, uncut recombinant pRSET-ggts 
plasmid; Lane 2, pRSET-ggts digested with PstI; Lane 3, pRSET-ggts digested with 








































































Figure 11. DNA sequences of H. pylori 88-3887 ggt, ggtl and ggts gene fragments 
cloned into pRSET-A. Sequence of ggtl is coloured blue and ggts is coloured red. 
Sequence of ggt is a combination of blue and red. 
 
 
4.2.3 Expression of rGGT, rGGTL and rGGTS 
The expression vector containing the correct ggt, ggtl or ggts insert was 
transformed into the expression host E. coli BL21 (DE3). The expression of rGGT 
was achieved at 3 hours after induction with 0.4 mM IPTG. There was no significant 
difference in the expression of rGGT with higher IPTG concentrations between 0.4 – 
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0.8 mM. rGGT was found to be approximately 62 kDa (Figure 12A) and accounted 
for about 10-15% of total proteins after induction as analyzed using ImageJ software 
version 1.44i. Expression of rGGTL and rGGTS was achieved 3 hours after induction 
with 0.2 mM IPTG. rGGTL and rGGTS were approximately 40 kDa (Figure 12B) and 
25 kDa (Figure 12C), respectively. The expressed rGGTL and rGGTS accounted for 
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Figure 12. Expressed recombinant proteins after IPTG induction. (A) Expression 
of rGGT. Lane M, Prestained Precision Protein Standards (Bio-Rad); Lane 1, whole 
cell lysate of untransformed E. coli BL21; Lane 2, whole cell lysate of E. coli BL21 
transformed with pRSET-A; Lane 3, whole cell lysate of uninduced E. coli BL21 
transformed with pRSET-ggt; Lane 4, 0.2 mM IPTG induction; Lane 5, 0.4 mM IPTG 
induction; Lane 6, 0.6 mM IPTG induction; Lane 7, 0.8 mM IPTG induction. (B) 
Expression of rGGTL. Lane M, Prestained Precision Protein Standards (Bio-Rad); 
Lane 1, whole cell lysate of E. coli BL21 transformed with pRSET-A; Lane 2, whole 
cell lysate of uninduced E. coli BL21 transformed with pRSET-ggtl; Lane 3, 0.2 mM 
IPTG induction; Lane 4, 0.4 mM IPTG induction; Lane 5, 0.6 mM IPTG induction; 
Lane 6, 0.8 mM IPTG induction. (C) Expression of rGGTS. Lane M, Prestained 
Precision Protein Standards (Bio-Rad); Lane 1, whole cell lysate of uninduced E. coli 
BL21 transformed with pRSET-ggts; Lane 2, 0.2 mM IPTG induction; Lane 3, 0.4 
mM IPTG induction; Lane 4, 0.6 mM IPTG induction; Lane 5, 0.8 mM IPTG 
induction. 
 
4.2.4 Localization of rGGT, rGGTL and rGGTS in different cell fractions 
 After ultrasonication, the expressed rGGT protein was observed to exist in 
both the soluble (Figure 13A, lane 1) and insoluble fraction of the cell lysate (Figure 
13A, lane 2). In contrast, rGGTL and rGGTS were found exclusively in the insoluble 
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Figure 13. SDS-PAGE protein profile of soluble and insoluble protein fractions. 
(A) rGGT, (B) rGGTL, (C) rGGTS. Lane M, Prestained Precision Protein Standards 
(Bio-Rad); Lane 1, Soluble fraction; Lane 2, Insoluble fraction. 
 
4.2.5 Purification of recombinant proteins by His-tag affinity chromatography 
rGGT was eluted from a His-tag affinity chromatography column in 2 ml 
fractions with an imidazole concentration gradient ranging from 0.1 – 1 M (Figure 
14A). Interestingly, 3 protein bands were obtained after purification (20 kDa, 40 kDa 
and 62 kDa respectively), indicating that rGGT is expressed as a 62 kDa precursor 
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that undergoes autocatalytic processing as has been previously reported (Boanca et 
al., 2006). Purification of rGGTL and rGGTS was carried out under denaturing 
conditions and a single protein band of 40 kDa and 25 kDa was obtained respectively 
(Figure 14B-C). The yield of each recombinant protein (rGGT, rGGTL and rGGTS) 
was approximately 12-15 μg/ml of culture. Purity of recombinant proteins was >95% 




























Figure 14. His-Tag affinity purification of recombinant proteins. (A) Purification 
of rGGT. Lane M, Prestained Precision Protein Standards (Bio-Rad); Lane 1, Soluble 
fraction of sonicated cells; Lanes 2-5, fractions eluted from His-tag column. (B) 
Purification of rGGTL. Lane M, Prestained Precision Protein Standards (Bio-Rad); 
Lane 1, Soluble fraction of sonicated cells; Lane 2, Insoluble fraction of sonicated 
cells; Lanes 3-7, fractions eluted from His-tag column. (C) Purification of rGGTS.  
Lane M, Prestained Precision Protein Standards (Bio-Rad); Lane 1, Soluble fraction 
of sonicated cells; Lane 2, Insoluble fraction of sonicated cells; Lane 3-6, fractions 
eluted from His-tag column. 
 
 
4.2.6 Confirming identity of rGGT by mass spectrometry 
MALDI-TOF mass spectrometry analysis confirmed the identity of the three 
protein bands obtained in Figure 14A as that of H. pylori GGT. The results indicate 
that the 40 kDa and 20 kDa protein bands are the large and small subunits of H. pylori 
GGT respectively while the 62 kDa protein band is that of the unprocessed rGGT 























Figure 15. Identification by MALDI-TOF mass spectrometry of the 3 protein 
bands of purified rGGT. Peptides coloured red were matched with the precursor (62 
kDa) GGT protein; Peptides highlighted in yellow were matched with the large 
subunit (40 kDa) of GGT protein; Peptides highlighted in blue were matched with the 
small subunit (20 kDa) of GGT protein. Intramolecular autocatalytic cleavage site of 
the proenzyme which generates the large and small subunit is indicated by a vertical 
arrow. 
 
4.3 Antibody production 
4.3.1 Polyclonal antibody against rGGTS 
4.3.1.1 Purification and characterization 
Antibody against rGGTS raised in an immunized rabbit was detected by 
ELISA using 10 ng wild type H. pylori total cell lysate or Δggt lysate as antigen 
(Figure 16). As observed, antibody titre increased by >3-fold 28 days after the first 



















Figure 16. Antibody production profile. Antibody titre against rGGTS detected at 
different time points. The graph was plotted based on the values of 1:400 diluted sera 
against 10 ng wild type H. pylori lysate (■) or Δggt lysate (□). Vertical arrows 
indicate days on which rabbit was injected with 150 μg rGGTS. 
 
 
 Antibody against rGGTS was purified from rabbit sera using Protein A 
sepharose (Figure 17A) and was subsequently assayed for its binding specificity to the 
small subunit of GGT using western blot analysis. A single protein band of ~20 kDa 
corresponding to the small subunit of GGT was observed in the lane loaded with wild 
type H. pylori total cell lysate (Figure 17B, lane 1). No protein bands were observed 
in the lane loaded with Δggt cell lysate (Figure 17B, lane 2). 
 
 
                                                                           
Figure 17. Western blot analysis using antiserum against rGGTS. (A) SDS-PAGE 
showing purified IgG from rabbit serum. Lane M, Prestained Precision Protein 
Standards (Bio-Rad); Lane 1, purified IgG. (B) Polyclonal antibodies raised against 
rGGTS were used as probe. Lane M, Prestained Precision Protein Standards (Bio-
Rad); Lane 1, H. pylori wild type lysate; Lane 2, H. pylori Δggt lysate. 
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4.3.2 Monoclonal antibody against rGGT 
4.3.2.1 Screening of immunized mice 
 A total of 5 BALB/c mice were immunized with rGGT. Sera were obtained 72 
days (after 3 boosters) and 93 days (after 4 boosters) following initial immunization. 
The antibody titre against rGGT was shown to be over 1:6000 for all five mice as 
assayed by indirect ELISA method using 0.1 ng rGGT as antigen (Figure 18A). The 
specificity of the antibody was also tested using western blot analysis. Sera from all 
five mice were able to detect GGT from H. pylori wild type lysate (Figure 18B). No 
GGT bands were detected from Δggt lysate. Based on the ELISA and western blot 




































         
      Mouse #1         Mouse #2        Mouse #3       Mouse #4         Mouse #5 
Figure 18. ELISA and western blot analysis using antiserum against rGGT. (A) 
Antibody titre against rGGT detected by ELISA 72 days and 93 days post-
immunization based on values of 1:6000 diluted sera. (B) Western blot analysis using 
antibodies raised in mice against rGGT. Lane M, Prestained Precision Protein 
Standards (Bio-Rad); Lane 1, H. pylori wild type lysate; Lane 2, H. pylori Δggt 
lysate. 
 
4.3.2.2 Characterization of MAbs 
Ten hybridomas were obtained from different cultures of mouse myeloma 
cells fused with splenocytes from mouse #2. The hybridomas were subsequently used 
to produce ascitic fluid in mice. Figure 19 shows western blot analysis against H. 
pylori wild type lysate using the MAbs as probes. Six of the MAbs recognized only 
the large subunit (Clones 1G5, 1G10, 1H5, 2B5, 2G1 and 4A11) while the other four 
recognized only the small subunit (Clones 1G1, 3C10, 3F4 and 4F11). All of these 
MAbs were of the IgG class and could be classified into three isotypes, IgGl, IgG2a 
and IgG2b. Interestingly, MAbs that recognized the large subunit of GGT were all 
IgG1 and those against the small subunit were all IgG2. Results are summarized in 
Table 7. 
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Figure 19. Specificity of MAbs raised against rGGT. Western blot analysis of H. 
pylon wild type lysate with ascitic fluids containing MAbs. Lanes: 1, 1G5; 2, 1G10; 3, 
1H5; 4, 2B5; 5, 2G1; 6, 4A11; 7, 1G1; 8, 3C10; 9, 3F4; 10, 4F11; 11, polyclonal 
mouse anti-H. pylori GGT IgG (positive control).  
 
Table 7. Summary of MAb isotypes and specificities. 
 
Specificity Clone ID Isotype Large subunit Small subunit 
1G5 IgG1 + - 
1G10 IgG1 + - 
1H5 IgG1 + - 
2B5 IgG1 + - 
2G1 IgG1 + - 
4A11 IgG1 + - 
1G1 IgG2b - + 
3C10 IgG2a - + 
3F4 IgG2a - + 
4F11 IgG2a - + 
 
4.3.2.3 Mapping of epitopes 
Using a series of overlapping peptides (15 amino acids each) covering the 
sequence of H. pylori GGT, the epitopes which the MAbs recognized were identified 
by indirect ELISA method. Both the ELISA and western blot results confirmed that 6 





subunit of GGT. Among the MAbs which were specific towards the large subunit, 3 
different minimum epitopes were identified (amino acid position 42-50, 309-317 and 
357-365 of GGT). All 4 MAbs towards the small subunit of GGT were found to 
recognize the same minimum epitope sequence (amino acid position 428-434 of 













Figure 20. Identification of epitopes recognized by MAbs. Three different epitopes 
coloured yellow (MAbs 1G5, 4A11), green (MAb 2B5) and magenta (1G10, 1H5, 
2G1) were identified on the large subunit of GGT. One epitope coloured blue (MAbs 
1G1, 3C10, 3F4, 4F11) was identified on the small subunit of GGT. Cleavage sites of 
precursor GGT giving the large subunit and small subunit are indicated by arrows. 
 
  
Epitopes that the 10 MAbs recognized were mapped on the 3-D crystal 
structure of recombinant H. pylori GGT (Boanca et al., 2007) as observed in Figure 
21. Individual epitopes are circled in red. Catalytic site of GGT present in the small 



















    
 
Figure 21. 3-D structures of individual large and small subunits of rGGT 
illustrating the epitopes which MAbs bind to. (A) Large subunit of rGGT. Epitope 
42-SSHPLASEI-50 recognized by MAb 1G5 and 4A11 is circled in red. (B) Large 
subunit of rGGT. Epitope 309-SKNIHIAAE-317 recognized by MAb 2B5 is circled 
in red. (C) Large subunit of rGGT. Epitope 357-QPDTVTPSS-365 recognized by 
MAb 1G10, 1H5 and 2G1 is circled in red. (D) Small subunit of rGGT. Epitope 428-
GNPNLYG-434 recognized by MAb 1G1, 3C10, 3F4 and 4F11 is circled in red. 
Catalytic site of rGGT is indicated by a yellow rectangle. 3-D crystal structure of 
rGGT was obtained from the Proten Data Bank (PDB ID: 2NQO) and viewed using 










4.4 Inhibition of GGT catalytic activity by MAbs 
4.4.1 Examination of neutralizing activity of MAbs from different clones 
Among the 10 MAbs, 4 MAbs (1G1, 3C10, 3F4 and 4F11) inhibited H. pylori 
GGT activity with varying degrees of inhibition ranging from ~30 to ~93% (Figure 
22). All 4 recognized the small subunit of GGT. The most potent inhibitor, MAb 1G1, 
inhibited 77.4% of GGT activity even at a low dose of 0.25 μg and achieved 
maximum inhibition of 93.0% at just 4 μg. MAbs 4F11, 3F4 and 3C10 inhibited 
80.7%, 71.9% and 32.0% GGT activity respectively when the maximum dose (30 μg) 
was used. The other 6 MAbs specific against the large subunit failed to inhibit the 
GGT activity even at the highest dose (30 μg) tested. In addition, mouse IgG2a and 








Figure 22. Neutralizing ability of MAbs on H. pylori 88-3887 GGT activity. A 
population of 5 × 106 H. pylori 88-3887 was pre-incubated with various amounts of 
MAb 1G1 (■), 4F11 (□), 3F4 (▲) or 3C10 (Δ) (0 to 30 μg of IgG protein) for 1 hour  
at 37°C on microtitre plates. Mouse IgG2a (●) and IgG2b (○) isotype controls were 
used in parallel at the same concentrations. Inhibition of GGT activity by MAbs was 
measured using GGT assay. Points are the averages for triplicate determinations.  
 
4.4.2 Neutralizing activity of MAbs on different H. pylori strains 
 The ability of the MAbs to neutralize GGT activity was tested on 






















1G1 showed the best neutralizing activity where it inhibited GGT activity of strains 
26695, SS1 and NCTC 11637 by as high as 94.7%, 63.5% and 87.9%, respectively. In 
addition, mouse IgG2a and IgG2b isotype negative controls did not inhibit GGT 
activity. In this study, potency of the various MAbs in neutralizing GGT activity 









































































Figure 23. Neutralizing ability of MAbs on different H. pylori strains. (A) H. 
pylori strain 26695. (B) H. pylori strain SS1. (C) H. pylori strain NCTC 11637. A 
population of 5 × 106 H. pylori was pre-incubated with various amounts (0 to 30 μg of 
IgG protein) of MAb 1G1 (■), 4F11 (□), 3F4 (▲) or 3C10 (Δ) for 1 hour at 37°C on 
microtitre plates. Mouse IgG2a (●) and IgG2b (○) isotype controls were used in parallel 




 MAb 1G1, which was found to be the most potent inhibitor out of the 10 
MAbs, was further tested for its ability to neutralize GGT activity of 7 clinical H. 
pylori strains. As observed in Figure 24, MAb 1G1 was effective in inhibiting their 












Figure 24. Neutralizing ability of MAb 1G1 on various clinical H. pylori strains. 
A population of 5 × 106 H. pylori was pre-incubated with 10 μg of MAb 1G1 for 1 
hour at 37°C on microtitre plates. Inhibition of GGT activity by MAbs was measured 























4.4.3 Comparison of H. pylori 88-3887 GGT amino acid sequence with other 
GGTs 
 The nucleotide sequence of H. pylori 88-3887 ggt gene (as sequenced in 
section 4.2.2) was translated into amino acid sequence using ExPASy Translate tool 
(web.expasy.org/translate/). Figure 25 shows the amino acid sequence alignment of H. 
pylori GGT (residues 416-464) with other bacterial and mammalian homologues 
corresponding to these same amino acid positions using Clustal 2.0.12. The 
neutralizing epitope sequence recognized by MAbs 1G1, 3C10, 3F4 and 4F11 is 
indicated by a black bar and it is observed that this epitope sequence is highly 
conserved within H. pylori species. In contrast, this 7-amino acid epitope is not found 
in the GGTs of other bacterial (Helicobacter suis, Helicobacter felis, Helicobacter 
mustelae, Helicobacter bilis, Helicobacter canis, Pseudomonas aeruginosa, 
Escherichia coli and Bacillus subtilis) as well as mammalian (cow, human and rat) 
homologues.  
 
H. pylori 88-3887   LNNEMDDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKV 464 
H. pylori 26695 LNNEMDDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKV 464 
H. pylori J99     LNNEMDDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKV 464 
H. pylori G27     LNNEMDDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKV 464 
H. pylori P12 LNNEMDDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKV 464  
H. pylori NCTC11637 LNNEMDDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKV 464 
H. pylori SS1  LNNEMDDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKV 464 
H. suis  LNDEMDDFSIKAGTPNLYGVIGGDANAIEPNKRPLSSMSPTIVLK-NNKV 454 
H. felis  LNNEMDDFSIKPGVPNLYGLVGGDANAIEPGKRPLSSMSPTIVLK-QNKV 459 
H. mustelae  LNNEMDDFSIKPGVANLYGLVGGDANAIAPKKRPLSSMTPTIVLK-DNKP 458 
H. bilis  LNNEMDDFSIKPGVANLYGLVGGEANAIVPRKRPLSSMSPTIILK-DGKL 461 
H. canis  LNNEMDDFSIKPGVPNQYGLVGGDANAIAPGKRPLSSMSPTIVLD-KSKL 398 
P. aeruginosa     LNDEMDDFTSKVGVPNMYGLIQGEANAIGPGRRPLSSMSPTIVTK-DGKT 460 
E. coli          LNNQMDDFSAKPGVPNVYGLVGGDANAVGPNKRPLSSMSPTIVVK-DGKT 475 
B. subtilis       LNNELTDFDAIPG----------GANEVQPNKRPLSSMTPTILFK-DDKP 477 
Cow     FNDEMDDFS-SPNIINQFGVPPSPANFIAPGKQPLSSMCPVIIVGDDGQV 464 
Human     FNNEMDDFS-SPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQV 465 
Rat     FNDEMDDFS-SPNFTNQFGVAPSPANFIKPGKQPLSSMCPSIIVDKDGKV 464 
 
Figure 25. Comparison of amino acid sequence of H. pylori GGT (residues 416-
464) and that of other bacterial and mammalian homologues. Multiple sequence 
alignment was performed using Clustal 2.0.12. Origin of the sequences are stated on 
the left. Numbers on the right indicate amino acid positions. The black bar 
corresponds to the position of the sequence recognized by the MAbs (1G1, 3C10, 3F4 
and 4F11) on H. pylori 88-3887 GGT. 
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4.5 Purification of nGGT from H. pylori 
H. pylori nGGT was purified in a one-step procedure by immunoaffinity 
chromatography using MAb 1G1. The purified H. pylori nGGT protein consisted of 
two protein bands with molecular masses of about 37 kDa and 20 kDa corresponding 
to the large and small subunit of GGT respectively (Figure 26). Purity of the protein 
was >95% as determined by silver staining after SDS-PAGE (data not shown). 
 
 
Figure 26. SDS-PAGE of purified native H. pylori GGT (nGGT). Lane M, 
Prestained Precision Protein Standards (Bio-Rad); Lane 1, H. pylori 88-3887 crude 
sample; Lane 2, unbound fraction; Lane 3, purified nGGT. 
 
4.5.1 Total yield and recovery 
Using this method, 0.067 mg of purified nGGT was obtained from an initial 
8.12 mg of crude sample and specific GGT activity was shown to increase by 10-fold 














4.6 Localization of GGT in H. pylori by immunogold-labeling TEM 
 Ultrathin sections of H. pylori wild type and Δggt sections were probed with 
MAb 1G1 and secondary anti-mouse antibody conjugated with 10 nm gold. Gold 
particles were mainly observed on the outer cell membrane and periplasmic space of 
H. pylori wild type (Figure 27A-B) but were absent in the ggt-isogenic mutant (Figure 
27C). Some gold particles were also observed in the cytoplasm of the bacteria. In 
contrast, no gold particles were observed in H. pylori wild type sections probed with 
pre-immune mouse sera (Figure 27D). 
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Figure 27. Localization of GGT in H. pylori by immunogold-labeling TEM. (A-B) 
H. pylori wild type and (C) Δggt labeled with MAb 1G1 and 10 nm gold particles. (D) 
H. pylori wild type labeled with pre-immune mouse sera. Red arrows indicate 
presence of GGT on the bacterial outer cell membrane or periplasmic space. Yellow 
arrows indicate presence of GGT in the bacterial cytoplasm. Micrographs are 







4.7 Construction of various H. pylori isogenic mutants 
Figure 28 shows the presence of the PCR amplified DNA fragments of various 
isogenic mutants that have been correctly constructed. Each fragment consists of the 
two flanking DNA fragments upstream and downstream (approximately 500 bp each) 
of the gene of interest on H. pylori strain 88-3887 genomic DNA. In place of the gene 
of interest is either the 1402 bp kanamycin resistance cassette or the 742 bp 
chloramphenicol resistance cassette. Thus, each of the isogenic construct comprises 
three DNA fragments (upstream region, specific antibiotic resistance cassette and 
downstream region) that were ligated and amplified, resulting in the construction of a 
gene-targeting construct used for the transformation of H. pylori strain 88-3887. 
ΔcagPAI was constructed by transforming plasmid pJP46 into H. pylori 88-3887. 
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Figure 28. PCR amplified products for generation of various knockout 
constructs. (A) PCR products for generation of ggt knockout construct. Lane M, 100 
bp DNA ladder; Lane 1, upstream region of ggt (557 bp, primers ggt1 and ggt2); Lane 
2, downstream region of ggt (522 bp, primers ggt3 and ggt4); Lane 3, kanamycin 
resistance cassette (1402 bp, primers kanF and kanR). (B) Δggt construct. Lane M, 1 
kb DNA ladder; Lane 1, ggt knockout construct (2442 bp, primers ggt1 and ggt4). (C) 
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ladder; Lane 1, upstream region of cagA (553 bp, primers cagA1 and cagA2); Lane 2, 
downstream region of cagA (546 bp, primers cagA3 and cagA4); Lane 3, 
chloramphenicol resistance cassette (742 bp, primers camF and camR). (D) ΔcagA 
construct. Lane M, 1 kb DNA ladder; Lane 1, cagA knockout construct (1799 bp, 
primers cagA1 and cagA4). (E) PCR products for generation of vacA knockout 
construct. Lane M, 100 bp DNA ladder; Lane 1, upstream region of vacA (543 bp, 
primers vacA1 and vacA2); Lane 2, downstream region of vacA (535 bp, primers 
vacA3 and vacA4); Lane 3, chloramphenicol resistance cassette (742 bp, primers 
camF and camR). (F) ΔvacA construct. Lane M, 1 kb DNA ladder; Lane 1, vacA 
knockout construct (1778 bp, primers vacA1 and vacA4). (G) PCR products for 
generation of ureAB knockout construct. Lane M, 100 bp DNA ladder; Lane 1, 
upstream region of ureAB (797 bp, primers ureAB1 and ureAB2); Lane 2, 
chloramphenicol resistance cassette (742 bp, primers camF and camR); Lane 3, 
downstream region of ureAB (513 bp, primers ureAB3 and ureAB4). (H) ΔureAB 
construct. Lane M, 1 kb DNA ladder; Lane 1, ureAB knockout construct (2010 bp, 
primers ureAB1 and ureAB4). 
 
After transformation of the various knockout constructs into H. pylori 88-3887, 
positive deletion mutants were confirmed by PCR. Chromosomal DNA extracted 
from the respective mutants gave a PCR product of a different size as compared to 
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Figure 29. Identification of isogenic mutants by PCR amplification. Genomic 
DNA of wild type H. pylori 88-3887 and various knockout strains were extracted and 
subjected to PCR using different primer sets. (A) Confirmation of Δggt. Lane M, 1 kb 
DNA ladder; Lane 1, wild type (2869 bp, primers ggt1 and ggt4); Lane 2, Δggt (2442 
bp, primers ggt1 and ggt4). (B) Confirmation of ΔcagA. Lane M, 1 kb DNA ladder; 
Lane 1, wild type (4730 bp, primers cagA1 and cagA4); Lane 2, ΔcagA (1799 bp, 
primers cagA1 and cagA4). (C) Confirmation of ΔvacA. Lane M, 1 kb DNA ladder; 
Lane 1, wild type (5006 bp, primers vacA1 and vacA4); Lane 2, ΔvacA (1778 bp, 
primers vacA1 and vacA4). (D) Confirmation of ΔureAB. Lane M, 1 kb DNA ladder; 
Lane 1, wild type (3619 bp, primers ureAB1 and ureAB4); Lane 2, ΔureAB (2010 bp, 
primers ureAB1 and ureAB4). (E) Confirmation of ΔcagA/ggt. Lane M, 1 kb DNA 
ladder; Lane 1, wild type (4730 bp, primers cagA1 and cagA4); Lane 2, ΔcagA (1799 
bp, primers cagA1 and cagA4); Lane 3, wild type (2869 bp, primers ggt1 and ggt4); 
Lane 4, Δggt (2442 bp, primers ggt1 and ggt4). (F) Confirmation of ΔvacA/ggt. Lane 
M, 1 kb DNA ladder; Lane 1, wild type (5006 bp, primers vacA1 and vacA4); Lane 2, 
ΔvacA (1778 bp, primers vacA1 and vacA4); Lane 3, wild type (2869 bp, primers 
ggt1 and ggt4); Lane 4, Δggt (2442 bp, primers ggt1 and ggt4). (G) Confirmation of 
ΔureAB/ggt. Lane M, 1 kb DNA ladder; Lane 1, wild type (3619 bp, primers ureAB1 
and ureAB4); Lane 2, ΔureAB (2010 bp, primers ureAB1 and ureAB4); Lane 3, wild 
type (2869 bp, primers ggt1 and ggt4); Lane 4, Δggt (2442 bp, primers ggt1 and 
ggt4). (H) Confirmation of ΔcagPAI. Lane M, 1 kb DNA ladder; Lane 1, wild type 
(absence of cagPAI empty site PCR fragment of 1908 bp, primers Luni1 and R5280); 






















4.8 Enumeration of H. pylori 
A plot of viable bacterial cell count (CFU/ml) against the OD600 reading based 
on different dilutions of a 3-day-old H. pylori strain 88-3887 culture was obtained 
(Figure 30). This standard curve was used in subsequent experiments to enumerate H. 
pylori.  
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Figure 30. Standard curve for enumeration of H. pylori. Viable cell count 
(CFU/ml) was plotted against OD600 for H. pylori strain 88-3887. Data are 
representative of 3 independent experiments. 
 
 
4.9 H. pylori GGT and H2O2 generation 
4.9.1 GGT induces H2O2 production 
 AGS cells were co-cultured with H. pylori 88-3887, Δggt or purified nGGT 
and H2O2 generation was quantified by a fluorescence-based analysis. Figure 31A 
shows that H2O2 generation was significantly increased in the presence of H. pylori 
wild type as compared to control cells (5.79 ± 0.35 μM vs 1.05 ± 0.11 μM; P<0.05) 
but this effect was dramatically decreased in the presence of Δggt (5.79 ± 0.35 μM vs 
2.67 ± 0.21 μM; P<0.05). In addition, H2O2 generation was also significantly 
increased in the presence of purified nGGT compared to control cells (2.82 ± 0.12 μM 
vs 1.05 ± 0.11 μM; P<0.05). The significance of GGT-mediated H2O2 generation was 
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further illustrated using primary human gastric epithelial cells which displayed a 
similar significant effect (Figure 31B). 
 
 



































Figure 31. Effect of H. pylori GGT on H2O2 generation. (A) AGS cells. (B) 
primary human gastric epithelial cells. The respective cells were treated with H. pylori 
wild type, WT; ggt-isogenic mutant, Δggt; or purified native GGT, nGGT. H2O2 
generation was examined by a fluorescence-based analysis. Uninfected cells, UN. 












4.9.2 Effects of inhibitor and enhancer on GSH-dependent iron reduction   
H2O2 production by AGS cells was assayed in the presence of purified nGGT 
under various conditions (Figure 32). Stimulation of GGT activity with its substrate 
GSH and the acceptor molecule glycyl-glycine significantly elevated the amount of 
H2O2 being generated compared to nGGT alone (8.31 ± 0.59 μM vs 2.82 ± 0.12 μM; 
P<0.01). Interestingly, H2O2 production was also increased with the addition of 
exogenous Fe3+ compared to cells treated with nGGT alone (4.86 ± 0.17 μM vs 2.82 ± 
0.12 μM; P<0.05). Not surprisingly, H2O2 production was further increased in the 
presence of nGGT, GSH and Fe3+ compared to cells treated with nGGT alone (17.6 ± 
0.76 μM vs 2.82 ± 0.12 μM; P<0.01). In contrast, addition of the GGT inhibitor SBC 
completely suppressed nGGT-mediated H2O2 production to a similar level as 
untreated cells, even in the presence of GSH. Similarly, H2O2 production was also 





































































Figure 32. H. pylori purified native GGT induces H2O2 generation in AGS cells. 
Cells were treated with SBC, 10 mM serine-borate complex; DFO, 50 μM 
desferrioxamine; GSH, 0.1 mM glutathione and 1 mM glycyl-glycine;  Fe3+, 20 μM 
ferric iron; nGGT, 1.5 mU H. pylori purified native GGT; BSA, 10 ng bovine serum 
albumin and combination of one or more compounds. UN, untreated cells. Values 









4.9.3 H. pylori GGT induces NF-κB activation 
 As shown in Figure 33, a substantial increase in NF-κB translocation was 
observed in the nuclear extract of AGS cells infected with wild type H. pylori. In 
contrast, Δggt-treated cells showed significantly reduced levels of NF-κB 
translocation as compared to wild type-treated cells (relative density 0.68 v 1; 
P<0.05). In addition, degradation of IκB was also greater in wild type-treated cells 
compared to Δggt-treated cells (relative density 1 v 4.61; P<0.01), further confirming 
the results. As it has been previously reported that CagA (Kim et al., 2006) and 
cagPAI (Glocker et al., 1998) may also play a role in NF-κB activation, the ability of 
ΔcagA, ΔcagA/ggt and ΔcagPAI in inducing NF-κB translocation was also 
investigated. Interestingly, it was observed that NF-κB activation was dependent on 
the cagPAI but independent of CagA. 
 
 
                                       
                       
                           
                         
 
 
Figure 33. H. pylori GGT induces NF-κB activation. AGS cells were treated with H. 
pylori wild type (WT) or various mutants. NF-κB and IκB were detected in the nuclear 
and cytosolic fractions respectively. Lam A/C, antibody against lamin A/C; β-tub, 
antibody against β-tubulin. Immunblots are representative of 3 independent 
experiments. 
 
 NF-κB   
Lam A/C   
 IκB   
β-tub 
 UN           WT          Δggt       Δcag    ΔcagA/ggt   ΔcagPAI   
Results 
120 
4.9.4 H. pylori GGT and IL-8 production 
4.9.4.1 IL-8 production induced by GGT  
 AGS cells were tested for enhanced IL-8 production following treatment with 
H. pylori or nGGT according to the method as described in section 3.13.3. As 
observed in Figure 34A-B, H. pylori wild type induced significantly higher levels of 
IL-8 production as compared to Δggt at both 4 and 24 hours post-infection (P<0.05). 
Interestingly, purified nGGT alone was also able to induce significantly greater IL-8 
generation by AGS cells compared to the control cells (P<0.05). Additionally, 
purified rGGT was tested for its ability to induce IL-8 secretion in AGS cells and 
showed similar results as nGGT.  
 To further confirm the role of GGT in inducing IL-8 production, primary 
human gastric epithelial cells were also treated with H. pylori, nGGT or rGGT. The 
results showed a similar trend as compared to AGS cells (Figure 34C-D). As 
macrophages are also an important source of IL-8 generation in the stomach mucosa, 
the ability of H. pylori, nGGT and rGGT in inducing IL-8 production was tested on 
primary human macrophages. Interestingly, wild type H. pylori induced significantly 
higher IL-8 production as compared to Δggt at 4 hours post-infection (P<0.05) but the 
difference was no longer significant 24 hours post-infection (Figure 34E-F). Despite 
this, it was noted that nGGT or rGGT alone was able to induce a significant amount 
of IL-8 generation in macrophages compared to untreated cells at both 4 and 24 hours 











































































































Figure 34. H. pylori GGT induces IL-8 production from various cell types. ELISA 
assay was employed to measure IL-8 generation from: AGS cells (A) 4 hours and (B) 
24 post-infection; primary human gastric epithelial cells (C) 4 hours and (D) 24 hours 
post-infection; and primary human macrophages (E) 4 hours and (F) 24 hours post-
infection. UN, uninfected cells; WT, wild type H. pylori; Δggt, ggt-isogenic mutant; 
nGGT, purified native GGT; rGGT, purified recombinant GGT. Values represent 


























4.9.4.2 Role of CagA and cagPAI in IL-8 induction 
The role of CagA in inducing IL-8 generation has been controversial (Nozawa 
et al., 2002; Lai et al., 2011). To determine whether CagA works in concert with GGT 
to induce IL-8 production, AGS cells were infected with ΔcagA or ΔcagA/ggt (Figure 
35). Interestingly, IL-8 production induced by ΔcagA was not significantly different 
from that induced by wild type H. pylori (P>0.05) but was significantly reduced when 
infected with ΔcagA/ggt (P<0.05). The role of other cagPAI proteins in IL-8 
induction was also tested by infecting AGS cells with ΔcagPAI. From the results, it 
was observed that ΔcagPAI induced significantly less IL-8 generation compared to 
wild type H. pylori (P<0.05), suggesting that certain protein(s) encoded in the cagPAI 
















Figure 35. Involvement of H. pylori cagPAI in IL-8 induction in AGS cells. 
ELISA assay of IL-8 generation from AGS cells after treatments with H. pylori wild 
type (WT) or various mutants for 24 hours. UN, uninfected cells. Values represent 











4.10 Internalization of H. pylori GGT in host cells 
 It was next investigated if GGT also translocates into host cells and if so, 
whether it exerts any effects intracellularly. To determine this, localization of H. 
pylori GGT in host AGS cells post-infection was performed using TEM, CLSM and 
western blot analysis.  
 
4.10.1 TEM 
 Localization of GGT in AGS cells after infection with H. pylori was carried 
out using immunogold-labeling TEM. GGT was observed to be present mainly in the 
nuclei (indicated by ‘Nu’) of AGS cells as indicated by 20 nm gold particles, with a 
few gold particles present in the cytosol 24 hours post-infection (Figure 36B-C). No 
gold particles were observed in the uninfected control (Figure 36A) as well as AGS 
cells infected with H. pylori Δggt (Figure 36D), indicating that the antibody used is 
specific for H. pylori GGT. It was also noted that AGS cells infected with H. pylori 
wild type (Figure 36B-C) showed the presence of vacuoles (indicated by ‘v’) and 
condensation of chromatin into compact patches against the nuclear envelope 
(indicated by ‘cc’), a hallmark of apoptosis (Kihlmark et al., 2001). These 





       
 
      
          














         
 



























         
 
       
 
 
Figure 36. Localization of H. pylori GGT in AGS cells 24 hours post-infection. 
AGS cells were infected with H. pylori wild type or Δggt for 24 hours. Uninfected 
cells served as control. Cells were then processed for immunogold-labeling TEM as 
described in section 3.9. (A) Uninfected AGS cells. (B-C) AGS cells infected with H. 
pylori wild type. (D) AGS cells infected with H. pylori Δggt. GGT was labeled with 
MAb 1G1 and 20 nm immunogold secondary antibody. Red arrows indicate presence 
of GGT in the nucleus. Blue arrow indicates presence of GGT in the cell cytoplasm. 





 The presence of H. pylori GGT in AGS cells was also investigated using 
immunofluorescence. No GGT was observed in uninfected AGS cells (Figure 37A) as 
well as in H. pylori Δggt-infected AGS cells (Figure 37B). GGT was observed to be 
present mainly on extracellular H. pylori as well as in the nuclei of AGS cells infected 
with H. pylori wild type (Figure 37C). Interestingly, AGS co-incubated with purified 









      









Figure 37. CLSM micrographs showing presence of H. pylori GGT in AGS cell 
nuclei. AGS cells were co-incubated with H. pylori wild type, Δggt or rGGT for 24 





described in section 3.14.1.2. (A) Uninfected AGS cells. (B) AGS cells infected with 
H. pylori Δggt. (C) AGS cells infected with H. pylori wild type. (D) AGS cells treated 
with rGGT. Blue, nucleus stained with Hoechst 33342; Red, H. pylori GGT labeled 
with MAb 1G1 and Cy3. Scale bar represents 5 μm. 
 
4.10.3 Western blot analysis of different cell fractions 
 Western blot analysis was employed to further confirm the presence of GGT 
in AGS cells after infection with H. pylori. Figure 38 shows that H. pylori GGT was 
detected in both the cytosolic and nuclear fractions of AGS cells as early as 1 hour 
post-infection. No β-tubulin nor lamin A/C was detected in the nuclear and cytosolic 
fractions respectively, indicating that the fractions were well separated and no cross-
contamination was present. 
 
 
             
                      
             
Figure 38. H. pylori GGT enters into host cells. AGS cells were infected with H. 
pylori wild type for 24 hours. The cytosolic and nuclear extracts were collected at 
various time-points and subjected to western blot analysis. Lane 1, 0 hour; Lane 2, 0.5 
hour; Lane 3, 1 hour; Lane 4, 2 hours; Lane 5, 4 hours; Lane 6, 24 hours; Lane 7, 
AGS infected with Δggt (24 hours). GGT, polyclonal antibody raised against rGGTS; 
β-tub, antibody against β-tubulin; Lam A/C, antibody against lamin A/C. 
 
 To further confirm that rGGT was able to enter into host cell nuclei in the 
absence of H. pylori as observed by CLSM (section 4.10.2), western blot analysis was 
carried out on the cytosolic and nuclear fractions of rGGT-treated cells. Figure 39 
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Figure 39. rGGT enters into host cells. AGS cells were co-incubated with rGGT for 
up to 24 hours. Cytosolic and nuclear extracts were obtained at various time-points. 
Lane 1, 0 hour; Lane 2, 0.5 hour; Lane 3, 1 hour; Lane 4, 2 hours; Lane 5, 4 hours; 
Lane 6, 24 hours. GGT, polyclonal antibody raised against rGGTS; β-tub, antibody 
against β-tubulin; Lam A/C, antibody against lamin A/C. 
 
 
4.10.4 Internalization of GGT by cells is a specific process 
 AGS cells were incubated with either rGGT or heat-denatured rGGT (95°C, 
10 minutes) and probed for the presence of intracellular rGGT after 2 and 4 hours. As 
observed in Figure 40, heat-denatured rGGT was not detected in AGS cells, implying 
that the uptake of rGGT requires it to be in its native conformation. 
 






Figure 40. Heat-denatured rGGT is unable to enter into AGS cells. AGS cells 
were co-incubated with either rGGT or heat-denatured rGGT. Lane 1, AGS co-
incubated with rGGT (2 hours); Lane 2, AGS co-incubated with heat-denatured rGGT 
(2 hours); Lane 3, AGS co-incubated with rGGT (4 hours); Lane 4, AGS co-incubated 
with heat-denatured rGGT (4 hours); Lane 5, rGGT positive control; Lane 6, rGGT 
(heat-denatured) positive control. GGT, polyclonal antibody raised against rGGTS; β-
tub, antibody against β-tubulin. 
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 AGS cells were also separately co-incubated with the individual recombinant 
subunits of GGT (rGGTL and rGGTS). Using western blot analysis, it was observed 
that neither rGGTL nor rGGTS could enter into AGS cells (Figure 41).  
 
 
                                 
Figure 41. rGGTL and rGGTS are unable to enter into AGS cells separately. 
AGS cells were co-incubated with rGGT, rGGTL or rGGTS for 24 hours. AGS whole 
cell lysates were probed using MAb 2B5 or MAb 1G1. Lane 1, AGS co-incubated 
with rGGT; Lane 2, AGS co-incubated with rGGTL; Lane 3, AGS co-incubated with 
rGGTS; Lane 4, rGGT positive control; Lane 5, rGGTL positive control; Lane 6, 
rGGTS positive control. 
                                    
4.10.4.1 GGT is endocytosed by a clathrin-dependent pathway 
 Since the uptake of GGT is specific and requires it to be in its native 
conformation, it was hypothesized that GGT enters into the cell via receptor-mediated 
endocytosis. To determine whether GGT was taken up by the cells by clathrin-
mediated endocytosis or caveolin-dependent endocytosis (Conner and Schmid, 2003), 
pharmalogical agents CPZ and NYS were used to inhibit the respective endocytic 
pathways (Pho et al., 2000). Drug cytotoxicity tests showed that CPZ at a 
concentration of 15 μg/ml and NYS at a concentration of 25 μg/ml maintained cell 
viability at 81% and 100% respectively (Figure 42). Hence, these concentrations, 
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which have also been reported to be used previously (Parker et al., 2010), were 



















Figure 42. Assessment of drug cytotoxicity of CPZ and NYS to AGS cells. AGS 
cells were treated with CPZ (5-25 μg/ml) or NYS (5-50 μg/ml) for 5 hours and cell 
viability was measured by MTT assay. Untreated cells (UN) served as control. CPZ, 
chlorpromazine; NYS, nystatin.  
 
 
 After treating AGS cells with the respective inhibitors, presence of rGGT in 
whole cell lysates 4 hours post-incubation was probed by western blot analysis 
(Figure 43A). It was observed that in the presence of CPZ, the amount of rGGT 
detected in whole cell lysates decreased to approximately 67% as compared to the 
uninhibited cells (treated with rGGT only) as determined by ImageJ software. The 
cells were then further separated into membrane and cytosolic fractions. Interestingly, 
it was found that majority of rGGT was present in the membrane fraction of CPZ-
treated cells while most were present in the cytosolic fraction in both NYS-treated and 
uninhibited cells (Figure 43B). These results indicate that GGT is likely to be taken 






                                                                                 
                                
 
 
                                
                                        
                                        
 
Figure 43. Effect of CPZ and NYS on rGGT internalization by AGS cells. AGS 
cells were either pre-treated with CPZ (15 μg/ml) or NYS (25 μg/ml) for 30 minutes 
and 60 minutes respectively and then incubated with rGGT for another 4 hours. (A) 
Presence of rGGT in whole cell lysates. (B)  Presence of rGGT in membrane and 
cytosolic extracts of cells. Lane 1, uninhibited cells (treated with rGGT only); Lane 2, 
CPZ-treated cells; Lane 3, NYS-treated cells. GGT, polyclonal antibody raised 
against rGGTS; β-tub, antibody against β-tubulin; HGFR, antibody against hepatocyte 




 Cells treated with CPZ or NYS were also observed under CLSM. From Figure 
44, it was noted that in CPZ-treated cells, the addition of rGGT led to its 
accumulation along the cell periphery and rGGT was also not observed in the nuclei 
of these cells. This was in contrast to uninhibited or NYS-treated cells where rGGT 
was found to be mainly intracellular. 
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Figure 44. CLSM micrographs showing inhibition of rGGT internalization in the 
presence of CPZ. AGS cells were pre-treated with CPZ (15 μg/ml) or NYS (25 
μg/ml) for 30 minutes and 60 minutes respectively before the addition of rGGT for 4 
hours. Control cells were not incubated with rGGT nor treated with any of the 
inhibitors. Green, actin cytoskeleton stained with phalloidin-488; Red, rGGT labeled 
rGGT + CPZ 
rGGT + NYS 
rGGT 
rGGT + CPZ 
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with MAb 1G1 and Cy3; Blue, nucleus stained with Hoechst 33342. rGGT present in 
the nuclei of NYS-treated and uninhibited (incubated with rGGT only) cells are 
indicated by white arrowheads. A merged image shows accumulation of rGGT on the 
periphery of CPZ-treated cells as indicated by yellow arrows. Scale bar represents 5 
μm. 
 
4.10.5 Nuclear import of GGT is dependent on importin β1 
4.10.5.1 GGT forms a complex with host protein importin β1 
 Co-IP of various importin β proteins and H. pylori GGT was carried out to 
determine if H. pylori GGT could be a possible cargo of these importins. Immunoblot 
analysis revealed that only importin β1 co-immunoprecipitated with GGT while 
importins β2 and β3 did not (Figure 45A, C and E). As a confirmation, reverse co-IP 
analysis showed that GGT only co-immunoprecipitated with importin β1 but not 
importins β2 and β3 (Figure 45B, D and F), suggesting that nuclear import of GGT 


















                                                                
 
 
                          
 
 
                                                              
Figure 45. H. pylori GGT co-immunoprecipitates with importin β1. AGS cell 
lysate was co-incubated with H. pylori 88-3887 lysate and subject to co-IP using MAb 
1G1 against GGT followed by immunoblotting with antibodies against (A) importin 
β1, (C) importin β2 and (E) importin β3. Reverse co-IP was carried out using 
polyclonal antibody against (B) importin β1, (D) importin β2 or (F) importin β3 
followed by immunoblotting with polyclonal antibody raised against rGGTS. In all 
experiments, lysates incubated with Protein G or protein A beads without antibody 
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4.10.5.2 siRNA knockdown of importin β1  
 Since H. pylori GGT co-immunoprecipitates with importin β1, it was 
hypothesized that nuclear import of GGT depended on importin β1. To study its role 
in nuclear import, knockdown of importin β1 expression was performed using siRNA 
against importin β1. Optimal siRNA amount was determined to be 80 pmol where 
importin β1 expression was decreased by >80% as observed in Figure 46. Hence, this 



























     
 
Figure 46. Dose-dependent knockdown of importin β1 using siRNA. AGS cells 
were transfected with various amounts of importin β1 siRNA (20-80 pmol). (A) 
Proteins from the total cell lysate 72 hours post-transfection were analyzed by western 
blotting. Lane 1, 0 pmol; Lane 2; 20 pmol; Lane 3, 40 pmol; Lane 4, 60 pmol; Lane 5, 
80 pmol siRNA. β-tub, antibody against β-tubulin. (B) Densitometric quantification of 
the corresponding bands was performed using ImageJ version 1.44i analysis software. 
Values are expressed as the percentage of importin β1 expression compared to control 












 Effect of importin β1 knockdown on nuclear import of GGT was investigated. 
It was observed under CLSM that knockdown of importin β1 expression resulted in 
rGGT being mainly found in the cytoplasm of AGS cells 4 hours post-incubation as 
opposed to untreated cells (incubated with rGGT only) where rGGT was observed to 
be mainly in the cell nuclei (Figure 47A). Likewise, it was also noted that the amount 
of rGGT in the cytosolic fractions of AGS cells was significantly increased in siRNA-
treated cells compared to untreated cells (relative density 1.65 v 1; P<0.05) although 
the total amount of rGGT in the whole cell lysates was similar in both cases as shown 
in western blot analysis (Figure 47B). In contrast, amount of rGGT in the nuclear 
fraction was significantly less in siRNA-treated cells compared to the control (relative 
density 0.55 v 1; P<0.05). Taken together, these results indicate that nuclear import of 
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Figure 47. Nuclear import of GGT is dependent on importin β1. (A) AGS cells were 
transfected with importin β1 (Imp β1) siRNA before the addition of rGGT for 4 hours. 
Red, rGGT labeled with MAb 1G1 and Cy3; Blue, nucleus stained with Hoechst 33342. 
Control cells were not incubated with rGGT nor treated with Imp β1 siRNA. A merged 
image shows accumulation of rGGT in the cytoplasm of Imp β1 siRNA-treated cells. 
Scale bar represents 5 μm. (B) AGS cells were transfected with Imp β1 siRNA or 
transfection reagent only (−). Proteins from the total whole cell, cytosolic and nuclear 
lysates were then analyzed by western blotting with antibodies as indicated. Importin β1, 
antibody against importin β1; GGT, antibody raised against rGGTS; β-tub, antibody 
against β-tubulin, Lam A/C, antibody against lamin A/C. Immunblots are representative 
of 3 independent experiments. 
 
4.10.6 Role of GGT in affecting nuclear GSH levels in AGS cells 
 Since GSH is one of the main substrates of GGT and levels of GSH in the cell 
nuclei are high (~15mM) (Bellomo et al., 1997), it was speculated that GGT may 
deplete nuclear GSH after it was imported into the nucleus. Thus, the role of GGT in 
the cell nucleus was next investigated. Using the fluorochrome CMFDA to detect 
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with wild type H. pylori as compared to cells infected with Δggt (Figure 48A). 
Interestingly, rGGT alone also induced a depletion of intracellular GSH level, 
indicating that GGT is involved. Using Hoechst 33342 staining to delineate the 
nuclear area, GSH content (CMFDA green fluorescence) within the nuclear perimeter 
was then measured and plotted in arbitrary units. As observed in Figure 48B, cells 
infected with H. pylori wild type displayed a significant depletion of nuclear GSH 
compared to cells infected with Δggt (P<0.01). Control cells, on the other hand, 
exhibited high levels of nuclear GSH. In addition, rGGT also significantly depleted 
nuclear GSH in a dose-dependent manner, strongly suggesting that one of the actions 
of GGT on the host is to reduce its GSH stores. 
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Figure 48. H. pylori GGT depletes nuclear GSH. (A) Representative CLSM 
micrographs of AGS cells co-incubated with H. pylori wild type (WT), Δggt or rGGT 
(0.5-10 mU) for 24 hours. Red, PI which stains dead cells; Green, CMFDA which 
marks GSH; Blue, Hoechst 33342 which stains nucleus. Control cells were not 
infected with H. pylori nor treated with rGGT. Scale bar represents 10 μm. (B) Mean 
CMFDA fluorescence intensity in nuclear area (defined by Hoechst 33342 staining) 
of 100 cells from at least 5 different fields was quantified using ImageJ software 






































4.10.6.1 Inhibition of endocytosis of GGT 
 To confirm that depletion of nuclear GSH was due to intracellular GGT, CPZ-
treated cells were co-incubated with rGGT and subject to CMFDA staining. Figure 49 
shows that rGGT (2 mU) induced significantly less GSH depletion when its uptake 
was inhibited by CPZ compared to NYS-treated and uninhibited (incubated with 
rGGT only) cells (P<0.05). As a control, CPZ itself did not induce any depletion of 

































Figure 49. Intracellular rGGT depletes nuclear GSH. AGS cells were pre-treated 
with CPZ (15 μg/ml) or NYS (25 μg/ml) before the addition of rGGT (2 mU) for 4 
hours. Control cells (UN) were not incubated with rGGT nor treated with any of the 
inhibitors. Mean CMFDA fluorescence intensity in nuclear area (defined by Hoechst 
33342 staining) of 100 cells from at least 5 different fields was quantified using 















4.10.6.2 Inhibition of nuclear import of GGT  
 To further prove that depletion of nuclear GSH was due to rGGT which had 
been imported into the nucleus, nuclear CMFDA fluorescence was measured in 
importin β1-knockdown cells treated with rGGT. Similarly, GSH depletion was 
significantly less in importin β1-knockdown cells co-incubated with rGGT as 
compared to normal cells treated with rGGT (P<0.05) (Figure 50). GSH levels in 
importin β1-knockdown cells remained similar to control cells. Taken together, the 































Figure 50. Nuclear-imported rGGT depletes nuclear GSH. AGS cells were 
transfected with importin β1 siRNA before addition of rGGT (2 mU) for 4 hours. 
Control cells (UN) were not incubated with rGGT nor treated with importin β1 
siRNA. Mean CMFDA fluorescence intensity in nuclear area (defined by Hoechst 
33342 staining) of 100 cells from at least 5 different fields was quantified using 













4.11 Role of H. pylori GGT in potentiating vacuolation in host cells 
4.11.1 Real-time phase contrast microscopy of vacuolation formation in H. 
pylori-infected AGS cells 
 Live cell imaging of infected AGS cells was carried out to compare if H. 
pylori wild type (Video 1) and Δggt (Video 2) induced different morphological 
changes in cells. Uninfected cells (Video 3) served as control (Videos 1-3 can be 
found in Appendix 35). As observed in Figure 51, micrographs of selected time points 
showing cell morphology of AGS cells were fairly similar when infected with either 
wild type or Δggt for the first 16 hours. The hummingbird phenotype, characterized 
by a beak-like extension of the cells (Moese et al., 2004), was observed in both cases 
(Figure 51A-B) from 4 to 14 hours post-infection (red arrows). From 12 hours, both 
strains also induced the formation of small vacuoles at the perinuclear region of AGS 
cells (yellow arrows). The number of vacuoles that started to appear continued to 
increase until about 16 hours post-infection where differences then began to be more 
apparent. In particular, in wild type-infected AGS cells, vacuolation continued to 
increase up to 22 hours post-infection (Figure 51A). However, in the Δggt-infected 
cells, vacuolation was observed to have plateaued off and did not show any marked 
increase after 16 hours (Figure 51B). Neither the hummingbird phenotype nor 
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Figure 51. Live-cell imaging of H. pylori-infected AGS cells. AGS cells were infected with (A) H. pylori wild type or (B) Δggt over a 24 hour 
period. (C) Uninfected cells served as control. Time-lapse micrographs are shown at 2 hour intervals. Time from the start of infection is 
indicated in white. Hummingbird phenotype is indicated with a red arrow. Perinuclear vacuoles are indicated with a yellow arrow. Scale bar 
represents 50 μm. See Videos 1, 2 and 3 respectively for the full time course (Appendix 35).        
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4.11.2 Vacuolation induction in AGS cells treated with H. pylori 
Neutral red dye was used to better visualize and semi-quantitate the 
vacuolation induced by H. pylori. As observed in Figure 52, no vacuoles were 
observed in uninfected AGS cells (Figure 52A-B). However, AGS cells co-cultured 
with H. pylori wild type took up more neutral red dye (Figure 52C-D) as compared 



































Figure 52. Cell morphology and neutral red uptake by AGS cells infected with H.  
pylori. (A) Uninfected AGS cells, (C) H. pylori wild type-treated AGS cells or (E) 
Δggt-treated AGS cells were observed using phase contrast microscopy. The cells 









under the microscope. Original magnification, 400. Extent of vacuolation is 
indicated by the intensity of red colouration retained within the cells. Uninfected cells 
served as control. 
 
 
This was further confirmed by a quantitative assay based on neutral red dye 
uptake assay where AGS cells co-cultured with Δggt accumulated significantly less 
neutral red dye than cells co-cultured with the wild type strain (P<0.05) starting from 
12 hours post-infection (Figure 53). As the extent of vacuolation started to plateau 
between 20 to 24 hours post-infection, subsequent experiments were carried out using 





























Figure 53. Time course of vacuolation in AGS cells co-cultured with H. pylori. 
AGS cells were co-cultured with H. pylori wild type (■) or Δggt (□) for various time-
points up to 24 hours. (▲) indicates uninfected cells. The cells were then subjected to 
neutral red dye uptake assay. Values represent mean ± SD of 3 independent 
experiments. *P<0.05, **P<0.01. 
 
 
4.11.3 Cellular vacuolation in various cell types infected with H. pylori 
 Primary human gastric epithelial cells were infected with H. pylori wild type 
or Δggt for 24 hours. Using phase contrast microscopy, it was observed that primary 
gastric cells were also susceptible to vacuolation induced by H. pylori. Similar to that 







B) while H. pylori wild type induced more vacuoles (Figure 54C-D) in the primary 
gastric epithelial cells as compared to that induced by Δggt (Figure 54E-F). Neutral 
red dye uptake assay was also carried out on the H. pylori-infected cells to quantitate 
vacuolation and the results showed a similar trend to that of AGS cells (Figure 55). 
 
   
 
   
 
   
 
Figure 54. Cell morphology and neutral red uptake by primary gastric cells  
infected with H. pylori. (A) Uninfected cells, (C) H. pylori wild type-treated cells or 
(E) Δggt-treated cells were observed using phase contrast microscopy. The cells were 
subjected to neutral red dye uptake assay (B, D and F, respectively) and observed 




































Figure 55. Neutral red dye uptake assay showing vacuolation in H. pylori-
infected primary gastric cells. Primary human gastric epithelial cells were co-
cultured with H. pylori wild type (WT) or Δggt for 24 hours. The cells were then 
subjected to neutral red dye uptake assay. Uninfected cells (UN) served as control. 
Values represent mean ± SD of 3 independent experiments. **P<0.01. 
 
 
The role of GGT in vacuole formation was also investigated in HeLa cells, a 
human cervical adenocarcinoma cell line. Similar to AGS and primary gastric cells, 
Δggt induced significantly less neutral red dye uptake in HeLa cells compared to H. 
























Figure 56. Vacuolation in HeLa cells infected with H. pylori. HeLa cells were co-
cultured with H. pylori wild type (WT) or Δggt for 24 hours. The cells were then 
subjected to neutral red dye uptake assay. Uninfected cells (UN) served as control. 






4.11.4 Involvement of GGT, VacA and urease in cellular vacuolation 
 
VacA has been reported as the inducer of vacuolation in host cells (Cover et 
al., 1993). This study examines its involvement by co-culturing AGS cells with 
ΔvacA. The results show that ΔvacA induced minimal vacuolation in AGS cells even 
after 24 hours post-infection (Figure 57), indicating that the vacuolation observed was 
dependent on the presence of VacA. It was also observed that ΔureAB induced 
significantly less vacuolation compared to the wild type strain (P<0.05), implying that 
urease does play a role in inducing vacuolation as previously reported (Cover et al., 
1991). Interestingly, Δggt induced significantly less vacuolation compared to ΔureAB 
(P<0.05). In addition, vacuolation induced by ΔureAB/ggt was abolished to a similar 


















Figure 57. Effects of GGT, VacA and urease in induction of vacuolation in AGS 
cells. AGS cells were co-cultured with H. pylori wild type (WT), Δggt, ΔvacA, 
ΔvacA/ggt, ΔureAB or ΔureAB/ggt at MOI 100 for 24 hours. The cells were then 
subjected to neutral red dye uptake assay. Uninfected cells (UN) served as control. 



































Apart from potentiating the vacuolating activity of VacA, it was also 
investigated if GGT could induce vacuolation independently. AGS cells were co-
incubated with rGGT alone and neutral red dye uptake assay was used to assess 
vacuolation. As observed in Figure 58, there was no significant difference (P>0.05) in 
neutral red dye uptake between rGGT-treated and untreated cells after 24 hours, 
implying that rGGT does not induce vacuolation on its own. Interestingly, when Δggt 
was supplemented with rGGT in AGS culture for 24 hours, vacuolation was almost 
restored to a similar level as that of H. pylori wild type (P<0.01), an effect not seen 
when ∆vacA or ∆vacA/ggt was co-incubated with rGGT. Co-incubation of H. pylori 
wild type and rGGT also significantly increased the extent of vacuolation compared to 






















Figure 58. Effects of rGGT on vacuolation in AGS cells. AGS cells were co-
cultured with H. pylori wild type (WT), Δggt, ΔvacA, ΔvacA/ggt and/or rGGT for 24 
hours. Control cells (UN) were not infected with H. pylori nor treated with rGGT. 
Vacuolating activity was measured using neutral red dye uptake assay. Values 







































4.11.5 Role of ammonia produced by GGT 
4.11.5.1 Vacuolation in glutamine-free media 
Glutamine, being one of the substrates of GGT (Shibayama et al., 2007), 
produces net ammonium ions upon hydrolysis by GGT. Since vacuolation by VacA 
requires the presence of weak bases such as ammonia (Cover et al., 1992), 
investigation was performed to determine if the absence of glutamine in the medium 
would affect the extent of vacuolation in H. pylori-infected AGS cells. Indeed, it was 
observed that there was a significant decrease (P<0.01) in neutral red dye uptake in 
wild type-infected cells in the absence of glutamine (Figure 59). In comparison, 
neutral red dye uptake by AGS cells co-cultured with Δggt and ΔvacA were not 



























Figure 59. Hydrolysis of glutamine by GGT produces ammonia required for 
vacuolation. AGS cells were co-cultured with H. pylori wild type (WT), Δggt or 
ΔvacA for 24 hours in the presence (■) or absence (□) of 2 mM glutamine. 
Vacuolating activity was measured using neutral red dye uptake assay. Uninfected 











4.11.5.2 Rescue of vacuolation induction using exogenous ammonium chloride 
It was next investigated if the addition of an external source of ammonia could 
restore the vacuolating effect of Δggt on AGS cells according to the earlier hypothesis 
that GGT hydrolyzes glutamine to produce ammonia needed for vacuolation 
induction. In these experiments, H. pylori wild type or Δggt was co-cultured with 
AGS cells in the presence of 3 mM ammonium chloride. Interestingly, neutral red dye 
uptake induced by Δggt was restored to the level of that induced by the parental strain 
(Figure 60). In contrast, neutral red uptake in control cells or AGS co-cultured with 
ΔvacA in the presence of ammonium chloride did not show significant difference in 
neutral red dye uptake (P>0.05), indicating that 3 mM ammonium chloride does not 




























Figure 60. Exogenous ammonium chloride rescues ability of Δggt to induce 
vacuolation. AGS cells were co-cultured with H. pylori wild type (WT), Δggt or 
ΔvacA for 24 hours in the absence (□) or presence (■) of 3 mM ammonium chloride. 
Vacuolating activity was measured using neutral red dye uptake assay. Uninfected 








4.11.6 Inhibition of GGT activity and its effects on vacuolation 
To further confirm that GGT activity potentiates vacuolation, its activity was 
inhibited by SBC, a competitive GGT inhibitor (Tate and Meister, 1978) as well as 
with MAbs possessing neutralizing activity as determined in section 4.4. Inhibition of 
GGT activity with SBC significantly decreased neutral red dye uptake induced by H. 
pylori wild type (P<0.01) but did not affect uninfected or Δggt-treated AGS cells 
(Figure 61). Similarly, neutralization of H. pylori GGT activity by using 4 MAbs 
(1G1, 3C10, 3F4 and 4F11) showed that three of them with neutralizing activity 
significantly decreased vacuolation (P<0.05) induced by H. pylori wild type by as 
high as 70.1% (Table 8). In addition, mouse IgG2a and IgG2b isotype negative controls 





























Figure 61. Inhibition of GGT activity affects vacuolation induced by H. pylori. 
AGS cells were co-cultured with H. pylori wild type or Δggt in the absence (□) or 
presence (■) of 10 mM SBC. Vacuolating activity was measured using neutral red 
dye uptake assay. Uninfected cells (UN) served as control. Values represent mean ± 







   Table 8. Inhibition of vacuolating activity of H. pylori by MAbs.  
 
MAb Neutral red dye uptake (% of WT) Inhibition (%) 
1G1 32.2 ± 1.5* 67.8 
4F11 29.9 ± 1.9* 70.1 
3F4 55.4 ± 1.6* 44.6 
3C10                       93.5 ± 1.7 6.5 
IgG2a isotype control 97.7 ± 2.0 2.3 
IgG2b isotype control 98.1 ± 2.1 1.9 
AGS cells were pre-incubated with MAbs 24 hours prior to treatment with H. pylori wild 
type (WT) for a further 24 hours. Mouse IgG2a and IgG2b isotype controls were used in 
parallel at the same concentration. Neutral red dye uptake is represented as a percentage 
of that induced by WT ± SD from 3 independent experiments. *P<0.05. 
 
 
4.12 Antibody titre against rGGT in patients infected with H. pylori 
Detection of anti-GGT antibodies in patient sera was carried out using rGGT 
as antigen. Figure 62 shows a box plot comparing anti-GGT titres from H. pylori-
positive and H. pylori-negative subjects. Median antibody levels against GGT of H. 
pylori-positive subjects were found to be significantly higher than that of H. pylori-














Figure 62. Seroprevalence to H. pylori GGT. Serum antibody titres to H. pylori in 
H. pylori-positive (n = 58) and –negative (n = 65) subjects. Serum antibodies to GGT 
were measured using ELISA with plates coated with rGGT. Boxes include 25th – 75th 
percentiles (interquartile range) and the median is shown as a bold line. Whiskers 
represent values within 1.5 × interquartile range of the lower and upper quartiles. 
Outliers are represented by empty circles. Data were analyzed statistically by Mann-


















5.1 Cloning, expression and purification of rGGT, rGGTL and rGGTS 
 E. coli has been extensively used as a host for the production of heterologous 
proteins. However, over-expression of these recombinant proteins may at times result 
in misfolding and aggregation of the protein in inclusion bodies (Baneyx and Mujacic, 
2004). In this study, rGGT, rGGTL and rGGTS were successfully cloned and 
expressed in E. coli. rGGT was expressed in the precursor form as a ~62 kDa protein 
(inclusive of the N-terminal 6 × His-tag), indicating that it was not processed into the 
active form within the E. coli host and this was probably due to the absence of the 
signal peptide as reported previously (Chevalier et al., 1999). rGGT was also present 
in both the soluble and insoluble fractions of E. coli sonicates in approximately equal 
proportions (Figure 13A). Since it was of interest to recover the biologically active 
form of the protein, rGGT was purified from the soluble instead of the insoluble 
fraction as insolubility generally indicates protein misfolding (Fahnert et al., 2004). 
Interestingly, after purification, rGGT underwent autoprocessing to form the active 
enzyme consisting of the large and small subunits (40 and 20 kDa respectively) as 
observed under SDS-PAGE (Figure 14A). Purified rGGT was also enzymatically 
active with GGT activity of ~68 U/mg, indicating that it was efficiently purified in a 
functional form. 
While rGGT was present in both the soluble and insoluble fractions, rGGTL 
and rGGTS were expressed exclusively in inclusion bodies (Figure 13B-C), an 
observation similar to a previous report (Boanca et al., 2006). This indicates that both 
subunits of GGT must be present for proper folding of the proteins. As rGGTL and 
rGGTS were expressed in an insoluble form, they were purified under denaturing 
conditions in order to solubilize the proteins. Refolding of the recombinant proteins 
was then carried out against PBS buffer containing decreasing concentrations of urea. 
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Recovery of rGGTL and rGGTS after dialysis was relatively lower (~40%) compared 
to rGGT (~90%) as rGGTL and rGGTS tended to precipitate during the dialysis 
process. Hence, although rGGTL and rGGTS were expressed in greater amounts 
compared to rGGT in E. coli, final protein yields of rGGT, rGGTL and rGGTS were 
fairly similar and moderate (12 – 15 μg/ml).  
 
5.2 MAbs against rGGT 
5.2.1 Epitopes recognized by MAbs – possible mode of inhibition 
 A total of ten hybridoma clones were obtained after fusing splenocytes from 
mouse #2 with mouse myeloma cells. Of these, six recognized the large subunit and 
four recognized the small subunit of GGT as determined by western blot analysis. To 
map the antigenic epitopes, a series of synthetic overlapping peptides covering the 
entire sequence of GGT was screened. This method has been used previously to 
screen epitopes for MAbs against H. pylori urease (Hirota et al., 2001) and allows for 
efficient identification of antigenic sequences. Among the MAbs targeting the large 
subunit of GGT, three different minimum epitopes were identified (residues 42-50: 
SSHPLASEI; 309-317: SKNIHIAAE and 357-365: QPDTVTPSS). Interestingly, for 
the MAbs targeting the small subunit of GGT, all four clones recognized the same 
minimum epitope (residues 428-434: GNPNLYG). Furthermore, MAbs against the 
small subunit of GGT were able to neutralize H. pylori 88-3887 GGT activity by as 
high as ~93% while those against the large subunit of GGT showed negligible 
inhibition, suggesting that the epitope found on the small subunit of GGT could be 
important for enzyme activity. 
 To investigate the underlying mode of inhibition by the MAbs, the catalytic 
site of GGT was examined. Biochemically, the active site of GGT has been 
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previously identified by Morrow et al. (2007). It comprises seven amino acids (Arg 
103, Asn 400, Glu 419, Asp 422, Ser 451, Ser 452 and Gly 472) which form hydrogen 
bonds with the substrate to rigidly hold it in place, one critical amino acid (Tyr 433) 
which is part of a mobile active-site loop and Thr 380 which is positioned optimally 
for nucleophilic attack of the γ-glutamyl peptide bond. In addition, there are two 
amino acids (Gly 472 and Gly 473) that help stabilize the intermediate substrate 
during catalysis. As observed from the epitope mapping results, none of the MAbs 
against the large subunit of GGT recognized epitopes involving Arg 103, the only 
amino acid residue of the large subunit involved in enzyme catalysis. Hence, this may 
explain why the MAbs against the large subunit of GGT were unable to inhibit its 
enzymatic activity. Interestingly, the epitope that MAbs against the small subunit of 
GGT recognized spans a Tyr 433-containing loop which was identified in the same 
report to be important for GGT activity whereby conformational changes in the loop 
could possibly regulate substrate binding and subsequent catalytic activity. Hence, it 
is hypothesized that these neutralizing MAbs may affect access of substrate to the 
active site of GGT by inhibiting the necessary conformational changes required to 
allow substrate binding. 
 Another point of interest is that although all four MAb clones against the small 
subunit recognized the same epitope, neutralizing activity differed between them, 
ranging from ~30 to ~93% (Figure 22). One reason that could explain this 
phenomenon is that the various MAbs clones may have different binding affinities to 
the same epitope which in turn could affect their neutralizing activity. Interestingly, 
similar observations have been reported for anti-Fas IgG1 antibodies where it was 
found that different MAb clones recognizing the same epitope elicited different 
biological effects (induction vs inhibition of apoptosis) which correlated with their 
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relative binding affinities for Fas (Komada et al., 1999). Affinity differences may 
arise due to amino acid sequence variations between the MAb clones which might 
affect the relative stability of the antibody-antigen complexes (Parhami-Seren and 
Margolies, 1996). Hence, to better visualize and map the actual amino acid residues 
involved in the binding between the MAbs and H. pylori GGT, more detailed analysis 
such as X-ray co-crystallography may be worth considering in future studies. In 
addition, surface plasmon resonance (Schuck, 1997) could also be carried out to 
determine the binding affinities between the respective MAbs and H. pylori GGT. 
 
5.2.2 Inhibitory action of MAbs on GGT activity – comparison between H. pylori 
strains and with other organisms 
The most potent neutralizing MAb 1G1 was generally effective in inhibiting 
the GGT activities of various H. pylori strains although some differences were 
observed in the extent of inhibition (46.0%-94.7%) between strains (Figures 23 and 
24). To explain this phenomenon, it is postulated that GGT from different H. pylori 
strains may differ slightly in their 3-D conformation which might in turn affect 
antibody-antigen binding. Alternatively, varying levels of GGT expression between 
H. pylori strains may potentially contribute to the differences in inhibition observed. 
However, no such correlations were observed in this study which may be due to the 
small sample size tested. Hence, more H. pylori strains could be tested in future 
studies to test this hypothesis. Notably, it was also observed that the MAbs had low 
inhibitory activity against H. pylori SS1, a highly mouse-adapted strain (Lee et al., 
1997). As the MAbs were raised in mice, it is speculated that this strain may have 
adapted in a way such that it avoids detection by anti-GGT mouse antibodies 
generated by the host. Interestingly, it was also noted that the 7-residue neutralizing 
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epitope identified on H. pylori GGT is not conserved in GGTs of other bacterial and 
mammalian homologues (Figure 25), suggesting that the MAbs are specific for H. 
pylori GGT. This was further supported by the inability of these MAbs in neutralizing 
bovine GGT activity even at the highest MAb dose (30 μg) tested (data not shown). 
 
5.2.3 Isotypes of MAbs generated against rGGT 
 It was observed that MAbs specific against the large subunit of GGT were all 
of IgG1 isotype while those against the small subunit of GGT were majority of IgG2a 
isotype. Production of IgG1 isotype is indicative of a Th2 response in mice while that 
of IgG2a signifies a Th1 response (Finkelman et al., 1988). This suggests that H. 
pylori GGT is capable of inducing a mixed Th1/Th2 adaptive immune response, a 
phenomenon also observed in individuals infected with H. pylori (Goll et al., 2007). 
Importantly, this mixed response has been implicated in the promotion of chronic 
infection by H. pylori and inhibition of pathogen clearance by the host (Goll et al., 
2007).  
 
5.3 Purification of nGGT using MAb 
 Purification of nGGT from H. pylori has been performed previously using a 
sequential combination of methods in the following order: cation exchange 
chromatography, hydrophobic interactive chromatography, size exclusion 
chromatography, followed by a second cation exchange chromatography (Shibayama 
et al., 2003). This purification method, although shown to be successful, is extremely 




 In this study, purification of nGGT from H. pylori was achieved using a one-
step affinity chromatography method. In particular, MAb 1G1 was immobilized on 
CNBr-activated Sepharose 4B and used to purify nGGT from H. pylori crude lysates. 
Unlike the previous methods of using ion exchange and gel filtration chromatography 
which only isolates proteins with similar characteristics, affinity chromatography has 
the advantage of isolating a specific protein in a simple and rapid manner, allowing 
purification to be achieved in a much shorter time. Using this method, purification of 
nGGT was extremely efficient where it was purified to a high purity comparable to 
previous methods (>95%) with only two bands of 37 and 20 kDa corresponding to the 
large and small subunit of GGT respectively (Figure 26). Total GGT activity recovery 
was also notably high at 75%. In addition, although low pH treatment was used to 
elute nGGT in the final purification step, nGGT was still enzymatically active (with 
GGT activity of 70.9 U/mg) after neutralization. This indicates that the catalytic site 
of the enzyme was not destroyed by the low pH treatment. Taken together, this simple 
and rapid purification method has been shown to effectively purify nGGT without 
affecting its enzymatic function. 
 
5.4 Subcellular localization of GGT in H. pylori 
 Although GGT is present in various bacterial species, its cellular localization 
differs among them. For example, GGT of E. coli has been found to localize 
exclusively in the periplasmic space as a soluble enzyme (Suzuki et al., 1986) 
whereas GGT of Proteus mirabilis was found to be mainly in the cell wall 
(peptidoglycan layer) and periplasmic space (Nakayama et al., 1984). On the other 
hand, GGT of Neisseria meningitis is mainly associated with the inner membrane 
facing the cytoplasmic side (Takahashi and Watanabe, 2004) while GGT of B. subtilis 
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was found to be mainly secreted into the extracellular medium (Xu and Strauch, 
1996). 
 To localize GGT in H. pylori, immunogold-labeling TEM was performed. 
This method is a powerful tool used for the precise localization of proteins in cells 
and several H. pylori proteins have been localized using this technique, including 
urease (Hawtin et al., 1990) and heat shock protein 20 (Du and Ho, 2003). In this 
study, post-embedding immunogold labeling was employed. This technique provides 
an advantage over pre-embedding labeling as the latter requires extensive detergent 
treatment necessary for the penetration of gold conjugates into cells which may lead to 
the loss of specimen ultrastructure. 
 From the immunogold-labeled transmission electron micrographs, gold 
particles of 10 nm in diameter were mainly observed in the periplasmic space and on 
the outer membrane of H. pylori (Figure 27A-B). As H. pylori GGT is synthesized as 
a pro-enzyme with a typical N-terminal signal peptide that targets the protein to the 
periplasmic space (Chevalier et al., 1999), presence of GGT in the periplasm was not 
surprising. It has been postulated that after the pro-enzyme is secreted into the 
periplasmic space, the signal peptide is cleaved and the protein is then efficiently 
processed into a large and small subunit which then associate in a non-covalent 
manner to form the active enzyme (Shibayama et al., 2003). Apart from the 
periplasm, many gold particles were also observed on the outer membrane of the 
bacterium. As H. pylori GGT has been previously reported to be secreted into the 
extracellular medium (Bumann et al., 2002), it is hypothesized that those GGT 
observed on the outer membrane were in the process of being secreted out of the 
bacterium although the mechanism of secretion has not been clearly elucidated to 
date. It is also worth noting that relatively few gold particles were found in the 
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cytoplasm of H. pylori, suggesting that GGT is efficiently secreted into the 
periplasmic space after expression. In addition, there were no gold particles observed 
in the two negative controls (Figure 27C-D), indicating that the MAb generated 
against GGT is specific. It is therefore postulated that as a surface and secreted 
protein of H. pylori, GGT may have a functional important role in interacting with 
gastric host cells during an infection. 
 
5.5 Pathogenic effects of GGT on host cells 
5.5.1 H. pylori GGT and H2O2 production 
H. pylori infection in humans has been reported to be associated with 
excessive ROS levels (Davies et al., 1994; Ding et al., 2007) and diminished GSH in 
the infected gastric mucosa (Shirin et al., 2001). Unfortunately, how H. pylori exerts 
such effects has not been clearly defined. It had been observed earlier that H. pylori 
nGGT is capable of inducing H2O2 production (Gong, 2006), however the mechanism 
by which this occurs remains unclear. To expand on the earlier study, the role of GGT 
in inducing H2O2 production was further investigated using AGS cells (Figure 31A) 
and primary gastric cells (Figure 31B). Interestingly, in the presence of both cell 
types, H. pylori Δggt was found to induce significantly less H2O2 generation 
compared to the parental strain (P<0.05), thus complementing the earlier findings 
using nGGT. 
Mammalian GGT-mediated catabolism of extracellular GSH has been 
documented to produce ROS by thiol-dependent iron reduction (Drozdz et al., 1998). 
This occurs when GGT cleaves the γ-glutamyl moiety of GSH, generating cysteinyl-
glycine which is a thiol with much higher reactivity compared to GSH (Dominici et 
al., 1999). As the pKa of cysteinyl-glycine is lower than that of GSH (Stark, 1991), 
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majority of it exists in the thiolate form (gly-cys–S-) at near-neutral pH. Thiolate 
anions are capable of starting redox reactions with ferric ions, leading to the 
production of ROS and thiyl radicals (Dominici et al., 1999) through a series of 
reactions as illustrated below: 
                        GSH                   γ-glutamate + gly-cys-S- + H+ 
  gly-cys-S- + Fe3+                   gly-cys-S● + Fe2+ 
  Fe2+ + O2                  Fe3+ + O2●-  
  O2●- + H2O                   O2 + H2O2 
 
As H. pylori GGT and mammalian GGT possess comparable hydrolysis rates 
(Boanca et al., 2006), it is postulated that H. pylori GGT can also induce H2O2 
production through GSH hydrolysis. Furthermore, GSH efflux has been reported for 
almost all mammalian cells (Meister and Anderson, 1983), including gastric cells 
(Shibayama et al., 2007). From Figure 32, AGS cells treated with nGGT showed a 
significant rise in H2O2 production compared with untreated cells (P<0.05) and 
exhibited an even higher level of H2O2 in the presence of GSH and glycyl-glycine 
(P<0.01). This effect was inhibited in the presence of SBC, an inhibitor of GGT. In 
addition, treatment with the iron chelator DFO which inhibits formation of H2O2 
generated by cysteinylglycine in the presence of transition metals (Dominici et al., 
1999) significantly reduced nGGT–dependent H2O2 generation (P<0.05). In contrast, 
the addition of exogenous Fe3+ significantly increased nGGT–mediated H2O2 
production (P<0.05), indicating that H. pylori–mediated H2O2 generation occurs, at 
least in part, through this postulated pathway. Moreover, iron chelation has been 
reported to protect gastric cells against oxidant stress induced by H. pylori infection 




ROS induces injury to the gastric mucosa, potentially predisposing the tissue 
to ulceration (Davies et al., 1992; Bandyopadhyay et al., 2002) and has also been 
suggested to be the causative factor for gastric cancer (Balkwill and Mantovani, 
2001).  In addition, oxidative stress was found to be related to H. pylori density as 
well as the development of severe gastric diseases (Zhang et al., 1997), suggesting 
that ROS is important in the pathogenesis of peptic ulcers. Interestingly, it has 
recently been reported that H2O2 not only affects the host but also induces the 
upregulation of several virulence genes in H. pylori, including CagA and VacA, 
thereby leading to even greater cell damage (Huang and Chiou, 2011). Taken 
together, the finding that GGT induces H2O2 generation through GSH hydrolysis 
suggests that GGT may participate in the development of peptic ulcers and could 
possibly be a contributing factor in the progression of gastric cancer in H. pylori 
infections.  
 
5.5.1.1 H. pylori GGT induces NF-κB activation and IL-8 upregulation in various 
cells types 
In unstimulated cells, the transcription factor NF-κB is sequestered by IκB 
proteins in the cytoplasm as an inactive complex (Jacobs and Harrison, 1998). In 
response to various stimuli (e.g. ROS, TLR activation, etc), IκB gets phosphorylated 
and degraded in the proteasome, leaving NF-κB free to enter into the nucleus where it 
induces the expression of several immunologically important target genes (Schmitz 
and Baeuerle, 1995). As H2O2 has been shown to activate NF-κB in gastric epithelial 
cells (Takada et al., 2003), NF-κB activation and degradation of IκB protein were 
analyzed using western blot method in this study. In H. pylori wild type-infected AGS 
cells, nuclear level of NF-κB was significantly increased while marked degradation of 
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IκB was observed concurrently (Figure 33). Interestingly, activation of NF-κB in cells 
infected with Δggt was found to be markedly reduced, indicating that GGT is 
involved in H. pylori-induced NF-κB activation. 
 Activation of NF-κB has been reported to induce expression of the chemokine 
IL-8 (Keates et al., 1997), an important mediator of the inflammatory response 
(Shimada et al., 1999). Furthermore, H. pylori infection has been associated with 
elevated levels of gastric IL-8 (Gionchetti et al., 1994; Fan et al., 1995). Importantly, 
H. pylori nGGT was earlier shown to induce generation of H2O2 which in turn 
activates NF-κB and induces IL-8 production in gastric cancer cells (Gong, 2006). 
Hence, the ability of H. pylori GGT in inducing IL-8 generation in various cells types 
was examined in this study. IL-8 production was found to be significantly reduced 
(P<0.05) in AGS cells infected with Δggt when compared with wild type-treated AGS 
cells (Figure 34A-B). Notably, it was also observed that IL-8 production in Δggt-
infected cells was not fully ablated. It is speculated that this residual IL-8 may have 
been induced through TLR2 and Nod1 activation by neutrophil activating protein 
(Amedei et al., 2006) and peptidoglycan (Viala et al., 2004) respectively. 
Furthermore, other H. pylori virulence factors such as OipA (Yamaoka et al., 2002a) 
and urease (Beswick et al., 2006) have also been reported to induce IL-8 secretion in 
gastric epithelial cells. In addition, both nGGT and rGGT alone induced significant 
levels of IL-8 in these cells (P<0.05). Furthermore, GGT-mediated NF-κB activation 
and IL-8 induction were also confirmed using luciferase reporter gene assay and IL-8 
mRNA analysis (by real-time PCR) respectively1 and the results strongly correlate 
with the findings presented in this study.  
Apart from AGS cells, nGGT and rGGT were also able to induce IL-8 
generation in primary human gastric epithelial cells with a similar trend as that 
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observed in AGS cells (Figure 34C-D). The main difference observed was that the 
induced IL-8 levels were excessively (~50 times) higher in primary gastric cells as 
compared to AGS cells. Similar observations have been observed in previous studies 
where the level of IL-8 induced by H. pylori was found to be 10-50 times higher in 
primary gastric epithelial cells as compared to that induced in MKN28, a gastric 
carcinoma cell line (Ogura et al., 1998).  
GGT-mediated IL-8 production was also investigated in macrophages, another 
important source of IL-8 in the gastric mucosa (Yoshikawa and Naito, 2000). IL-8 
levels were found to be significantly reduced (P<0.05) in macrophages co-cultured 
with Δggt compared with wild type-treated cells 4 hours post-infection (Figure 34E-
F), indicating that GGT is able to induce IL-8 in this cell type. However the observed 
difference in IL-8 was no longer significant between wild type- and Δggt-infected 
cells after 24 hours, suggesting that immune cells may be more influenced by other 
bacterial factors at later time-points. For example, VacA has been shown to induce 
IL-8 generation in promonocytic U937 cells and the difference in IL-8 stimulation 
between ΔvacA and the parental strain was found to be significant (P<0.01) even up 
to 12 hours post-infection (Hisatsune et al., 2008). Another point to note is that, in 
this study, the difference in IL-8 generation between wild type- and Δggt-infected 
cells at 4 hours, although significant (P<0.05), was not as pronounced in macrophages 
compared to primary gastric or AGS cells. A possible reason for this observation is 
that macrophages respond differently to H. pylori virulence factors compared with 
gastric epithelial cells as has been described for cagPAI (Maeda et al., 2001). 
Nevertheless, it was observed that in the presence of nGGT or rGGT alone, IL-8 
generation in macrophages was significantly increased (P<0.05), clearly indicating 
that GGT is capable of inducing IL-8 production in multiple cell types. Taken 
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together, the results from this study show that GGT is capable of inducing H2O2 
generation, NF-κB activation and IL-8 production in host cells. 
 
5.5.1.1.1 Contributory role of cagPAI but not CagA 
CagA has been shown to induce IL-8 production in gastric epithelial cells 
(Kim et al., 2006; Lim et al., 2009). However, its role remains debatable as 
conflicting results have also been observed by others (Crabtree et al., 1995b; Sharma 
et al., 1995; Nozawa et al., 2002). In addition, it has been reported that NF-κB 
activation (and IL-8 induction) in gastric epithelial cells requires other proteins 
encoded within the cagPAI rather than CagA (Glocker et al., 1998; Li et al., 1999). 
To this end, the role of CagA and proteins encoded within the cagPAI in IL-8 
induction was investigated using ΔcagA and ΔcagPAI respectively. It was observed 
that NF-κB activation (Figure 33) and IL-8 production (Figure 35) was independent of 
CagA. However, ΔcagPAI induced less NF-κB activation as well as IL-8 production 
compared with the wild type strain (P<0.05), indicating that protein(s) encoded in the 
cagPAI (but not CagA) were indeed involved in the stimulation of IL-8 which is in 
agreement with a previous report (Fischer et al., 2001). In addition, translocation of 
H. pylori peptidoglycan into gastric epithelial cells through the T4SS (which is 
encoded by the cagPAI) has also been shown to induce NF-κB activation and IL-8 
production through Nod1 signalling (Viala et al., 2004). Thus, the role of cagPAI here 
may be to transport peptidoglycan into host cells. Notably, NF-κB activation and IL-8 
production were significantly lower in AGS cells co-cultured with ΔcagA/ggt 
compared to cells infected with ΔcagA. This observation reinforces the importance of 
GGT in H. pylori-induced NF-κB activation and IL-8 generation. 
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5.5.1.2 H. pylori GGT and DNA damage 
 ROS is known to cause oxidative DNA damage and induce strand breaks in 
DNA (Kryston et al., 2011). Hence, it was postulated that GGT-mediated H2O2 
production may also play a role in inducing DNA damage. In collaboration with Dr. 
Gong M., extent of DNA damage was found to be significantly higher (P<0.05) in 
wild type-infected compared to Δggt-infected AGS cells as determined using flow 
cytometry analysis for 8-hydroxyguanosine and Comet assay.1 Furthermore, nGGT 
also induced significantly more DNA damage compared to control cells (P<0.05). 
Interestingly, the presence of N-acetylcysteine (NAC), a H2O2 scavenger, inhibited 
DNA damage induction, thus indicating a role of GGT-mediated H2O2 in inducing 
DNA damage. Taken together, these results clearly show that GGT-mediated H2O2 is 
capable of inducing DNA damage in gastric epithelial cells. Considering the evidence 
that increased oxidative DNA damage is linked to the severity of H. pylori–mediated 
gastroduodenal diseases (Farinati et al., 1998; Ladeira et al., 2004), the results further 













5.5.2 Internalization of H. pylori GGT by gastric epithelial cells 
 Being a secreted enzyme of H. pylori, GGT has the potential to mediate 
important host-pathogen interactions. Hence, it was of great interest to investigate if 
GGT could translocate into host cells and whether there were any subsequent 
downstream effects. In this study, three different techniques (immunogold-labeling 
TEM, CLSM and western blot analysis) were used to show that GGT was indeed 
capable of entering into AGS cells upon H. pylori infection. All three methods 
showed consistent results in that GGT localized mainly to the host cell nucleus after 
translocation (Figures 36-38). Interestingly, it was also noted that in the absence of H. 
pylori, rGGT alone was able to enter into the cells, indicating that uptake of GGT is 
independent of other bacterial factors. From the time-course study, GGT was detected 
in the nuclei of AGS cells within 1 hour of infection with H. pylori while rGGT was 
detected within 30 minutes post-incubation (Figures 38-39). One possible reason to 
explain this apparent discrepancy could be due to the time taken for GGT to be 
secreted out of H. pylori before it can be taken up by the cells. Nevertheless, uptake of 
GGT has been shown to be a rapid process and the timing is comparable to that of 
other H. pylori factors that also enter into host cells (e.g. VacA) (Gauthier et al., 
2005). It was therefore of interest to investigate into how GGT was taken up by host 
cells. 
 
5.5.2.1 Endocytosis pathway involved 
 Cellular uptake of extracellular proteins requires specific endocytic 
mechanisms as proteins are unable to pass through the cell membrane freely. H. pylori 
has generally been considered a non-invasive pathogen (Petersen and Krogfelt, 2003) 
although it has been previously observed to invade gastric epithelial cells albeit with a 
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low invasion frequency of 1-3% (Wyle et al., 1990; Noach et al., 1994b) through a 
zipper-like mechanism (Kwok et al., 2002). However, it is unlikely that GGT detected 
in AGS cells came from internalized H. pylori for two main reasons. Firstly, TEM 
results from this study show that H. pylori GGT was detected within AGS cells even 
in the absence of intracellular bacteria (Figure 36B-C) and secondly, rGGT alone 
(without bacteria) was also capable of being endocytosed by AGS cells (Figures 37 
and 39). These observations suggest that uptake of H. pylori GGT by gastric cells 
occurs via a pinocytic mechanism rather than ingestion of the whole bacterium. 
 Of the four main pinocytic mechanisms, the study went on to investigate if 
uptake of GGT was a non-selective process or one that required a specific recognition 
of the protein. Heat-denaturation of rGGT was found to completely abrogate its 
uptake by AGS cells (Figure 40), suggesting that recognition of GGT native structure 
prior to endocytosis is required. Furthermore, rGGTL or rGGTS on its own were also 
unable to be taken up by the cells (Figure 41). Hence, it was hypothesized that 
internalization of GGT occurred via receptor-mediated endocytosis rather than the 
non-selective macropinocytic pathway (Kerr and Teasdale, 2009). 
 Selective uptake of molecules can occur via three mechanistically different 
pathways, namely clathrin-mediated endocytosis, caveolin-mediated endocytosis and 
clathrin- and caveolin-independent endocytosis. Inhibitors of clathrin-mediated and 
caveolae-mediated endocytosis were used to investigate the pathway by which H. 
pylori GGT is internalized by AGS cells. Various ways of inhibiting clathrin-
mediated endocytosis have been reported including the use of hypertonic sucrose 
(Daukas and Zigmond, 1985), potassium depletion (Larkin et al., 1983) and cytosolic 
acidification (Sandvig et al., 1988). These methods, however, have unwanted side 
effects on the cells such as inhibiting other internalization pathways (e.g. caveolae-
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mediated endocytosis) (Page et al., 1998) and/or affecting the actin cytoskeleton 
(Rajasekaran et al., 2001; Suzuki and Namiki, 2007) which may confound the results 
obtained and obscure interpretations. Another widely used inhibitor of clathrin-
mediated endocytosis is the pharmalogical agent CPZ. CPZ is a cationic amphipathic 
drug that inhibits clathrin-mediated endocytosis by translocating clathrin from the 
plasma membrane to intracellular vesicles (Wang et al., 1993) and is relatively 
specific in action. However, one disadvantage of CPZ is that it is cytotoxic to cells at 
high concentrations (Vercauteren et al., 2010). Cell viability of AGS in the presence 
of CPZ was thus determined and it was found that >80% of cells remained viable at a 
CPZ concentration of 15 μg/ml (Figure 42). Hence, this concentration was used to 
inhibit clathrin-mediated endocytosis in subsequent experiments. It is noted, however, 
that these cells may have some dysfunctional activities even though they remained 
viable. Inhibition of caveolin-dependent endocytosis has been achieved using the 
antibiotic NYS whose mechanism of action is to sequester cholesterol (Chen et al., 
2011), hence disrupting formation of caveolae on the cell membrane. NYS is specific 
in action and does not affect the clathrin-mediated endocytotic pathway (Smart and 
Anderson, 2002), making it a suitable candidate for probing caveolae-mediated 
endocytosis. Similarly, cytotoxicity of NYS was investigated on AGS cells and it was 
found that at a concentration of 25 μg/ml, cells remained 100% viable (Figure 42). 
 Using CPZ and NYS to inhibit clathrin-mediated and caveolae-mediated 
endocytosis respectively, addition of rGGT resulted in its accumulation mainly in the 
membrane fraction of CPZ-treated AGS cells (Figure 43B). In contrast, rGGT was 
observed to be mostly present in the cytosolic fractions of NYS-treated and 
uninhibited cells (incubated with rGGT only), suggesting that rGGT is endocytosed 
via the clathrin-mediated pathway. CLSM micrographs of similarly-treated cells 
Discussion 
177 
showed analogous results (Figure 44), further confirming the findings. A point to 
note, however, is that a small amount of rGGT was still detected in the cytosol of 
AGS cells at the concentration of CPZ used (Figure 43B). There are two possible 
explanations that may account for this observation. Firstly, the concentration of CPZ 
(15 μg/ml) used in this study, though less cytotoxic to cells, may not be sufficient in 
completely blocking clathrin-mediated endocytosis (Parker et al., 2010). A second 
possible reason for this observation is that H. pylori GGT may be taken up by cells 
through more than one pathway (e.g. clathrin- and caveolin-independent endocytosis). 
Interestingly, internalization of VacA by cells has also been suggested to occur via 
more than one endocytic pathway (Ricci et al., 2000). Nevertheless, the results clearly 
show that uptake of H. pylori GGT is mainly dependent on clathrin-mediated 
endocytosis although other less dominant pathways of internalization may also be 
involved. 
 
5.5.2.2 Nuclear import mechanism 
 After investigating the route of entry into the cells, it was next of interest to 
determine how GGT enters into the cell nuclei. Cytoplasmic-nuclear transport is a 
highly selective process that requires imported proteins to be “recognized” by their 
NLSs and docked to the NPC so as to pass through the otherwise impermeable 
nuclear membrane (Chook and Suel, 2011). As proteins in the importin β family have 
been reported to be the main mediators of nuclear import (Chook and Blobel, 2001), it 
was first investigated if H. pylori GGT complexes with them. Using co-IP, H. pylori 
GGT was found to complex with importin β1 but not with importins β2 and β3 
(Figure 45). This led to the postulation that importin β1 may be the mediator of GGT 
import into the cell nucleus. Subsequently, using siRNA knockdown of importin β1 
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expression, nuclear import of GGT was found to be indeed dependent on importin β1 
(Figure 47). 
 Nuclear-targeted proteins contain NLSs which are first recognized by 
importins before they are being imported into the nucleus by the latter (Marfori et al., 
2011). Importin β1 can bind the NLS of their cargoes either directly or through an 
adaptor protein known as importin α which generally binds to classical NLSs (Chook 
and Suel, 2011). From this study, it is not clear how GGT is transported into the cell 
nuclei as it was not predicted to contain a classical NLS using PredictNLS software 
(https://rostlab.org/owiki/index.php/PredictNLS) and NucPred (Brameier et al., 
2007). Hence, it is unlikely that GGT is imported into the cell nuclei via the classical 
importin α/β pathway. However, since nuclear import of GGT is dependent on 
importin β1, it is also possible that GGT may either be “piggy-backing” on a host 
protein that contains a classical NLS or itself contain an atypical NLS (Marfori et al., 
2011) that can be recognized by importin α. Alternatively, GGT could also be 
transported into the cell nucleus by a non-classical pathway whereby it interacts 
directly with importin β1 (without the need for importin α) as has been reported for 
many proteins including HIV-1 Tat and Rev proteins (Truant and Cullen, 1999). 
Unfortunately, apart from the classical NLSs, these atypical NLSs are less well-
defined and lack consistent consensus motifs, hence making it extremely difficult to 
predict their presence in GGT. 
 
5.5.2.3 GGT depletes nuclear GSH 
 GSH has been considered essential for survival in eukaryotic but not in 
prokaryotic cells (Grant et al., 1996). It is a major antioxidant in cells and functions to 
neutralize free radicals and reactive oxygen compounds (Valko et al., 2006). In the 
Discussion 
179 
nucleus, GSH protects the genome against oxidative stress or ionizing radiation 
(Biaglow et al., 1983) and has also been documented to play an important role in the 
synthesis of DNA (Thelander and Reichard, 1979). In addition, GSH has been 
suggested to help maintain nuclear homeostasis (Dijkwel and Wenink, 1986) as well 
as regulate cell proliferation (Atzori et al., 1990). 
Several studies have demonstrated that the cell nucleus is more reduced 
compared to the cytosol (15mM GSH vs 11mM respectively) (Bellomo et al., 1997; 
Schafer and Buettner, 2001). Since GGT was earlier found to localize mainly to the 
cell nucleus after internalization, it was hypothesized that GGT would deplete nuclear 
GSH levels, leading to a redox imbalance. As it is not possible to specifically measure 
nuclear GSH concentrations using standard cell fractionation and cytochemical 
methods (Soderdahl et al., 2003), confocal microscopy using the fluorochrome 
CMFDA followed by image analysis was used in this study. This method has been 
used in many studies (Voehringer et al., 1998; Markovic et al., 2007) as CMFDA 
binds reduced GSH with a high specificity of 95% (Hedley and Chow, 1994) and the 
intensity of fluorescence can be correlated with the amount of GSH present in 
different cell compartments. In this study, it was found that AGS cells infected with 
H. pylori wild type had significantly lower levels of nuclear GSH as compared to cells 
infected with Δggt (Figure 48). In addition, rGGT alone (in the absence of bacteria) 
was also able to deplete nuclear GSH levels in a dose-dependent manner, providing 
direct evidence that GGT plays a vital role in reducing nuclear GSH. Furthermore, 
inhibition of endocytosis or nuclear import of rGGT (using CPZ and importin β1 
siRNA respectively) both led to significantly less nuclear GSH depletion compared to 
uninhibited cells treated with rGGT (Figures 49 and 50). Taken together, the results 
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indicate that import of GGT into the nucleus contributes significantly to the depletion 
of nuclear GSH levels. 
GSH in the nucleus plays an important role in cellular physiology. A depletion 
of nuclear GSH has been reported to interfere with cell cycle progression, leading to a 
decrease in cell proliferation (Markovic et al., 2010). This is because cells require a 
reduced nuclear environment to maintain normal cell cycle progression (Markovic et 
al., 2009). In addition, reduction in nuclear GSH levels has been found to be 
associated with DNA fragmentation and apoptosis in cells exposed to ionizing 
radiation, indicating that GSH plays a critical role in protecting nuclear DNA integrity 
(Morales et al., 1998). Coincidentally, H. pylori GGT has also been previously 
reported to cause apoptosis in gastric epithelial cells (Shibayama et al., 2003), inhibit 
T cell proliferation (Schmees et al., 2007) and induce cell cycle arrest (Kim et al., 
2010). However, the exact underlying mechanisms as to how GGT elicits such 
cellular effects have not been clearly elucidated. It is therefore hypothesized that GGT 













5.5.3 H. pylori GGT potentiates cell vacuolation 
5.5.3.1 Morphological changes induced by GGT 
 Real-time microscopy was carried out to investigate the morphological 
changes in AGS cells induced by H. pylori wild type and Δggt. It has been previously 
reported that infection by H. pylori induces the hummingbird phenotype in AGS cells 
which is characterized by thin, needle-like elongations with lengths ranging from 20 
to 70 μm (Moese et al., 2004). This phenomenon occurs due to H. pylori CagA being 
translocated and phosphorylated in AGS cells, leading to the activation of various 
signalling pathways which induce cytoskeletal arrangements (Backert et al., 2001). In 
this study, it was observed that both H. pylori wild type (Figure 51A) and Δggt 
(Figure 51B) induced the hummingbird phenotype in AGS cells from 4 hours post-
infection, suggesting that GGT probably does not affect translocation of CagA nor the 
subsequent signalling pathways involved in cytoskeletal rearrangements. 
 Apart from the hummingbird phenotype, H. pylori infection has also been 
reported to induce the formation of large vacuoles in AGS cells (Konishi et al., 1992). 
This morphology is induced by the cytotoxin VacA which forms anion-selective 
channels in endosomal compartments and through a series of events, eventually lead 
to subsequent influx of water into the endosomes (Papini et al., 2001). In addition, 
vacuoles induced by VacA have been reported to originate from the perinuclear 
region which then rapidly fill up the cell cytoplasm (Papini et al., 1996). From the 
time-lapse images, it was observed that both H. pylori wild type and Δggt induced the 
formation of small perinuclear vesicles that started to be visible 12 hours post-
infection. In wild type-infected AGS cells, these vacuoles started to increase until 
almost the entire cell cytoplasm was filled at 24 hours post-infection. However, it was 
noted that the vacuoles in Δggt-infected cells did not increase much after 16 hours 
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post-infection. Neutral red dye uptake results (Figure 53) strongly correlated with the 
morphological observations, further confirming the results. Through these initial 
findings, it was postulated that GGT played an important role in the vacuolation 
process. 
 
5.5.3.2 Observations among different cell lines used 
 VacA-induced vacuolation has been reported to affect several cell lines albeit 
with varying sensitivities (de Bernard et al., 1998). Hence, it was also of interest to 
investigate whether GGT affected vacuolation in other cell lines. In particular, two 
types of cells were chosen in this study: primary human gastric epithelial cells and the 
HeLa cell line. Primary human gastric epithelial cells were chosen as they are not 
transformed and would better mimic the characteristics of cells in vivo. In addition, 
they have also been previously reported to be susceptible to VacA-induced 
vacuolation (Harris et al., 1996). The HeLa cell line was also employed as it is highly 
susceptible to VacA-induced vacuolation (de Bernard et al., 1998) and has been 
extensively used in many studies involving VacA (Cover et al., 1993; Papini et al., 
1993a; Gauthier et al., 2007).  
 From the results, it was observed that both primary human gastric epithelial 
cells and HeLa cells were indeed highly susceptible to vacuolation induced by H. 
pylori wild type as measured by neutral red dye assay (Figures 55 and 56 
respectively). Interestingly, vacuolation induced by Δggt was also significantly less 
(P<0.01) than that induced by the wild type strain in both cell types, indicating that 
the mechanism by which GGT affects vacuolation is not exclusive to gastric cells and 
is possibly common to all susceptible cell types. Furthermore as vacuolation in 
primary human gastric epithelial cells were also affected by GGT, coupled with the 
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observation that H. pylori-induced cytoplasmic vacuolation has been reported in vivo 
(Telford et al., 1994), it is postulated that GGT would play an important role in 
potentiating vacuolation in the natural infection setting. 
 
5.5.3.3 Interplay between H. pylori GGT, urease and VacA in vacuolation  
In this study, it was observed that AGS cells co-cultured with Δggt displayed 
significantly less neutral red dye uptake (P<0.05) as compared to the wild type strain 
(Figure 53). This difference was prominent after 12 hours and showed a similar trend 
up to 24 hours post-infection. Interestingly, although Δggt induced significantly more 
vacuolation as compared to ΔvacA (P<0.05) 24 hours post-infection (Figure 57), this 
was approximately 2.8-fold lesser than that induced by wild type after taking into 
account the background neutral red dye uptake by the control cells. Furthermore, the 
ability of Δggt to induce vacuolation was restored when rGGT was exogenously 
supplemented to the cell culture medium although rGGT was not found to possess 
intrinsic vacuolating activity (Figure 58). Taken together, the results show that 
although vacuolation requires the presence of VacA, the extent of vacuolation induced 
is also dependent on the potentiating effect of GGT. 
Previous studies have shown that VacA induces the formation of vacuoles in 
cells but not unless ammonia or other permeant weak bases are present in the 
extracellular medium (Cover et al., 1992; Ricci et al., 1997). In view of this, it was 
noted that one of the principal physiological roles of H. pylori GGT is to metabolize 
extracellular glutamine as a source of glutamate for its own metabolism, a reaction 
which would inevitably result in the generation of ammonia (Shibayama et al., 2007). 
Results from this study show that the extent of vacuolation in AGS cells infected with 
H. pylori wild type in glutamine-free medium was significantly decreased (P<0.01) to 
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the level of that induced by Δggt (Figure 59), suggesting that glutamine could be a 
potential source of ammonia (through hydrolysis by GGT) which is vital in 
vacuolation induction by VacA (Cover et al., 1992). To further confirm our theory, an 
exogenous supply of ammonia in the form of ammonium chloride successfully 
rescued the ability of Δggt to induce vacuolation to the level of that induced by the 
wild type strain (Figure 60). These results indicate that the absence of GGT does not 
affect the upstream events leading to vacuolation since ammonium chloride alone was 
sufficient to restore vacuolating activity of Δggt. Hence, Δggt, devoid of expressed 
GGT to provide the function of generating ammonia from glutamine, could be one of 
the reasons why significantly less vacuolation was observed when AGS cells were co-
cultured with Δggt as compared to wild type. Furthermore, inhibition of GGT activity 
either by SBC or MAbs with neutralizing activity (as determined in section 4.4) 
markedly inhibited H. pylori-induced vacuolation (Figure 61 and Table 8), indicating 
that vacuolation induction is indeed dependent on GGT activity. 
Urease has been previously reported to be the main potentiator of VacA-
dependent vacuolation by converting urea to carbon dioxide and ammonia (Cover et 
al., 1991). However, results from this study indicate that it is not the only factor 
contributing to the generation of ammonia required for vacuolation as ΔureAB was 
still able to induce a significant amount (P<0.05) of vacuolation in AGS cells (Figure 
57). This is in agreement with a previous report whereby vacuolation induced in Sfl 
Ep cells by broth-culture filtrates from a urease-isogenic mutant did not differ 
significantly to that induced by the parental strain in the absence of urea (Konishi et 
al., 1992). In the same report, it was also found that a large portion of ammonia in the 
broth filtrates was a urease-independent metabolic product of the bacteria, indicating 
that there are other bacterial factors responsible for the production of ammonia 
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essential for vacuolation induction. Interestingly, neutral red uptake induced by Δggt 
was significantly lesser than that induced by ΔureAB (P<0.05), suggesting that GGT 
could be the other important ammonia-generating factor. In addition, vacuolation 
induced by ΔureAB/ggt was abolished to a similar level as that induced by ΔvacA. 
Collectively, the results suggest that GGT and urease are the two main potentiators of 
VacA-mediated vacuolation and it is proposed that GGT may play a more major role 
here as compared to the latter.   
Induction of cell vacuolation is strongly associated with pathogenic strains of 
H. pylori and is believed to induce cell suffering and eventually cell death (Papini et 
al., 1993b; de Bernard et al., 1998), resulting in a chronic inflammatory response in 
the gastric mucosa of the host (Papini et al., 1994). This study shows that although 
GGT does not have intrinsic vacuolating activity, it plays an important role alongside 
VacA in inducing vacuolation in gastric epithelial cells by hydrolyzing glutamine, 
yielding ammonia that strongly potentiates vacuole formation. Hence, this could be 
another reason as to why H. pylori with higher GGT activity is associated with more 
severe gastroduodenal diseases (Gong, 2006). 
 
5.5.4 Proposed mechanism of GGT-mediated H. pylori pathogenesis 
 In summary, it is proposed that H. pylori GGT influences cellular processes 
via several pathways as illustrated in Figure 63: (1) GGT generates ROS from GSH 
hydrolysis via thiol-dependent iron reduction. This in turn activates the NF-κB 
pathway, upregulates expression of the inflammatory chemokine IL-8 and induces 
DNA damage in host cells. (2) GGT is internalized by gastric epithelial cells via 
clathrin-mediated endocytosis where it then localizes to the cell nucleus in an 
importin β1-dependent manner. Subsequently, nuclear GSH is depleted by GGT, 
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making the cell more vulnerable to ROS insults which GGT itself produces via 
extracellular GSH hydrolysis. This redox imbalance may then lead to downstream 
effects such as DNA damage and apoptosis. (3) H. pylori secretes VacA which 
induces vacuolation in host cells. Through the generation of ammonia from glutamine 
hydrolysis, GGT (and to a lesser extent, urease) potentiates VacA-dependent 
vacuolation, resulting in additional stress on the cell. Taken together, GGT is a potent 
virulence factor that elicits multiple routes of damage in host cells.   
 
Figure 63. Proposed model outlining the roles of GGT in H. pylori pathogenesis. 
 
Apart from directly damaging gastric epithelial cells as evident from this 
study, production of the chemokine IL-8 by gastric epithelial cells (in response to 
GGT and other H. pylori factors) subsequently attracts immune cells such as 












































However, these innate immune defenses are not sufficient to clear the infection as H. 
pylori is able to evade phagocytosis and killing by these cells, leading to chronic 
inflammation and an increase in local tissue damage (Grebowska et al., 2008). In 
addition, GGT has also been reported to inhibit the proliferation of T cells (Schmees 
et al., 2007), hence playing an immunosuppressive role. Furthermore, GGT has been 
shown to induce expression of FoxP3 transcription factor (Fassi Fehri et al., 2010), a 
master regulator and marker of regulatory T cells. Regulatory T cells regulate the 
adaptive immune response by suppressing the immune responses of other immune 
cells and have been implicated to play an important role in H. pylori-related gastric 
carcinogenesis (Kandulski et al., 2010). Hence, GGT also plays a substantial role in 
modulating the immune response such that persistent infection by the bacterium and 
chronic inflammation can occur, both of which are important aspects in the 
development of gastroduodenal diseases and cancer (Coussens and Werb, 2002). 
 
5.6 GGT as a potential diagnostic marker for H. pylori infections 
 Various tests have been developed for detecting H. pylori infection and these 
can be broadly divided into invasive and non-invasive methods. Invasive tests include 
endoscopic examination and biopsy-based histology and culture of the organism. 
These tests are extremely reliable in detecting for H. pylori  (Gold et al., 2000) but are 
expensive and require expertise to carry out, hence they may not be the most 
appropriate method-of-choice under some clinical settings. Non-invasive methods, on 
the other hand, include urea breath test, stool antigen test and serology. These tests do 
not require the need for endoscopy and are hence more suitable for certain groups of 
patients (especially young children). In addition, tests such as serology are cheaper in 
cost and more convenient.  
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As GGT is both surface localized and secreted by H. pylori, it was 
investigated if H. pylori GGT could be a suitable candidate antigen for use in 
serodiagnosis. Using rGGT as antigen, the level of anti-GGT antibody was found to 
be significantly higher (P<0.01) in serum from H. pylori-positive patients compared 
to H. pylori-negative controls although relatively wide variations were observed 
among both groups of subjects (Figure 62). In addition, ELISA readings were 
comparatively high in serum from H. pylori-positive patients (0.98  0.39), indicating 
that H. pylori GGT is capable of inducing a relatively strong immune response during 
bacterial infection.  
Compared to whole cell antigens or ultrasonicates currently used in some H. 
pylori diagnostic tests (Hoang et al., 2004; Leal et al., 2008), purified rGGT antigen 
has the advantage of reducing the risks of non-specific binding and cross-reactivity to 
antigens of other species. This would result in increased specificity although 
sensitivity of the test may be slightly decreased (Hirschl et al., 1990). Other 
advantages of using rGGT as an antigen is that GGT is found in all H. pylori strains, 
is highly conserved within H. pylori species and shares only 22% protein sequence 
homology to human GGT (Chevalier et al., 1999), thus making it an ideal candidate 
for use in detecting H. pylori infections. In all, this study has uncovered the potential 
of using anti-GGT in patients’ sera to detect for H. pylori infections. Additionally, the 
strong association between H. pylori GGT activity and peptic ulcer disease (Gong, 
2006) leads us to speculate that the use of purified rGGT as an antigen may have a 
prognostic potential in identifying individuals at risk of developing severe gastric 






This study has demonstrated H. pylori GGT to be an important virulence 
factor of the bacterium. To this end, using purified nGGT and rGGT as well as 
various H. pylori isogenic constucts, three distinct findings were established as 
illustrated in Figure 63. Firstly, GGT was found to induce the generation of ROS, 
activate NF-κB, upregulate the production of IL-8 and induce oxidative DNA damage 
in gastric epithelial cells. This suggests that GGT contributes to the pro-inflammatory 
response of the host during H. pylori infection. Secondly, GGT was shown to be 
internalized through clathrin-mediated endocytosis and subsequently imported into 
the nuclei of gastric epithelial cells in an importin β1-dependent manner. This novel 
property of GGT results in the depletion of nuclear GSH, an important antioxidant 
present in host cells. Hence, it is evident that GGT not only generates ROS 
extracellularly, but also infiltrates into the host cell nucleus to decrease its antioxidant 
defence, potentially increasing the susceptibility of the cells to oxidant-mediated 
injury. Thirdly, GGT was also observed to strongly potentiate VacA-dependent 
vacuolation through the generation of ammonia from glutamine, thus provoking 
further stress on the host. As chronic inflammation, DNA damage and depletion of 
nuclear GSH are important cornerstones in carcinogenesis (Rakoff-Nahoum, 2006; 
Markovic et al., 2010; Kryston et al., 2011), it is hypothesized that GGT could play 
an imperative role in H. pylori-mediated gastric cancer. 
MAbs raised against rGGT were found to be potent inhibitors of H. pylori 
GGT enzymatic activity. Importantly, the neutralizing epitope was identified as 
GNPNLYG (residues 428-434) which is highly conserved in H. pylori GGT and 
spans a Tyr 433-containing loop critical for catalytic activity (Morrow et al., 2007). 
Neutralizing MAbs against GGT may help attenuate the virulence of the bacterium. 
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Thus, these MAbs could be humanized and further investigated as a possible future 
therapeutic approach against H. pylori. Being a surface-localized (this study) and 
secreted protein of H. pylori (Bumann et al., 2002), GGT was also found to induce a 
host immune response where a significantly higher anti-GGT antibody level was 
observed in H. pylori-positive subjects compared to H. pylori-negative controls 
(P<0.05). Thus the potential of rGGT in being a diagnostic marker for H. pylori 
infections could be further explored with a larger sample size so as to validate its 
practical use.  
 Taken together, the results from this work have conclusively shown that GGT 
is a critical virulence factor of H. pylori with pleiotropic effects. The enzyme is not 
only important for the pathogen’s own metabolism but also damages host cells 
through which more nutrients may be released for its benefit and survival in the 
hostile gastric environment. Intriguingly, the findings in this study provide new 
insights into the mechanisms underlying H. pylori pathogenesis where the pathogenic 
role of GGT should not be underrated. Given that all H. pylori strains express GGT 
(Chevalier et al., 1999) and are therefore all potentially able to cause disease, GGT 
should be considered as a promising target for the development of new therapeutic 
approaches in the management of H. pylori infection. 
 
5.8 Future work 
 As H. pylori GGT was found to be specifically recognized and subsequently 
internalized by gastric epithelial cells via clathrin-mediated endocytosis, it would be 
of great interest to identify the specific receptor(s) involved in this recognition in 
future studies. In addition, the exact molecular events underlying the route of GGT 
from the cell membrane to host cell nuclei have not been elucidated. For example, it is 
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currently not known how GGT, which is present in the endosome after endocytosis, is 
able to bind cytoplasmic importin β1 before being imported into the nucleus. One 
possibility could be that GGT-bearing endosomes may first fuse with Golgi, undergo 
retrograde transport to the endoplasmic reticulum (ER) and subsequently get extracted 
into the cytosol by the ER-associated degradation system as has been hypothesized for 
EGFR nuclear entry (Lo et al., 2006). Whether GGT indeed uses this pathway to 
escape from endosomes requires future extensive research. 
 It is also intriguing that despite a highly conserved GGT sequence (Chevalier 
et al., 1999), there exists substantial differences in GGT activity between different H. 
pylori strains (Gong and Ho, 2004). Hence, the underlying mechanism(s) governing 
regulation of GGT expression in H. pylori is another area of considerable interest. 
Few studies have examined this in detail although there is some evidence that 
expression of GGT may be regulated both at the transcriptional and post-
transcriptional levels (Tsao et al., 2009; Wachino et al., 2010). Understanding the 
mechanisms underlying its regulation would certainly shed more light into GGT-
mediated pathogenesis and could possibly lead to novel therapeutic approaches 
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Note: “qsp” stands for “quantité suffisante pour” or “quantity sufficient for”. 
Appendix 1 
Chocolate blood agar 
For a 500 ml preparation: 
Blood agar base No. 2 (Oxoid)    20.0 g 
Distilled water       475 ml 
Horse blood (Quad Five)     25 ml 
        
1. The blood agar base No. 2 and distilled water were mixed in a 500 ml bottle. 
2. The mixture was then autoclaved at 121°C for 20 minutes.  
3. The agar was cooled to 50°C before the horse blood was added aseptically. 
4. The blood was lysed by immersing the bottle containing the molten agar in an 
80°C water bath for 10 minutes with constant swirling.  
5. The chocolate blood agar was subsequently cooled to 50°C before pouring into 
sterile petri dishes (Sterilin). 
6. The plates were stored at 4°C until use.  
 
Appendix 2  
Medium for screening antibiotic resistant constructs 
 
Kanamycin stock (20 mg/ml) 
For a 10 ml preparation: 
Kanamycin (Sigma-Aldrich)     200 mg 




Chloramphenicol stock (15 mg/ml) 
For a 10 ml preparation: 
Chloramphenicol (Sigma-Aldrich)    150 mg 
Absolute ethanol (Merck)     10 ml (qsp) 
 
1. The respective antibiotic solutions were sterilized by filtering through a 0.22 µm 
filter (Millipore). 
2. They were then kept as 500 µl aliquots at -20°C until use. 
 
Chocolate blood agar + kanamycin (20 µg/ml) or chloramphenicol (15 µg/ml) 
For a 500 ml preparation: 
Blood agar base No. 2 (Oxoid)    20.0 g 
Distilled water       475 ml 
Horse blood (Quad Five)     25 ml 
        
1. The blood agar base No. 2 and distilled water were mixed in a 500 ml bottle. 
2. The mixture was then autoclaved at 121°C for 20 minutes.  
3. The agar was then cooled to 50°C before the horse blood was added aseptically. 
4. The blood was lysed by immersing the bottle containing the molten agar in an 
80°C water bath for 10 minutes with constant swirling.  
5. The chocolate blood agar was subsequently cooled to 50°C before addition of 500 
μl kanamycin (20 mg/ml) or 500 μl chloramphenicol (15 mg/ml) and poured into 
sterile petri dishes (Sterilin). 





Brain Heart Infusion broth with glycerol 
For a 300 ml preparation: 
Brain Heart Infusion (Oxoid)     11.4 g 
Yeast Extract (Oxoid)      1.2 g 
Glycerol       60 ml 
Distilled water       210 ml 
Horse serum (Gibco)      30 ml 
 
1. The brain heart infusion, yeast extract, glycerol and distilled water were mixed.  
2. The mixture was then autoclaved at 121°C for 20 minutes. 
3. The medium was cooled before 30 ml of horse serum was added.  
 
Appendix 4 
0.01 M Tris-EDTA (TE) buffer  
For a 1 litre preparation: 
Tris-base (Merck)      1.211 g 
EDTA (Sigma-Aldrich)     0.372 g 
Distilled water       1000 ml (qsp) 








Reaction mixture for PCR amplification 
For a 50 µl reaction mixture: 
50 ng genomic DNA (working stock of 10 ng/µl)  5 µl 
50 pmol primer (forward and reverse)   5 µl each 
1 unit Taq DNA polymerase (Finnzymes)    0.5 µl 
200 µM each of dATP, dGTP, dCTP, dTTP (Promega) 1 µl each 
10× incubation buffer (Finnzymes)    5 µl 
(10 mM Tris-HCl, 50 mM KCl, 2 mM MgCl2, 0.01% gelatin) 
Sterile distilled water       25.5 µl 
 
Appendix 6 
6 × DNA Loading buffer 
For a 100 ml preparation: 
Bromophenol blue (Bio-Rad)     0.2 g 
Xylene cyanol FF (Sigma-Aldrich)    0.2 g 
Glycerol (QRec)      60 ml 
EDTA (Sigma-Aldrich)     1.861 g 











For preparation of a 10 mg/ml stock solution: 
Ethidium bromide (Sigma-Aldrich)    100 mg 
Distilled water       10 ml (qsp) 
 
The solution was kept in the dark at room temperature until use.  
 
Appendix 8 
Tris-Acetate-EDTA (TAE) Buffer 
For a 1 litre 50 × TAE buffer preparation: 
Tris-base (Merck)      242.28 g 
Glacial acetic acid (Schedelco)    57.1 ml 
EDTA (Sigma-Aldrich)     37.22 g 
Distilled water       1000 ml (qsp) 
 
For a litre of 1× TAE buffer preparation: 











Polyacrylamide gel reagents 
 
Resolving gel buffer (1.5 M Tris-HCl, pH 8.8) 
Tris-base (Merck)      90.86 g 
Distilled water       500 ml (qsp) 
 
Stacking gel buffer (0.5 M Tris-HCl, pH 6.8) 
Tris-base (Merck)      30.29 g 
Distilled water       500 ml (qsp) 
 
10% Ammonium persulphate (APS) 
Ammonium persulphate (Bio-Rad)    0.5 g 
Distilled water       5 ml (qsp) 
Only freshly-prepared APS solution was used. 
 
The resolving and stacking gels were prepared as follows: 
Resolving gel (12%) 
For 1 gel (8.5 cm by 7.5 cm): 
Resolving gel buffer      2.5 ml 
40% acrylamide (Bio-Rad)     3.0 ml 
10% SDS (Merck)      100 µl 
TEMED (MP Biochemicals)     5 µl 
10% APS (Bio-Rad)      50 µl 
Distilled water       4.35 ml 
Appendices 
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Stacking gel (4%) 
For 1 gel (8.5 cm by 7.5 cm): 
Stacking gel buffer      1.26 ml 
40% acrylamide (Bio-Rad)     0.5 ml 
10% SDS (Merck)      50 µl 
TEMED (MP Biochemicals)     5 µl 
10% APS (Bio-Rad)      25 µl 
Distilled water       3.18 ml 
 
Appendix 10 
5 × Reducing Loading Buffer 
For a 10 ml preparation: 
SDS (Merck)       1  g 
1 M Tris (pH 6.8) (Merck)     1.563 ml 
β-mercaptoethanol (Sigma-Aldrich)    1.25 ml 
Glycerol (QRec)      2.5 ml 
Bromophenol blue (Bio-Rad)     2.5 mg 
Distilled water       10 ml (qsp) 
 









SDS-PAGE Running Buffer 
For 1 litre of 10 × SDS-PAGE running buffer: 
Tris-base (Merck)      30.3 g 
Glycine (Fisher Scientific)     150.14 g 
SDS (Merck)       10 g 
Distilled water       1000 ml (qsp) 
 
Appendix 12 
Coomassie blue solution (R-250) 
Coomassie Blue R-250 (Bio-Rad)    0.6 g 
Methanol (Schedelco)      250 ml 
Glacial acetic acid (Schedelco)    50 ml 




Methanol (Schedelco)      400 ml 
Glacial acetic acid (Schedelco)    100 ml 









LB (Luria-Bertani) Medium 
For a 1 litre preparation: 
Tryptone (Oxoid)      10 g 
Yeast extract (Oxoid)      5 g 
NaCl (Sigma-Aldrich)     10 g 
Distilled water       1000 ml (qsp) 
 
1. The solution was adjusted to pH 7.2 with 5 M NaOH. 
2. The mixture was then autoclaved at 121°C for 20 minutes. 
 
Appendix 15 
LB (Luria-Bertani) Agar plate 
For a 1 litre preparation: 
Agar Technical (Agar No. 3) (Oxoid)   12 g 
LB medium        1000 ml (qsp) 
 
1. The mixture was then autoclaved at 121°C for 20 minutes. 
2. It was then cooled to 50°C before pouring into sterile petri dishes.  








Ampicillin Stock (50 mg/ml) 
For a 10 ml preparation: 
Ampicillin (sodium salt) (Sigma-Aldrich)   500 mg 
Distilled water       10 ml (qsp) 
 
1. The solution was sterilized by filtering through a 0.22 µm filter (Millipore). 
2. It was then kept as 500 µl aliquots at -20°C until use. 
 
LB + Ampicillin (50 µg/ml) Agar Plate 
For a 1 litre preparation: 
AgarTechnical (Agar No. 3) (Oxoid)    12 g 
LB medium       1000 ml (qsp) 
 
1. The mixture was then autoclaved at 121°C for 20 minutes. 
2. It was then cooled to 50°C before 1 ml of ampicillin (50 mg/ml) was added.  













For a 200 ml preparation: 
CaCl2.6H2O (Merck)      43.82 g 
Distilled water       200 ml (qsp) 
 
1. The solution was sterilized by filtering through a 0.22 µm filter (Millipore). 
2. It was then kept as 10 ml aliquots at -20°C until use. 
3. When using, dilute with 90 ml of distilled water, filter through 0.45 µm filter 
(Millipore) and keep on ice.  
 
Appendix 18 
100 mM Isopropyl-β-D-thiogalactoside (IPTG) stock 
IPTG (Bio-Rad)      0.24 g 
Distilled water       10 ml (qsp) 
 
Dispense into 1 ml aliquots and store at -20ºC. 
 
X-galactosidase (X-Gal) (20 mg/ml)  
5-bromo-4-chloro-3-indolyl-ß-D-galactoside (Bio-Rad) 20 mg 
Dimethylformamide (Sigma-Aldrich)   1 ml 
 




LB + Ampicillin (50 µg/ml) + IPTG + X-Gal plate 
On a LB + Ampicillin agar plate (Appendix 16), add: 
100 mM IPTG (Bio-Rad)     40 µl 
20 mg/ml X-Gal (Bio-Rad)     40 µl 
 
Spread with a spreader and incubate at 37ºC for 30 minutes. 
 
Appendix 19 
Phosphate buffered saline (PBS) 
For 1 litre of 10 × PBS preparation: 
NaCl (Sigma-Aldrich)     80 g 
KH2PO4 (Merck)      2.4 g 
Na2HPO4.2H2O (Merck)     14.4 g 
KCl (Merck)       2 g 
Distilled water       1000 ml (qsp) 
The solution was adjusted to pH 7.4 before use. 
 
Appendix 20 
His-tag affinity chromatography buffers 
(A) 8 × Binding buffer 
Imidazole (Sigma-Aldrich)     1.36 g 
NaCl (Sigma-Aldrich)     116.88 g 
Tris-base (Merck)      9.69 g 
Distilled water        500 ml (qsp) 
pH was adjusted to 7.9 using 5N HCl. 
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(B) 8 × Charge buffer 
NiSO4.6H2O (Merck)      52.57 g 
Distilled water        500 ml (qsp) 
 
(C) 8 × Wash buffer 
Imidazole (Sigma-Aldrich)     16.34 g 
NaCl (Sigma-Aldrich)     116.88 g 
Tris-base (Merck)      9.69 g 
Distilled water       500 ml (qsp) 
pH was adjusted to 7.9 using 5N HCl. 
 
(D) 4 × Elute buffer 
Imidazole (Sigma-Aldrich)     27.23 g 
NaCl (Sigma-Aldrich)     11.69 g 
Tris-base (Merck)      0.97 g 
Distilled water       100 ml (qsp)  
pH was adjusted to 7.9 using 5N HCl. 
 
(E) 4 × Strip buffer 
EDTA (Sigma-Aldrich)     14.89 g 
NaCl (Sigma-Aldrich)     11.69 g 
Tris-base (Merck)      0.97 g 
Distilled water        100 ml (qsp) 





GGT activity assay reagents 
 
 (A) Assay buffer solution 
Tris-base (Merck)      1.21 g 
Distilled water       100 ml 
The solution was adjusted to pH 8.0 before use. 
 
(B) Donor substrate solution (γ-glutamyl-ρ-nitroanilide) 
γ-glutamyl-ρ-nitroanilide (Sigma-Aldrich)   80 mg 
1M HCl (VWR)      1 ml 
Distilled water       19 ml 
 
1. The substrate was dissolved at room temperature by stirring. 
2. 30 ml distilled water was added and pH was adjusted to 8.0 using  
0.05-0.1 g Tris base. 
3. Distilled water was further added to a final volume of 60 ml. 
4. Solution was aliquoted and stored at -20°C until use. 
 
(C) Acceptor solution (Glycyl-glycine) 
Glycyl-glycine (Sigma-Aldrich)    0.66 g 
Distilled water       50 ml 






Lysis buffer for H. pylori 
For a 100 ml preparation: 
Tris-base (pH 7.5) (Merck)      0.606 g 
NaCl (Sigma-Aldrich)     0.584 g 
Glycerol (QRec)      10 ml 
Triton-X 100 (Bio-Rad)     1 ml 
Distilled water       100 ml (qsp) 
 
Appendix 23 
Coating buffer (0.1 M Sodium carbonate, pH 9.5) 
NaHCO3 (Sigma-Aldrich)     7.13 g 
Na2CO3 (Merck)      1.59 g 
Distilled water       1000 ml (qsp) 
 
Appendix 24 
PBS-Tween buffer (0.05%) 
For a 1 litre preparation: 
Tween 20 (Merck)      0.5 ml 








Appendix 25  
Western blot transfer buffer (pH 9.2) 
For a litre of 1 × transfer buffer: 
Tris-base (Merck)      3 g 
Glycine (Fisher Scientific)     14.4 g 
Methanol (Schedelco)      200 ml 
Distilled water       1000 ml (qsp) 
 
Appendix 26  
CNBr affinity chromatography reagents 
(A) Coupling buffer 
NaHCO3 (Sigma-Aldrich)     0.84 g 
NaCl (Sigma-Aldrich)     2.922 g 
Distilled water       100 ml (qsp) 
Solution was adjusted to pH 8.3 before use. 
 
(B) Blocking buffer 
Tris-base (Merck)      1.21 g 
Distilled water        100 ml (qsp) 
Solution was adjusted to pH 8.0 before use. 
 
(C) Elution buffer 
Glycine (Fisher Scientific)     0.375 g 
Distilled water       100 ml (qsp) 
Solution was adjusted to pH 2.5 before use. 
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(D) Neutralization buffer 
Na2HPO4 (Merck)      3.55 g 
Distilled water       100 ml (qsp) 
Solution was adjusted to pH 10.3 before use. 
 
Appendix 27 
Urease Reagent (pH 6.8) 
For a 500 ml preparation: 
Urea (Bio-Rad)      10 g 
NaH2PO4.H2O (Merck)     0.22 g 
Na2HPO4 (Merck)      0.51 g 
Phenol Red (Sigma-Aldrich)     750 µl 
Distilled water       500 ml (qsp) 
 
1. Urea, NaH2PO4.H2O, Na2HPO4 and distilled water were mixed and adjusted to pH 
6.8. 
2. The solution was sterilized by filtration through a 0.22 µm filter (Millipore).  
3. Phenol red that was sterilized by autoclaving at 121°C for 20 minutes was then 
added to the filtrate.  
4. The reagent was stored at 4°C until use.  
 
During testing, 0.5 ml of the culture was added to 0.5 ml of urease test reagent. A 






Growth medium for AGS cells 
For a 1 litre preparation: 
Nutrient Mixture F-12 Ham Kaighn's Modification  11.3 g 
NaHCO3 (Sigma-Aldrich)     1.17 g 
Fetal calf serum (HyClone)     100 ml 
Nanopure water       1000 ml (qsp) 
 




Growth medium for HeLa cells and primary human macrophages 
For a 1 litre preparation: 
RPMI-1640 (Invitrogen)     890 ml 
L-glutamine (200 mM) (Gibco)    10 ml    
Fetal calf serum (HyClone)     100 ml 
 
1. Fetal calf serum was filtered through a 0.22 µm filter (Millipore).  









Growth medium for primary human gastric epithelial cells 
(A) Leibovitz’s L-15 medium 
Leibovitz’s L-15 (Sigma-Aldrich)    98 ml 
Penicillin/Streptomycin (Gibco)    1 ml 
Fungizone/Amphotericin B (Gibco)    1 ml 
 
(B) Coating solution 
Fibronectin (1 mg/ml) (Gibco)    1 ml 
Type I rat tail collagen (5 mg/ml) (Gibco)   1 ml 
BSA (1 mg/ml) (Merck)     1 ml  
Leibovitz’s L-15 medium (Gibco)    100 ml (qsp) 
 
(C) Enzymatic isolation of gastric cells 
Collagenase Type II (Gibco)     87 mg 
Dispase (Gibco)      68.5 mg 
Trypsin Inhibitor (Gibco)     1 mg 
BSA (Merck)       125 mg 
Leibovitz’s L-15 medium      100 ml (qsp) 
 
(D) Growth medium for primary gastric cells 
Nutrient Mixture F-12 Ham Kaighn's Modification  88 ml 
Fetal calf serum (HyClone)     10 ml 
Penicillin/Streptomycin (Gibco)    1 ml 




Cytosolic and nuclear protein extraction buffers 
 
(A) Buffer A 
HEPES (Sigma-Aldrich)     240 mg 
KCl (Merck)       70 mg 
EDTA (Sigma-Aldrich)     3.7 mg 
MgCl2 (Merck)      31 mg 
Tween 20 (Sigma-Aldrich)     0.2 ml 
DTT (Bio-Rad)      15.42 mg                  
PMSF (Merck)      8.71 mg 
Distilled water       100 ml (qsp) 
 
(B) Buffer C 
HEPES (Sigma-Aldrich)     480 mg 
NaCl (Sigma-Aldrich)     2.3 g 
EDTA (Sigma-Aldrich)     3.7 mg 
MgCl2 (Merck)      31 mg 
Glycerol (QRec)      25 ml 
DTT (Bio-Rad)      15.42 mg 
PMSF (Merck)      8.71 mg 







Cell Lysis buffer 
For a 100 ml preparation: 
Tris-base (pH 7.5) (Merck)     0.606 g 
NaCl (Sigma-Aldrich)     0.584 g 
Glycerol (QRec)      10 ml 
Triton-X 100 (Bio-Rad)     1 ml 
Protease inhibitor (Roche)     10 tablets 
Distilled water        100 ml (qsp) 
 
Appendix 33 
MTT assay reagents 
 
(A) MTT [3-(4, 5- dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide] stock 
solution 
MTT (Sigma-Aldrich)                                                             25 mg 
PBS buffer (pH 7.4)                                                      5 ml 
 
The solution was filter sterilized and stored at 4°C. 
 
(B) Lysis solution 
SDS (Merck)                                                                           10 g 
Dimethyl sulfoxide (MP Biomedicals)                    99.4 ml 





Neutral red dye uptake assay reagents 
 
(A) BSA-PBS solution (0.3% w/v) 
BSA (Merck)       0.3 g 
PBS buffer (pH 7.4)      100 ml 
 
(B) Neutral red dye solution (0.05% w/v) 
Neutral red (BDH Chemicals)    0.05 g 
BSA-PBS solution (0.3% w/v)    100 ml 
 
The solution was filtered through a 0.22 µm filter before use. 
 
(C) Neutral red dye extraction solution 
Ethanol (Sigma-Aldrich)     70 ml 
HCl (37%) (VWR)      1 ml 












Live-cell imaging of H. pylori-infected AGS cells 
 
Video 1. AGS cells infected with H. pylori wild type for 24 hours. 
 
Video 2. AGS cells infected with H. pylori Δggt for 24 hours. 
 
Video 3. Uninfected AGS cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
